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Abstract 
Cellular senescence, the irreversible loss of replicative capacity of somatic cells, has 
been associated with diseases of accelerated lung ageing, including Chronic Obstructive 
Pulmonary Disease (COPD). However, the mechanisms underlying senescence of 
airway epithelial cells, particularly the role of telomere dysfunction in this process, are 
poorly understood. The aim of this work was to investigate senescence and telomere 
dysfunction in airway epithelial cells from patients with COPD and bronchiectasis, in 
the ageing murine lung and in the context of cigarette smoke exposure. DNA damage 
foci (γH2A.X) and foci associated with telomeres (telomere-associated foci (TAF)), 
along with other senescence-associated markers, were increased in small airway 
epithelial cells from patients with COPD, without significant telomere shortening. With 
age, TAF increased in large and small airway epithelial cells of the murine lung and 
predicted age-dependent lung emphysema, independently of telomere length. Moreover, 
fourth generation telomerase-null mice showed early-onset emphysema. Exposure to 
cigarette smoke was found to increase TAF in large and small airway epithelial cells of 
the murine lung and in epithelial cells and fibroblasts in vitro. Cigarette smoke may 
accelerate telomere dysfunction via reactive oxygen species (ROS) and contribute to 
Ataxia telangiectasia mutated (ATM)-dependent secretion of pro-inflammatory 
cytokines interleukin (IL)-6 and IL-8. Inhibition of mechanistic target of rapamycin 
complex 1 (mTORC1) by rapamycin alleviated age-associated increases in TAF in vivo 
and supressed cigarette smoke-induced increases in TAF and inflammatory cytokine 
release in vitro. Cigarette smoke increases mitochondrial-derived ROS, which is 
supressed by culturing cells at low oxygen pressure and by treating cells with rapamycin. 
These results suggest that activation of a DNA damage response at telomeres may be 
induced by oxidative stress from altered mTOR signalling and/or dysfunctional 
mitochondria. Telomere dysfunction could contribute to inflammatory processes and the 
functional decline that occurs in the ageing lung and in the context of cigarette smoke-
induced accelerated lung ageing.  
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Chapter 1. Introduction  
1.1 Cellular senescence  
Cellular senescence is classically defined as the irreversible loss of division potential in 
somatic cells (Campisi and d'Adda di Fagagna 2007). Hayflick and Moorehead first 
described cellular senescence more than 50 years ago when they observed that normal 
human diploid fibroblasts irreversibly lost the ability to divide in culture following 
extensive passaging (Hayflick and Moorhead 1961). These cells remained viable for 
prolonged periods of time in culture but failed to proliferate even in the presence of 
ample space, nutrients and growth factors. This form of senescence was termed 
“replicative senescence”.  Subsequently, other groups found that senescence could 
occur prior to the onset of replicative senescence, which is known as “stress-induced 
premature senescence” or SIPS (Kuilman, Michaloglou et al. 2010). Two hypotheses 
were made following these observations. The first hypothesis, based on the fact that 
transformed cells proliferate indefinitely in culture, was that cellular senescence acts as 
an anti-cancer or tumour suppressive mechanism. The second hypothesis stemmed from 
the knowledge that repair and regeneration of tissues declines with age, thus it was 
suggested that cellular senescence recapitulates cellular ageing in vivo (Hayflick 1965). 
Therefore senescence was considered to be both beneficial and deleterious in vivo: on 
the one hand, protecting organisms against cancer yet on the other hand contributing to 
age-dependent tissue dysfunction. The concept that cellular senescence can be both 
beneficial and harmful to organisms can be explained by an evolutionary theory of 
ageing: antagonistic pleiotropy (Williams 1957; Campisi 2003). Antagonistic pleiotropy, 
in the ageing context, suggests that senescence is beneficial to young organisms by 
acting as a tumour suppressor mechanism and therefore promoting survival. However, 
the senescence process, which is retained into later life, becomes detrimental to older 
organisms as senescent cells accumulate with age and contribute to age-related 
deterioration. There is now considerable evidence that senescence is a potent anti-
cancer mechanism (Campisi 2001; Dimri 2005) and mounting evidence implicates 
senescence in the ageing process (Campisi 2013; van Deursen 2014). In fact, cellular 
senescence is now accepted as a cellular hallmark of ageing (Lopez-Otin, Blasco et al. 
2013). Additionally, it is becoming increasingly recognised that senescence is important 
for many other diverse biological processes, including wound healing, tissue repair and 
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embryonic development (Krizhanovsky, Yon et al. 2008; Jun and Lau 2010; Munoz-
Espin, Canamero et al. 2013; Storer, Mas et al. 2013). 
 
1.2 Causes of cellular senescence 
Cellular senescence can be induced by a range of different stimuli (Campisi and d'Adda 
di Fagagna 2007; Kuilman, Michaloglou et al. 2010), which will be described in detail 
in the following sections.  
1.2.1 Telomere dysfunction  
Telomeres are specialised structures at the ends of chromosomes consisting of repetitive 
DNA (5’-TTAGGG-3’) repeats, which function mainly to protect the ends of linear 
chromosomes from erosion or fusion by DNA repair processes (Blackburn 1991; 
d'Adda di Fagagna, Teo et al. 2004). Telomeric repeats are reduced during each S-phase 
due to the so called “end-replication problem” – the inability of standard DNA 
polymerases to synthesise DNA in a 3’-5’ direction leading to incomplete replication of 
the lagging strand and progressive telomere shortening, which was predicted to explain 
Hayflick’s observations of finite cell division in cells grown in culture (Olovnikov 1971; 
Watson 1972). It was later demonstrated that telomeres do in fact shorten with serial 
passaging, however it was unknown whether telomere shortening was causal in 
replicative senescence (Harley, Futcher et al. 1990).  This was confirmed when it was 
shown that ectopic expression of the catalytic subunit of telomerase, the enzyme 
responsible for maintaining telomere length, in normal human cells prevents telomere 
shortening and senescence (Bodnar, Ouellette et al. 1998). Telomeres are stabilised by a 
complex of proteins, known as shelterin (de Lange 2005). Six proteins constitute 
shelterin: telomeric repeat-binding factor 1 (TRF1), TRF2 and protection of telomeres 
protein 1 (POT1), which recognise the telomere repeat sequence, and TERF1-
interacting nuclear factor 2 (TIN2), Tripeptidyl peptidase 1 (TPP1) and telomeric 
repeat-binding factor 2-interacting protein 1 (RAP1) (de Lange 2005), which arrange 
mammalian telomeres into a loop structure, known as the T-loop, to protect 
chromosome ends (Griffith, Comeau et al. 1999). During replicative senescence the 
progressive loss of telomere repeats destabilises T-loops and consequently increases the 
probability of telomere uncapping i.e. loss of shelterin (Griffith, Comeau et al. 1999). 
Telomere uncapping due to telomere shortening, has been shown to trigger a classical 
DNA damage response (DDR) similar to double-strand breaks (DSBs), leading to arrest 
of cell-cycle progression (d'Adda di Fagagna, Reaper et al. 2003; Takai, Smogorzewska 
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et al. 2003; Herbig, Jobling et al. 2004). Telomere shortening is not solely a result of the 
end-replication problem, evidenced by the observations that telomere length is very 
heterogeneous between cells in the same culture and senescent cells isolated from 
young cultures can have short telomeres (Lansdorp, Verwoerd et al. 1996; Martin-Ruiz, 
Saretzki et al. 2004). This suggests that replicative senescence can be stress-dependent. 
Accordingly, it is known that telomeres are more sensitive to oxidative stress, acquiring 
oxidative single-strand damage at a much faster rate than the bulk of the genome 
(Petersen, Saretzki et al. 1998). This is possibly due to the fact that telomere repeats 
contain guanine triplets (Henle, Han et al. 1999), which are particularly sensitive to 
oxidative modifications, and that repair of single-strand breaks (SSBs) is less efficient at 
telomeres (Petersen, Saretzki et al. 1998). Thus, telomeres enter DNA replication with 
higher frequencies of SSBs compared to the rest of the genome, which contributes 
significantly to telomere erosion (von Zglinicki, Saretzki et al. 1995). In accordance, it 
has been demonstrated that chronic, low-grade oxidative stress shortens telomeres and 
reduces replicative lifespan, whereas overexpression of anti-oxidant enzymes or the use 
of free-radical scavengers reverses it (von Zglinicki, Pilger et al. 2000; von Zglinicki 
2002; Serra, von Zglinicki et al. 2003). Additionally, low oxygen has been shown to 
extend replicative lifespan and reduce telomere shortening rates in human fibroblasts by 
decreasing reactive oxygen species (ROS) generation (Richter and von Zglinicki 2007). 
Mitochondrial-derived oxidative stress is thought to contribute to telomere dysfunction 
(Passos, Saretzki et al. 2007). It was shown that anti-oxidants selectively targeted to the 
mitochondria counteract telomere shortening and increase lifespan of fibroblasts under 
mild oxidative stress (Saretzki, Murphy et al. 2003). Similarly, treatments with agents 
that affect mitochondrial ROS generation extend lifespan and decelerate telomere 
shortening (Kang, Lee et al. 2006). Additionally, mild chronic uncoupling of 
mitochondria improves telomere maintenance and extends telomere-dependent lifespan 
due to a reduction in mitochondrial ROS generation (Passos, Saretzki et al. 2007). 
Overall, these data suggest that telomere shortening occurs due to the end-replication 
problem in combination with other factors, such as oxidative stress-induced damage.  
Telomere dysfunction is not only contributed to by telomere shortening. Our 
group recently demonstrated that genotoxic and oxidative damage induces a DDR at 
both genomic and telomeric regions (referred to as telomere associated DNA damage 
foci or TAF) and this damage occurs irrespectively of telomerase expression (Hewitt, 
Jurk et al. 2012). Additionally, it was observed that TAF increase in the murine gut and 
liver with age but there was no significant difference found between telomere length 
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distributions in TAF and non-TAF, suggesting that telomere length is not the sole 
defining factor in TAF induction (Hewitt, Jurk et al. 2012). Similarly, in a murine 
model for chronic-inflammation where the ageing process is accelerated, telomere 
dysfunction was not associated with shortened telomere length (Jurk, Wilson et al. 
2014). Furthermore, our lab demonstrated that while the great majority of DDR foci 
were resolved soon after their formation, TAF were relatively long-lived (Hewitt, Jurk 
et al. 2012). These data were independently confirmed by d’Adda di Fagagna’s group 
(Fumagalli, Rossiello et al. 2012). Additionally, the authors show that DDR activation 
at telomeres is not associated with loss of TRF2 or telomere shortening. The authors 
suggest that this persistence of DNA damage foci at telomeres occurs because telomeres 
resist DNA-damage repair. Consistent with this notion, the authors demonstrated that 
DSBs induced in budding yeast failed to be repaired when next to telomere repeats due 
to the supressed recruitment of ligase IV, the enzyme responsible for DNA ligation in 
non-homologous end joining (NHEJ) (Fumagalli, Rossiello et al. 2012). These findings 
are supported by earlier reports demonstrating that ligase IV-mediated NHEJ is 
inhibited at telomeres by components of the shelterin complex, such as TRF2, as a 
mechanism of preventing end-to-end fusions (Smogorzewska and de Lange 2002; Bae 
and Baumann 2007). Similarly, it was shown that loss of TRF2 contributes to the 
activation of a DDR at telomeres and senescence (van Steensel, Smogorzewska et al. 
1998). Cesare et al. have proposed a three-state model of telomere-end protection. In 
this model, the ‘closed state’ is a telomere-length dependent structure (likely the T-loop) 
that protects chromosome ends against a DDR. The ‘intermediate state’ is suggested to 
offer partial protection: a DDR is induced at telomeres but sufficient shelterin is bound 
to prevent end-to-end fusions. The ‘uncapped state’ is both DDR positive and fusogenic 
and might result from insufficient shelterin binding (i.e. telomere uncapping) (Cesare, 
Kaul et al. 2009). Thus, telomeres that contribute to persistent DDR signalling and 
senescence are likely in the intermediate state and have sufficient shelterin still bound. 
In accordance, it has been demonstrated that during replicative senescence of human 
fibroblasts, DDR positive telomeres retain TRF2 and its binding partner RAP1 and are 
not associated with end-to-end fusions (Kaul, Cesare et al. 2012).  
Taken overall, this suggests that telomere dysfunction, whether due to telomere 
shortening or damage at longer telomeres, fuels persistent DDR signalling. This 
highlights the importance of telomeres in both replicative senescence and in SIPS, in 
response to a variety of stresses (Suram and Herbig 2014).  
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1.2.2 Non-telomeric DNA damage-induced senescence   
Senescence that occurs prior to the stage at which it is induced by telomere shortening is 
known as SIPS (Kuilman, Michaloglou et al. 2010), which can be induced by telomeric 
or non-telomeric DNA damage. Genomic DNA damage occurring at non-telomeric sites, 
if severe enough, may also generate the persistent DDR signalling needed for 
senescence growth arrest (Nakamura, Chiang et al. 2008). Damage that induces DSBs is 
usually acute and severe, such as ionizing radiation, and is especially potent at inducing 
senescence (Di Leonardo, Linke et al. 1994). Many chemotherapeutic drugs, such as 
bleomycin, cause severe DNA damage and induce senescence in normal cells (Robles 
and Adami 1998). Furthermore, they also induce senescence in tumour cells both in 
vitro and in vivo, a phenomenon known as drug-induced senescence that may be 
exploited as a cancer therapy (Schmitt, Fridman et al. 2002; te Poele, Okorokov et al. 
2002; Roninson 2003). Chronic oxidative stress of low intensity mainly generates 
oxidative base modifications and base excision repair intermediates, i.e. SSBs. 
Exposure to hyperoxia, which produces genotoxic ROS, has been shown to cause both 
SSBs and DSBs, which may induce a persistent DDR and cellular senescence (Roper, 
Mazzatti et al. ; Helt, Cliby et al. 2005). 
1.2.3 Oncogene-induced senescence  
Oncogenes may also trigger a robust DDR leading to senescence induction, termed 
oncogene-induced senescence (OIS). Oncogenes are mutant versions of normal genes 
that, in conjunction with other mutations, have the potential to transform cells. OIS was 
first observed when an oncogenic form of RAS, a transducer of mitogenic signals, was 
expressed in normal human fibroblasts. Serrano and colleagues noted the striking 
resemblance between these cells and those that had undergone replicative senescence 
(Serrano, Lin et al. 1997). Other members of the RAS signalling pathway were later 
implicated in OIS, including RAF, MEK, MOS and BRAF, as well as pro-proliferative 
nuclear proteins (such as E2F-1) when overexpressed or expressed as oncogenic 
versions (Lin, Barradas et al. 1998; Zhu, Woods et al. 1998; Dimri, Itahana et al. 2000; 
Michaloglou, Vredeveld et al. 2005). Evidence suggests that OIS results from 
oncogene-induced DNA hyper-replication, which leads to prematurely terminated 
replication forks and DNA damage, such as DSBs, ultimately triggering a DDR 
(Bartkova, Rezaei et al. 2006; Di Micco, Fumagalli et al. 2006). Experimental 
downregulation of this DDR prevents senescence and allows cells that have become 
senescent in response to RAS to re-enter the cell-cycle, demonstrating that it has a 
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causal role in both initiation and maintenance of OIS (Bartkova, Rezaei et al. 2006; Di 
Micco, Fumagalli et al. 2006). Interestingly, it has recently been shown that oncogenes 
can cause transient non-telomeric and persistent telomeric DDR foci in somatic human 
cells, leading to senescence (Suram, Kaplunov et al. 2012). This suggests that OIS is not 
telomere-independent and its stability could be due to telomeric DNA damage being 
irreparable.  Thus, similar to replicative and SIPS, OIS may also result from activation 
of a DDR triggered by DNA damage. In contrast, some forms of OIS are DDR 
independent, such as senescence caused by E2F-3 or BRAF activation (Lazzerini 
Denchi, Attwooll et al. 2005; Kaplon, Zheng et al. 2013). Either way, OIS seems to be a 
mechanism to counteract excessive mitogenic stimulation from oncogenes that induce 
cell growth, which would otherwise put cells at risk of malignant transformation.  
1.2.4 Senescence caused by chromatin perturbation  
Chromatin organisation, either compressed (heterochromatin) or loosely configured 
(euchromatin), determines the extent to which genes are active or silent and depends on 
histone modifications, such as methylation and acetylation. Generally, heterochromatin 
is associated with gene silencing, whereas euchromatin is associated with active 
transcription. Chromatin decompression by exposure to inhibitors of histone 
deacetylases (HDAi) has been shown to induce senescence (Ogryzko, Hirai et al. 1996; 
Munro, Barr et al. 2004). The mechanisms by which this occurs are poorly understood 
and may depend on species and cell type. One study demonstrated that human cells 
deficient in the cell-cycle inhibitor p16 were resistant to HDAi-induced senescence, 
suggesting that that the p16
INK4A
-pRb pathway is a major mediator of HDAi-induced 
senescence (Munro, Barr et al. 2004). In contrast, pathways involving the cell-cycle 
inhibitor p21 are important for HDAi-induced senescence of mouse embryonic 
fibroblasts (Romanov, Abramova et al. 2010). Genetic overexpression of Sirtuin 1 
(SIRT1), a nicotinamide adenine dinucleotide (NAD)-dependent HDAC involved in 
many biological processes, protects against SIPS (Yao, Chung et al. 2012).  The finding 
that HDAi causes senescence is surprising and contradictory to the belief that global 
induction of heterochromatin contributes to the stability of the senescent state (Howard 
1996). These distinct heterochromatic structures that accumulate in senescent cells, 
designated senescence-associated heterochromatic foci (SAHF), are associated with the 
stable repression of E2F target genes required for cell-cycle progression (Narita, Nunez 
et al. 2003). This suggests that senescence can be induced by both heterochromatin 
disruption and formation, a paradox that could be explained by the notion that both 
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events cause extensive but incomplete changes in chromatin structure and may alter the 
expression of different critical genes (Campisi and d'Adda di Fagagna 2007).  
1.2.5 Other inducers of senescence  
Prolonged exposure to anti-proliferative cytokines, such as interferon-β, induces 
senescence by increasing intracellular ROS leading to activation of a DDR (Moiseeva, 
Mallette et al. 2006). Similarly, pro-inflammatory mediators released by senescent cells 
may induce senescence in nearby cells (Acosta, Banito et al. 2013). Senescence can also 
occur without detectable DDR signaling. “Cell-culture stress” occurs naturally in vitro 
and induces senescence without significant telomere erosion. The causes are unknown 
but could include inadequate growth conditions (Ramirez, Morales et al. 2001). Cells 
may also senesce without a DDR by inactivation of various tumour suppressors. For 
example, inactivation of the tumour suppressor phosphatase and tensin homolog deleted 
on chromosome 10 (PTEN) rapidly induces DDR-independent senescence (Alimonti, 
Nardella et al. 2010). Additionally, ectopic expression of the cyclin-dependent kinase 
(CDK) inhibitors (CDKi) p16 and p21 induces several aspects of the senescence 
phenotype in young human diploid fibroblasts without an obvious DDR (McConnell, 
Starborg et al. 1998). Overall, a myriad of senescence-inducing stimuli have, and are 
still being, identified and may act through the DDR or independently. 
1.3 Signalling pathways activated in senescence 
Although there are many senescence-inducing stimuli, the senescent cell-cycle arrest is 
established and maintained by two main pathways: the p53-p21 and p16
INK4A
-pRb 
tumour suppressor pathways (Figure 1.1) (Campisi and d'Adda di Fagagna 2007).  
1.3.1 The DNA damage response 
The DDR can be triggered by both telomeric and non-telomeric DNA damage, 
including SSBs and DSBs. Three phosphatidylinositol 3-kinase (PI3K)-like protein 
kinases (PI3KKs) are known to function as the primary transducers of DDR signalling: 
ataxia-telangiectasia mutated (ATM), ATM and Rad3-related (ATR), and DNA-
dependent protein kinase (DNA-PK) (Shiloh 2003). ATM plays a primary role in 
responding to DSBs, whereas ATR is known to be strongly activated by single-stranded 
DNA. Nevertheless, ATM and ATR kinase specificities are closely related and their 
signalling pathways share many components. DNA-PK is recruited to DSBs and plays a 
role in the NHEJ repair pathway (Shiloh 2003). 
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DSBs are initially sensed by poly (ADP-ribose) polymerase (PARP) which then 
recruits the MRE11–RAD50–NBS1 (MRN) complex. The PARP-MRN complex is one 
of the first factors to be localised to the DNA lesion and enables the assembly of large 
macromolecular complexes, known as foci, that facilitate repair responses (D'Amours 
and Jackson 2002; van den Bosch, Bree et al. 2003). NSB1 then recruits ATM (Uziel, 
Lerenthal et al. 2003; Lee and Paull 2005). ATM then undergoes autophosphorylation, 
leading to dissociation of the inactive ATM dimer producing active monomers with 
kinase activity (Bakkenist and Kastan 2003). Active ATM then phosphorylates a host of 
factors, including the histone variant H2A.X at serine 139 forming phosphorylated 
H2A.X (γH2A.X) at the site of damage (Rogakou, Pilch et al. 1998; Rogakou, Boon et 
al. 1999; Burma, Chen et al. 2001). Phosphorylated H2A.X is recognised by a phospho-
specific domain of the mediator of DNA damage checkpoint 1 (MDC1). Recruitment of 
MDC1 stimulates further accumulation of the MRN complex, amplifying local ATM 
activation and the spreading of γH2A.X along the chromatin from the site of damage 
(Stucki and Jackson 2006). Phosphorylation of H2A.X spans for megabases around the 
DSB and corresponds to thousands of nucleosomes, forming the so-called nuclear foci 
(Rogakou, Boon et al. 1999). γH2A.X is required to maintain factors of the DDR in an 
active state and this increase in the local concentration of several activated DDR factors 
at the site of DNA damage generates a positive feedback loop with ATM to maintain 
the foci, amplifying repair signals. The DNA damage mediator p53 binding protein 1 
(53BP1) is one DDR factor that is recruited to the site of damage by exposure to 
modified histone residues, which further boosts downstream DDR by establishing 
binding to MDC1 (Huyen, Zgheib et al. 2004; Eliezer, Argaman et al. 2009). 53BP1 is 
hyperphosphorylated by ATM and localises to nuclear foci (Anderson, Henderson et al. 
2001), playing an important role in activating downstream ATM substrates (Wang, 
Matsuoka et al. 2002). Additionally, 53BP1 is an important DDR factor involved in 
NHEJ DNA repair (Nakamura, Sakai et al. 2006).  
Alternatively, ultraviolet (UV) light damage and replication stress lead to the 
generation of local regions of replication protein A (RPA)-coated single-stranded DNA, 
which causes ATR to be recruited to the site of damage (Namiki and Zou 2006). 
Notably, during the end stages of DSB repair, RPA-coated single-stranded DNA is 
generated which also activates ATR (Zou and Elledge 2003). ATR binds to DNA by its 
DNA-binding subunit ATRIP, which activates a less well defined feedback loop 
through the activation of the RAD9- HUS1-RAD1 (9-1-1) and RAD17-RFC complexes, 
as well as TOPBP1 (d'Adda di Fagagna 2008). Activated ATR can then phosphorylate 
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its downstream targets, including H2A.X, forming DNA damage foci, and the 
checkpoint kinase 1 (Chk1) and 2 (Chk2) (Cortez, Guntuku et al. 2001; Helt, Cliby et al. 
2005). Chk1 and Chk2 transiently localise to the DNA damage foci to be 
phosphorylated by ATR and ATM but once activated they dissociate and freely diffuse 
throughout the nucleus (d'Adda di Fagagna 2008). Original reports indicated that Chk1 
and Chk2 are phosphorylated by ATR and ATM, respectively but it is now known that 
both ATM and ATR can phosphorylate Chk1 and Chk2 with specificity depending on 
the form of DNA damage (Helt, Cliby et al. 2005). Chk1 and Chk2 are involved in both 
S and G2 checkpoints and act by phosphorylating and inactivating the cell division 
cycle 25A and C (CDC25A/C) proteins, which are key cell-cycle regulators (Bartek and 
Lukas 2003). CDC25 proteins are phosphatases that are important for cell proliferation 
as they activate cyclin-dependent kinases (CDKs) but also cause their DDR-mediated 
inactivation by exclusion from the nucleus or proteolytic degradation (Shen and Huang 
2012; Neelsen, Zanini et al. 2013). Ultimately, the checkpoint kinases are the 
downstream elements of the DDR signalling cascade that connect the DDR to the core 
of the cell-cycle progression machinery. Therefore, if a DNA damage response is 
signaled, this leads to cell-cycle arrest via activation of tumour suppressor pathways. 
1.3.2 Control by the p53-p21 pathway 
Stimuli that generate a DDR, which is centered around the ATM kinase, induce 
senescence primarily through the p53 pathway (Campisi and d'Adda di Fagagna 2007). 
p53 is a tumour suppressor and a transcriptional activator induced by stress, the basic 
function of which is to prevent cells with DNA damage from entering S-phase (Toledo 
and Wahl 2006). p53 controls the expression of various genes implicated in response to 
genome instability and DNA damage and acts to cease cell proliferation by inducing 
two main cellular responses: apoptosis (programmed cell death) or senescence 
(Beausejour, Krtolica et al. 2003; Gao, Shen et al. 2011; Gatta, Dolfini et al. 2011; 
Rufini, Tucci et al. 2013). When inactive, p53 is associated with the E3 ubiquitin-
protein ligase human double minute 2 (HDM2), which both inhibits p53 transcriptional 
activity and targets it for degradation (Li, Brooks et al. 2003). Activation of the DDR, 
however, leads to phosphorylation and stabilisation of p53 and prevents HDM2 from 
binding (Chehab, Malikzay et al. 2000; Webley, Bond et al. 2000). Phosphorylation 
elevates DNA binding and transcriptional activities of p53 (Vaziri, West et al. 1997). 
p53 is activated by the Chk1 and Chk2 kinases and can be directly phosphorylated by 
ATM on Serine 15 (Banin, Moyal et al. 1998; Chehab, Malikzay et al. 2000; Calabrese, 
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Mallette et al. 2009). However, ATM mainly exerts its effects on p53 indirectly by 
phosphorylation of Chk2 or modifications of HDM2 (Ahn, Schwarz et al. 2000; Maya, 
Balass et al. 2001). ATR can also phosphorylate and activate Chk1 and Chk2 and so is 
also involved in p53 activation (Helt, Cliby et al. 2005; Jazayeri, Falck et al. 2006; 
Wang, Redpath et al. 2006). As a major transcriptional regulator, p53 has multiple 
downstream targets that inhibit cell-cycle progression. The main transcriptional target of 
p53, and mediator of p53-dependent senescence, is the CDKi p21 (also termed 
CDKN1a, p21Cip1, Waf1 or SDI1) (Brown, Wei et al. 1997; Herbig, Jobling et al. 
2004). Indeed, inactivation of p21 prevents mouse embryonic fibroblasts and normal 
human fibroblasts from undergoing p53-dependent senescence in response to DNA 
damage (Brugarolas, Chandrasekaran et al. 1995; Brown, Wei et al. 1997). Additionally, 
inactivation of Chk2 in human fibroblasts leads to decreased p21 expression and 
increased replicative lifespan due to failure of p53 activation in response to telomere 
erosion and DNA damage (Gire, Roux et al. 2004). p21 also has multiple targets, in 
particular it inhibits cyclin-CDK complexes, including cyclin E-CDK2, and 
proliferating-cell nuclear antigen (PCNA), which are required for passage through the 
cell cycle (Xiong, Zhang et al. 1992; Harper, Adami et al. 1993; Xiong, Hannon et al. 
1993; Waga, Hannon et al. 1994). CDKs stimulate cell-cycle progression by 
phosphorylating proteins required for transition to the next stage of the cell cycle. The 
inhibition of cyclin E-CDK2 by p21 prevents the phosphorylation of pRb (the product 
of the retinoblastoma tumour suppressor gene), which when hyperphosphorylated 
becomes inactivated and no longer binds and inhibits the activity of E2F transcription 
factors, which transcribe genes required for G1-S-phase transition (Sherr 1994; 
Weinberg 1995).  
1.3.3 Control by the p16
INK4A
-pRb pathway 
Stimuli that produce a DDR can also engage the p16
INK4A 
(also termed CDKN2a), 
hereafter referred to as p16, -pRb pathway. p16 is a CDKi that can prevent pRb 
phosphorylation and inactivation independently of p53 (Alcorta, Xiong et al. 1996). p16 
localises to the perinuclear cytoplasm and following activation translocates to the 
nucleus where it functions as a cyclin D-CDK4/6 inhibitor preventing the 
phosphorylation of pRb (Serrano, Hannon et al. 1993; Sherr 1994; Weinberg 1995). 
Some senescence-inducing stimuli act primarily through the p16-pRb pathway, which is 
particularly true in human epithelial cells, which become senescent with relatively long 
telomeres and high p16 expression (Kiyono, Foster et al. 1998; Ramirez, Morales et al. 
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2001). In most cases, engagement of the p16-pRb pathway occurs secondary to the 
engagement of the p53 pathway, as occurs in fibroblasts (Stein, Drullinger et al. 1999; 
Beausejour, Krtolica et al. 2003; Jacobs and de Lange 2004). The relative contribution 
of these two pathways to cell-cycle arrest is also species specific. For example, telomere 
dysfunction-induced senescence primarily engages the p53 pathway in mouse cells, 
whereas both pathways are activated in human cells (Smogorzewska and de Lange 2002; 
Beausejour, Krtolica et al. 2003; Jacobs and de Lange 2004). However, studies suggest 
that p16 is probably not essential for most types of senescence in humans. Human 
fibroblasts mutant for p16 still senesce following periods of prolonged replication 
(Brookes, Rowe et al. 2004). Additionally, mouse embryonic fibroblasts lacking p16 
still senesce in response to γ-irradiation, replicative exhaustion and oncogenes 
(Krimpenfort, Quon et al. 2001). However, overexpression of p16 alone is enough to 
induce cellular senescence (Coppe, Rodier et al. 2011) and it has been demonstrated in 
human cells that high levels of p16 at senescence prevents cells from proliferating even 
after p53 inactivation, whereas cells with low levels of p16 at senescence are able to 
resume growth following p53 inactivation, suggesting p16 provides an additional 
barrier in cells that fully engage the p16-pRb pathway (Beausejour, Krtolica et al. 2003). 
Moreover, loss of p16-pRb activity upregulates p53 and p21 expression in human 
epithelial cells (Zhang, Pickering et al. 2006), suggesting that there is reciprocal 
regulation between the two pathways. p16 expression is upregulated gradually with the 
induction of senescence and coincides with aspects of the senescent phenotype, 
persisting for months after senescence induction. In contrast, p21 expression is maximal 
at the initiating stages of senescence and then declines after the cell has become 
senescent, suggesting that p16 upregulation may be required for maintenance of the 
senescent cell-cycle arrest (Alcorta, Xiong et al. 1996; Stein, Drullinger et al. 1999; 
Beausejour, Krtolica et al. 2003). The p16-pRb pathway is involved in the generation of 
SAHFs, which are ultimately portions of a single condensed chromosome enriched for 
the histone variant macroH2A that silence genes required for proliferation, namely E2F 
target genes (Narita, Nunez et al. 2003; Zhang, Chen et al. 2007). The p16-pRb pathway 
can establish self-maintaining SAHFs, which could be due to the ability of pRb to 
complex with histone-modifying enzymes that form repressive chromatin, thereby 
leading to SAHF generation (Macaluso, Montanari et al. 2006). p16 expression is 
induced by oncogenes, such as oncogenic RAS (Serrano, Lin et al. 1997), oxidative 
stress (Chen, Stoeber et al. 2004), radiation (Meng, Wang et al. 2003) and telomere 
dysfunction (Jacobs and de Lange 2004). It is not entirely clear how senescence-causing 
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stimuli induce p16 expression, however one possibility is that DNA damage signals 
activate p38MAPK signalling, which then activates p16 (Iwasa, Han et al. 2003; 
Bulavin, Phillips et al. 2004; Ito, Hirao et al. 2006; Spallarossa, Altieri et al. 2010). 
1.3.4 P38MAPK pathway 
The p38 mitogen-activated protein kinase (p38MAPK) is important for senescence 
growth arrest and can activate both p53-p21 and p16-pRb tumour suppressor pathways 
(Iwasa, Han et al. 2003). Indeed, p38MAPK activity is required for oncogenic RAS-
induced senescence and inhibition can delay the onset of replicative senescence (Deng, 
Liao et al. 2004; Davis and Kipling 2009). X-ray irradiation has been shown to induce 
p38 with similar dynamics to those of p16, increasing only slightly initially, rising 
substantially between 2-4 days and peaking at 8-10 days (Freund, Patil et al. 2011), 
consistent with p38 inducing p16 expression. Additionally, it has been shown that 
p38MAPK enhances mitochondrial ROS production, which causes cyclic activation of 
p53 through the replenishment of DNA damage foci, contributing to stabilisation of an 
ongoing DDR during senescence (Passos, Nelson et al. 2010).  
In summary, the main pathways that control induction and maintenance of 
senescence are the p53-p21 and p16-pRb pathways, which both prevent E2F from 
transcribing genes that are needed for cell proliferation. It seems that these pathways 
may interact and have compensatory effects but can act independently. The relative 
contributions of these pathways to the senescent growth arrest depend on stimuli, 












Figure 1.1. Pathways involved in senescence induction. Many signals that induce 
senescence, such as dysfunctional telomeres and DNA damage, trigger a DNA damage 
response (DDR) leading to the activation of ataxia-telangiectasia mutated (ATM) and 
Rad3-related (ATR) kinases and formation of DNA damage foci. Many stressors may 
also induce senescence, independently of a DDR. Either way, the p53-p21 and p16-
retinoblastoma protein (pRb) tumour suppressor pathways are usually engaged. Active 
p53 establishes senescence, mainly by inducing the expression of the cyclin-dependent 
kinase (CDK) inhibitor p21, which suppresses the phosphorylation and thus inactivation 
of pRb. Senescence signals that engage the p16-pRb pathway induce the expression of 
p16, another CDK inhibitor, which also suppresses pRb inactivation. pRb halts cell 
proliferation by inhibiting the activation of E2F, a transcription factor required for the 
expression of cell-cycle progression genes. HDM2, human double minute 2; Chk1/2, 
checkpoint kinase 1/2; CDC25, cell division cycle 25; p38MAPK, p38 mitogen-
activated protein kinase.    
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1.4 Characteristics of senescent cells 
Cellular senescence is marked by a number of distinct phenotypic changes. However, 
no hallmark of senescence identified so far is entirely specific to the senescent state. 
Furthermore, the phenotype of senescent cells may differ depending on the type of 
senescence (e.g. replicative senescence vs. SIPS) (Dierick, Eliaers et al. 2002) or stage 
of senescence development (Baker and Sedivy 2013). Nonetheless, senescent cells 
display several common characteristics, which in combination, define the senescent 
state (Figure 1.2) (Rodier and Campisi 2011).   
1.4.1 Growth arrest  
The initiating step in senescence is the induction of stable cell-cycle arrest, which 
typically involves prolonged inhibition of cyclin-CDK activity induced by activation of 
the tumour suppressor pathways (as above). Thus, senescent cells are non-dividing. 
Senescent cells usually arrest growth with a DNA content that is typical of G1 phase yet 
they remain metabolically active and have the ability to remain viable in culture for 
prolonged periods of time (Dulic, Drullinger et al. 1993; Di Leonardo, Linke et al. 1994; 
Herbig, Jobling et al. 2004). In some cases, the features of the senescence growth arrest 
may differ, depending on the species, genetic background of the cell and stimuli. For 
example, a defect in the stress-signalling kinase MKK7 induces a G2-M arrest in mouse 
fibroblasts (Wada, Joza et al. 2004), loss of ATM in human fibroblasts containing TAF 
leads to G2 arrest (Herbig, Jobling et al. 2004) and some oncogenes cause cells to arrest 
with a DNA content that is typical of G2 (Zhu, Woods et al. 1998; Di Micco, Fumagalli 
et al. 2006). The senescence growth arrest is essentially irreversible, as proliferation 
cannot be stimulated by known physiological stimuli. However, studies have argued 
that “escape scenarios” do exist. For example, inactivation of p53 allows senescent cells 
to re-enter the cell-cycle (Beausejour, Krtolica et al. 2003).  
1.4.2 Apoptosis resistance  
Apoptosis is a controlled form of cell death, which like senescence, can occur in 
response to cellular stress and is an important anti-cancer mechanism (Ellis, Yuan et al. 
1991; Green and Evan 2002). Whereas senescence prevents the proliferation of 
damaged cells, apoptosis eliminates them. It is not clear what determines whether cells 
undergo apoptosis or senescence (Childs, Baker et al. 2014). The nature and intensity of 
the damage may be important (Seluanov, Gorbunova et al. 2001). The type of cell may 
also be a factor. For example, fibroblasts and epithelial cells tend to senesce following 
damage, whereas lymphocytes tend to undergo apoptosis (Campisi and d'Adda di 
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Fagagna 2007). It is likely that the senescence and apoptosis regulatory systems 
communicate through the tumour suppressor protein p53, which is strongly involved in 
both programmes, but the mechanisms are still not entirely understood (Seluanov, 
Gorbunova et al. 2001). One study demonstrated that both the cellular level of telomere 
dysfunction and p53 gene status determined whether cells underwent apoptosis or 
senescence in murine liver cells. This study demonstrated that cells underwent p53-
dependent senescence or p53-independent apoptosis, depending on the level of telomere 
dysfunction in a cell (Lechel, Satyanarayana et al. 2005).  
Many cell types, such as fibroblasts, acquire resistance to apoptosis when they become 
senescent (Wang 1995; Seluanov, Gorbunova et al. 2001; Sanders, Liu et al. 2013). 
Other cells are less resistant to apoptosis. For example, senescent fibroblasts resist 
ceramide-induced apoptosis, whereas senescent endothelial cells do not (Hampel, 
Malisan et al. 2004). Apoptosis resistance may explain the stability of senescent cells 
for prolonged periods of time in culture and the increasing number of senescent cells 
with age (Haake, Roublevskaia et al. 1998). The mechanisms governing resistance of 
apoptosis by senescent cells are not fully understood. In some cells, it could be that p53 
preferentially trans-activates genes that arrest proliferation rather than those that 
promote apoptosis (Jackson and Pereira-Smith 2006). Additionally, it has been shown 
that histone modifications confer apoptosis resistance to senescent human fibroblasts by 
regulating altered expression of the anti- and pro-apoptotic genes B-cell lymphoma 2 
(Bcl-2) and bcl-2 associated X protein (Bax) (Sanders, Liu et al. 2013). Additionally, 
data show that p53-dependent apoptotic pathways are specifically blocked in senescent 
fibroblasts (Seluanov, Gorbunova et al. 2001).  
1.4.3 Changes in gene expression 
Senescent cells show striking alterations in gene expression, which result in traits 
associated with the senescence phenotype. For example, changes in gene expression of 
known cell-cycle inhibitors or activators are responsible for the senescent growth arrest 
(Shelton, Chang et al. 1999; Chang, Swift et al. 2002; Mason, Jackson et al. 2004; 
Trougakos, Saridaki et al. 2006). The CDKi p21 and p16 are cell-cycle inhibitors that 
are often expressed by senescent cells, which act to maintain pRb in a 
hypophosphorylated and active state (discussed above) (Di Leonardo, Linke et al. 1994; 
Alcorta, Xiong et al. 1996; Herbig, Jobling et al. 2004; Jacobs and de Lange 2004). 
Senescent cells also repress genes that promote cell-cycle progression, such as 
replication-dependent histones, c-FOS, cyclin A, cyclin B and PCNA (Seshadri and 
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Campisi 1990; Stein, Drullinger et al. 1991; Pang and Chen 1994). Some of these genes 
are repressed because the transcription factor E2F, which induces them, is also 
repressed in senescent cells (Dimri, Hara et al. 1994). Senescent cells are unable to 
express genes required for proliferation, even in the presence of pro-mitogenic factors, 
which distinguishes them from quiescent cells, which are also non-dividing (Dimri, 
Hara et al. 1994). Many senescent cells overexpress genes that encode secreted proteins, 
such as extracellular matrix (ECM) degrading enzymes, inflammatory cytokines and 
growth factors, which can alter the tissue microenvironment and affect the behaviour of 
neighbouring and distal cells (Tchkonia, Zhu et al. 2013). This is known as the 
senescence-associated secretory phenotype (SASP) (discussed below).   
1.4.4 Senescence markers  
Several markers have been used to identify senescent cells in culture and in vivo. Some 
of these markers reflect the activation of mechanisms that contribute to the senescence 
program, such as the induction of tumour suppressor pathways, however for others, it is 
unclear as to what extent they contribute mechanistically (Kuilman, Michaloglou et al. 
2010). The first marker to be used for the identification of senescent cells was 
senescence-associated-β-galactosidase (Sen-β-Gal) activity (Dimri, Lee et al. 1995). 
Dimri and colleagues demonstrated that Sen-β-Gal, which is histochemically detected in 
senescent cells at pH 6.0, is active in senescent human fibroblasts and keratinocytes in 
culture and Sen-β-Gal positive cells age-dependently increase in human skin (Dimri, 
Lee et al. 1995). It is known that β-Gal is a lysosomal hydrolase enzyme and it has been 
proposed that Sen-β-Gal probably derives from the lysosomal β-Gal and reflects the 
increased lysosomal biogenesis that occurs commonly in senescence (Lee, Han et al. 
2006). Sen-β-Gal is still not solely specific to the senescent state as prolonged 
confluence in culture can also lead to Sen-β-Gal positivity (Dimri, Lee et al. 1995). 
There is currently no evidence pointing to the specific involvement of Sen-β-Gal in the 
senescence response (Lee, Han et al. 2006).  
More obvious markers to use for the identification of senescent cells are those 
that reflect proliferation arrest and lack of DNA replication. DNA replication is detected 
by incorporation of 5-bromodeoxyuridine (BrdU) or 
3
H-thymidine, or by 
immunostaining for proteins such as PCNA and Ki67 (Muskhelishvili, Latendresse et al. 
2003). However, these markers do not distinguish between senescent cells and quiescent 
or differentiated post-mitotic cells.  
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As discussed above, the p53-p21 and p16-pRb pathways commonly mediate the 
induction and maintenance of the senescence program. Consequently, components of 
these pathways have been used to identify senescent cells. p53 displays increased 
activity and/or levels in human fibroblasts undergoing replicative or premature 
senescence (Vaziri, West et al. 1997; Bunz, Dutriaux et al. 1998). Rb also accumulates 
in its active hypophosphorylated form in senescent cells (Stein, Beeson et al. 1990). In 
addition, p16, an important regulator of senescence, is expressed by many senescent 
cells and is used to identify senescent cells both in vitro and in vivo (Serrano, Lin et al. 
1997; Beausejour, Krtolica et al. 2003; Itahana, Zou et al. 2003; Krishnamurthy, Torrice 
et al. 2004; Herbig, Ferreira et al. 2006; Jeyapalan, Ferreira et al. 2007). p21 also often 
accumulates in senescent cells and has been used as a marker of senescence, reflecting 
the activation of this tumour suppressor pathway (Di Leonardo, Linke et al. 1994; 
Alcorta, Xiong et al. 1996; Herbig, Jobling et al. 2004; Herbig, Ferreira et al. 2006). 
Some senescent cells can also be identified using DNA dyes, such as 4’6-
diamidino-2-phenylindole (DAPI), which detect alterations in chromatin structure. 
While cycling or quiescent human cells display overall homogeneous staining patterns, 
senescent cells often show strikingly different punctate staining patterns. These DNA 
SAHF are enriched in certain heterochromatin-associated histone variants (for example, 
histone 3 Lysine 9 methylation, γH2A.X and macro H2A) and proteins (such as, 
heterochromatin protein-1 (HP1)) (Narita, Nunez et al. 2003). SAHFs also sequester 
genes involved in cell-cycle control, such as E2F target genes, which is thought to 
reinforce senescence growth arrest. Indeed, SAHFs have been correlated with the 
irreversibility of the senescent cell-cycle arrest (Beausejour, Krtolica et al. 2003; Narita, 
Nunez et al. 2003). When SAHF formation is circumvented, senescence can be 
bypassed (Narita, Nunez et al. 2003; Zhang, Poustovoitov et al. 2005). As well as 
transcriptionally silencing genes, chromatin modification leads to the upregulation of 
genes encoding secreted proteins with pro-inflammatory activity, further linking SAHF 
formation to progression of the senescence phenotype (Shelton, Chang et al. 1999; 
Zhang, Pan et al. 2003).    
Several reports have described senescence-associated DNA damage foci (SDFs) 
as markers for senescent cells in vitro and in vivo (d'Adda di Fagagna, Reaper et al. 
2003; Takai, Smogorzewska et al. 2003; Herbig, Jobling et al. 2004; Sedelnikova, 
Horikawa et al. 2004; Di Micco, Fumagalli et al. 2006). SDFs are subnuclear foci that 
contain DDR proteins, such as γH2A.X and 53BP1 and represent sites of DNA damage 
and DDR activity (d'Adda di Fagagna, Reaper et al. 2003). These foci can be detected 
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by immunofluorescence because chromatin modifications generated by the DDR spread 
over megabases (Rogakou, Boon et al. 1999). Recently, Rodier and colleagues 
suggested that persistent DNA damage foci (termed DNA segments with chromatin 
alterations reinforcing senescence (DNA-SCARS)) are distinguishable from transient 
foci and act as reservoirs for active DDR signalling, being important for maintaining 
senescent growth arrest and features of the SASP (Rodier, Munoz et al. 2011). These 
foci result from both genomic DNA damage, such as DSBs, and dysfunctional 
telomeres (d'Adda di Fagagna, Reaper et al. 2003; Herbig, Jobling et al. 2004; 
Sedelnikova, Horikawa et al. 2004). SDFs resulting from telomere 
shortening/uncapping have been termed telomere dysfunction-induced foci (TIF) (Takai, 
Smogorzewska et al. 2003; Herbig, Jobling et al. 2004). Recently, it has been 
demonstrated that SDFs may also be present at longer telomeres and occur 
independently of telomerase activity and are therefore referred to as telomere-associated 
foci (TAF) (Fumagalli, Rossiello et al. 2012; Hewitt, Jurk et al. 2012). Senescence 
induced by telomere dysfunction reflects a DDR that is activated with direct 
contribution from telomeres and both TIF and TAF have been described as markers of 
telomere-induced senescence. It has recently been shown that DDR signalling is 
persistently active months and even years following induction of the senescence state 
and therefore SDFs may be used to identify senescent cells long after the establishment 
of senescence (Fumagalli, Rossiello et al. 2014).   
Senescence is accompanied by changes in the nucleus, such as increased nuclear 
size and irregularity and increased density of nuclear pore complexes (Mehta, Figgitt et 
al. 2007). Additionally, some senescent cells may show alterations in nuclear envelope 
proteins, such as lamin A and B, which connect the nuclear envelope to the chromatin 
(Dechat, Pfleghaar et al. 2008). Lamin B1 loss may serve as a biomarker of senescence 
in vitro and in vivo as it is lost from both murine and human cells during OIS, SIPS and 
replicative senescence and in mouse tissues following irradiation, but not in quiescence 
(Shimi, Butin-Israeli et al. 2011; Freund, Laberge et al. 2012). Data suggests that lamin 
B1 downregulation is a key trigger of local and global chromatin changes that impact on 
gene expression, suggesting that this may be an important step in the progression to full 
senescence (Shah, Donahue et al. 2013).  
Sirtuins are conserved NAD-dependent protein and HDACs that play critical 
roles in a variety of processes, including stress resistance, senescence and ageing 
(Michan and Sinclair 2007). SIRT1 is the best characterised mammalian sirtuin and is 
important for maintaining transcriptionally silent chromatin and regulating transcription 
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of nuclear factor (NF)-κB-dependent genes. Activation or overexpression of SIRT1 has 
been shown to increase lifespan in yeast, worms and mice (Lin, Defossez et al. 2000; 
Tissenbaum and Guarente 2001; Howitz, Bitterman et al. 2003; Bordone, Cohen et al. 
2007; Satoh, Brace et al. 2013) and decreased SIRT1 expression has been described in 
the senescence context (Sasaki, Maier et al. 2006; Vassallo, Simoncini et al. 2014).  
These markers are associated with, but not exclusive to, the senescent state. 
Therefore, markers should be investigated in combination in order to identify senescent 
cells. Lawless and colleagues identified Ki67 negativity in combination with γH2A.X 
positivity (> 5 per nucleus) as strong criteria for identifying senescent cells in both cell 
culture and tissue sections (Lawless, Wang et al. 2010).  
1.4.5 Morphological changes  
Cell senescence is generally associated with changes in cellular morphology. Depending 
on the inducer of senescence, senescent cells can become large, flat and multinucleated. 
An increase in cellular volume and a flattened morphology has been noted for human 
skin fibroblasts undergoing replicative senescence (Bayreuther, Rodemann et al. 1988). 
A flattened morphology is seen in cells undergoing RAS-induced senescence (Serrano, 
Lin et al. 1997) and DNA damage-induced senescence (Chen, Prowse et al. 2001). 
However, human melanocytes undergoing BRAF-induced senescence acquire a more 
spindle-shaped morphology (Michaloglou, Vredeveld et al. 2005).  
1.4.6 The senescence-associated secretory phenotype  
Cells undergoing senescence exhibit profound changes in their secretomes (Shelton, 
Chang et al. 1999). A major consequence of this is the secretion of a plethora of 
proteins, including pro-inflammatory cytokines and chemokines, growth factors and 
proteases (Tchkonia, Zhu et al. 2013). Collectively, these factors are referred to as the 
senescence-associated secretory phenotype (SASP) or senescence messaging secretome 
(SMS) (Coppe, Patil et al. 2008; Kuilman and Peeper 2009). The SASP is one of the 
key characteristics that distinguishes senescent cells from quiescent and terminally 
differentiated cells, therefore SASP components, along with other markers, may also be 
exploited to identify senescent cells. It has been suggested that development of the 
SASP reflects progression from transient cell-cycle arrest to full senescence (Correia-
Melo, Hewitt et al. 2014; van Deursen 2014), likely due to the triggering of extensive 
chromatin remodelling and SAHF formation, which are known to regulate SASP 
production and reinforce senescence (discussed above). Rodier and colleagues 
demonstrated that for the induction of several of the SASP factors, persistent DNA 
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damage is required (Rodier, Coppe et al. 2009). Because DNA damage does not 
accompany all senescent settings, it was suggested that a DDR but not senescence per 
se is required for the SASP (Rodier, Coppe et al. 2009). Consistent with this, primary 
human fibroblasts overexpressing p21 or p16 undergo senescent growth arrest but fail to 
activate a DDR and do not produce a SASP (Coppe, Rodier et al. 2011). However, 
several senescence-inducing stimuli lead to the development of the SASP independently 
of DNA damage, implying the existence of DDR-independent mechanisms (Munoz-
Espin, Canamero et al. 2013; Storer, Mas et al. 2013). SASP factors vary in distinct cell 
types and under different senescence inducers. It is not surprising then that senescent 
cells impact various biological processes including cell proliferation, angiogenesis, local 
inflammation and wound healing (Shelton, Chang et al. 1999; Krtolica, Parrinello et al. 
2001; Coppe, Kauser et al. 2006; Jun and Lau 2010). However, pro-inflammatory 
cytokines and chemokines, such as interleukin IL-6 and IL-8 are among the SASP 
factors that are highly conserved among different types of cells and types of senescence 
(Shelton, Chang et al. 1999; Coppe, Patil et al. 2008), suggesting that attracting immune 
cells and inducing local inflammation are common properties of senescent cells. 
Recently, it has been discovered that senescent cells can spread the senescence 
phenotype to healthy neighbouring cells via secretion of SASP factors, including 
transforming growth factor-β (TGF-β) and IL-1α, and so have a “bystander effect” 
(Acosta, Banito et al. 2013). In addition to affecting the microenvironment and 
neighbouring cells, secreted SASP factors also affect the cells that produce them and so 
have autocrine as well as paracrine effects. Indeed, some inflammatory factors establish 
and maintain senescence arrest. For example, signalling through CXCR2 (a receptor for 
IL-8) reinforces both replicative and OIS growth arrest through a self-amplifying 
secretory network and inhibition of this receptor both delays senescence onset and 
decreases DDR activation (Acosta, O'Loghlen et al. 2008). Similarly, IL-6 is required to 
induce and maintain OIS in a cell-autonomous fashion (Kuilman, Michaloglou et al. 
2008). Mechanistically, it’s still not completely understood how the SASP contributes 
to the reinforcement of cellular senescence (Correia-Melo, Hewitt et al. 2014). However, 
evidence suggests that positive feedback loops between DDR signalling and 
components of the SASP, such as inflammatory factors and ROS, lead to new DNA 
damage and maintain DDR signalling (Passos, Nelson et al. 2010; Jurk, Wilson et al. 
2014). The NF-κB family of transcriptional factors regulate expression of many genes 
involved in stress-responses and inflammation, such as cytokines and enzymes (Pahl 
1999), and have been shown to be important in regulating components of senescence 
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and the SASP (Freund, Patil et al. 2011; Rovillain, Mansfield et al. 2011). Indeed, 
multiple lines of evidence suggest that NF-κB activity links the DDR with production of 
SASP components, underscoring the importance of this family of transcription factors 
in promoting stability and progression of senescence (Passos, Nelson et al. 2010; Osorio, 
Barcena et al. 2012; Tilstra, Robinson et al. 2012; Jurk, Wilson et al. 2014).  
1.4.7 Progression to deep senescence  
Senescent cells can remain viable for prolonged periods of time, both in culture and in 
tissues where they may eventually progress to a stage that has been termed ‘late’ or 
‘deep’ senescence (Baker and Sedivy 2013). Little is known about this phenomenon but 
it is thought that ‘deep’ senescence is maintained by persistent DDR signalling (Passos, 
Nelson et al. 2010), and is associated with further changes to the cell, including 
depletion of core histones and extrusion of chromatin into the cytoplasm, resulting in 
the formation of cytoplasmic chromatin fragments (CCFs) (Ivanov, Pawlikowski et al. 
2013). CCFs are strongly positive for H3K27me3 and γH2A.X, contain DNA, and are 
processed via lysosome-mediated proteolysis, leading to histone loss (Ivanov, 
Pawlikowski et al. 2013). It has been suggested that these events likely drive 
transcriptome diversity among senescent cells, even in those resulting from the same 
























Figure 1.2. Development of the senescence phenotype – a multistep process. 
Mounting evidence suggests that cellular senescence is a dynamic and evolving process. 
Initially, stressors can lead to activation of a DNA damage response (DDR) and 
induction of tumour suppressor pathways resulting in cell-cycle arrest. At this point, it 
may be possible for cells to re-enter the cell cycle, for example, if damage is repairable. 
Sustained activation of the p53-p21 and p16-pRb pathways leads to progression from 
transient to stable cell-cycle arrest and early senescence. Lamin B1 downregulation, 
triggering extensive chromatin remodelling, leads to progression to full senescence and 
production of the senescence-associated secretory phenotype (SASP). Secretion of 
bioactive molecules, such as SASP factors and reactive oxygen species (ROS) acts to 
reinforce senescence and induce senescence in neighbouring cells by autocrine and 
paracrine mechanisms, respectively. Further progression of the senescence phenotype 
may lead to ‘deep’ senescence, driven by additional changes, such as chromatin 
budding and histone loss. The development of deep senescence is thought to further 
drive SASP heterogeneity. Some markers of cellular senescence are shown, including 
senescence-associated-β-galactosidase (Sen-β-Gal) (blue) expression, formation of 
senescence-associated heterochromatin foci (SAHF) (pink), the presence of DNA 









1.5 The involvement of reactive oxygen species in induction of telomere 
dysfunction and senescence 
The Free Radical Theory of Ageing suggests that ROS, which are generated inside the 
cell as by-products of normal redox reactions, react with cellular constituents such as 
DNA and proteins, the accumulation of which leads to the progressive changes of 
ageing (Harman 1956). Since mitochondria are the major producers of ROS in cells 
(Chance, Sies et al. 1979), it was later suggested that mitochondria play an important 
role in time-dependent cellular ROS generation (Harman 1972). Evidence suggests that 
ROS are likely to be involved in the induction and stabilisation of cellular senescence. 
During cellular senescence, it has been shown that mitochondrial dysfunction increases 
as cells reach the end of their replicative lifespan, leading to increased ROS generation 
(Passos, Saretzki et al. 2007). Additionally, it has been shown that ROS can accelerate 
telomere shortening by inducing SSBs at telomeres, with antioxidants and other 
interventions that reduce ROS being able to prevent telomere shortening and extend 
replicative lifespan (von Zglinicki, Saretzki et al. 1995; von Zglinicki 2002; Saretzki, 
Murphy et al. 2003; Serra, von Zglinicki et al. 2003). Elevated ROS levels are also 
implicated in SIPS and OIS (Saretzki, Murphy et al. 2003; Moiseeva, Bourdeau et al. 
2009). Evidence suggests that ROS may act as signalling molecules to stabilise 
senescence (Passos, Saretzki et al. 2007). For example, activation of pathways 
downstream of the DDR, such as overexpression of p21 and p16, result in elevated ROS 
(Macip, Igarashi et al. 2002; Takahashi, Ohtani et al. 2006). It has also been 
demonstrated that ROS levels increase in senescent cells as a result of mitochondrial 
dysfunction induced through activation of p21, which in turn replenish short-lived DNA 
damage foci, maintaining an ongoing DDR and stability of senescence (Passos, Nelson 
et al. 2010). Additionally, it has been shown that senescent cells can induce a DDR in 
neighbouring cells via gap junctions and processes involving ROS (Nelson, 
Wordsworth et al. 2012). It is also possible that ROS could lead to bystander effects and 
impact on tissues, similar to the SASP. In the study by Nelson and colleagues, it was 
shown that senescent cells can induce senescence in intact bystander cells in vitro and 
that senescent cells are clustered in vivo, suggesting that senescent cells induce 
senescence in nearby cells (Nelson, Wordsworth et al. 2012). Evidence links ROS to 
reinforcement of senescence by the SASP. In the study by Acosta and colleagues 
demonstrating that CXCR2 inhibition delays senescence onset and decreases DDR 
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activation, the authors propose that this could be due to a reduction in ROS (Acosta, 
O'Loghlen et al. 2008). Interferon-β, a possible component of the SASP, induces 
senescence by increasing intracellular ROS, which leads to activation of a DDR 
(Moiseeva, Mallette et al. 2006). TGF-β is known to play a role in the paracrine 
mechanisms of the SASP (Acosta, Banito et al. 2013) and neutralising antibodies or 
chemical inhibitors against the TGF-β type II receptor decrease ROS production 
downstream of the DDR induced in both telomere-dependent and -independent fashions 
(Passos, Nelson et al. 2010). Another potential link between the SASP and ROS is NF-
κB, the main regulator of the SASP, which has roles in the regulation of mitochondrial 
function and oxidative stress (reviewed in (Correia-Melo, Hewitt et al. 2014)). Finally, 
the p38MAPK pathway has been shown to be important for ROS generation in both 
SIPS and replicative senescence and for maintenance of the DDR (Passos, Nelson et al. 
2010) and it is known that p38MAPK regulates the SASP mainly through NF-κB 
transcriptional activity (Freund, Patil et al. 2011). 
Therefore, ROS are implicated in, and are important to, multiple steps in the 
induction and maintenance of senescence as well as the inflammatory processes 
associated with senescent cells. 
1.6 Significance of senescence in vivo 
Following the discovery of senescence in vitro, Hayflick and Moorehead postulated that 
this program paralleled ageing in vivo, likely contributed to the development of age-
related disease and supressed the development of cancer (Hayflick 1965). For decades 
there has been debate between researchers as to whether senescence exists in vivo or if it 
is a phenomenon exclusive to tissue culture and only in the last ten years studies have 
provided conclusive evidence that senescence occurs and is important in vivo (Burton 
and Krizhanovsky 2014).  
1.6.1 Evidence for senescent cells in vivo  
Senescence-associated markers have been used to identify senescent cells in vivo with 
the limitation that no marker is exclusive to the senescent state. Senescent cells are 
found in many renewable tissues in rodents, primates and humans (Krishnamurthy, 
Torrice et al. 2004; Jeyapalan, Ferreira et al. 2007; Waaijer, Parish et al. 2012). 
Senescent cells are also found at sites of benign dysplastic or preneoplastic regions in 
vivo, but not at the malignant counterparts, consistent with senescence being an anti-
cancer mechanism (Collado, Gil et al. 2005; Michaloglou, Vredeveld et al. 2005; Suram, 
Kaplunov et al. 2012). The majority of evidence for the presence of senescence in vivo, 
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however, comes from the link between cellular senescence, ageing and age-related 
disease.  
1.6.2 Senescence and ageing 
There is considerable evidence that cellular senescence contributes to the ageing process. 
Using combinations of senescent markers previously mentioned, a number of studies 
have demonstrated that senescent cells accumulate in vivo with age. An age-dependent 
increase in Sen-β-Gal staining was shown in dermal fibroblasts and epidermal 
keratinocytes in human skin samples (Dimri, Lee et al. 1995). Interestingly, it has been 
demonstrated that younger biological age is associated with fewer levels of p16 positive 
cells in human skin biopsies (Waaijer, Parish et al. 2012). Dermal fibroblasts expressing 
p16 and harbouring TAF accumulate in the skin of baboons with advancing age 
(Jeyapalan, Ferreira et al. 2007). Herbig and colleagues also documented previously that 
senescent fibroblasts increased in the skin of ageing baboons, as indicated by the 
presence of TAF, which correlated with increased p16 expression (Herbig, Ferreira et al. 
2006). The examples mentioned thus far have investigated senescence of mitotic cells. 
However, evidence also suggests that non-dividing cells undergo senescent-like changes 
and increase in tissues with age. For example, it was demonstrated that TAF increase in 
liver hepatocytes and hippocampal neurones in baboons with age (Fumagalli, Rossiello 
et al. 2012). Consistent with the notion of post-mitotic cell senescence, Jurk et al. have 
described an age-dependent increase in neurones expressing multiple markers of 
senescence, including Sen-β-Gal, IL-6 and γH2A.X, in the brains of C57BL/6 mice 
(Jurk, Wang et al. 2012). These results suggest that the accumulation of senescent cells 
in tissues with age is not just contributed to by proliferation-competent cells. Other 
reports have also shown that senescent cells increase in frequency in a range of murine 
tissues with age. Increased p16 mRNA and protein expression was observed in almost 
all rodent tissues with advancing age (Krishnamurthy, Torrice et al. 2004). SIRT1 
protein expression decreases with age in murine tissues that have declining mitotic 
activity, such as the thymus and testis (Sasaki, Maier et al. 2006). Increased frequencies 
of γH2A.X foci-positive cells have been observed in the murine lung, spleen, small 
intestine, liver hepatocytes and dermis (Wang, Jurk et al. 2009). In line with this, our 
group reported an exponential increase in number of TAF per cell in murine liver 
hepatocytes and intestinal crypt enterocytes with age but found no significant increase 
in non-colocalising foci with age in either tissue (Hewitt, Jurk et al. 2012). This 
suggests that TAF are persistent and accumulate in tissues with age, whereas non-TAF 
Chapter 1 Introduction 
 
 26 
do not. Furthermore, in murine models of accelerated ageing, such as the progeroid 
mouse, the abundance of cells expressing chronically elevated levels of senescence-
associated markers, such as p16, is increased in a number of tissues (Baker, Perez-
Terzic et al. 2008). Similarly, in a mouse model for chronic inflammation that leads to 
accelerated ageing, frequencies of senescent cells identified by TAF were increased in 
the liver and gut (Jurk, Wilson et al. 2014). Interestingly, frequencies of TAF-
containing senescent cells were shown to quantitatively predict mean and maximum 
lifespan in both short- and long-lived mice cohorts (Jurk, Wilson et al. 2014).   
It is unknown as to why senescent cells accumulate in tissues and organs with 
age. Stimuli that induce senescence, such as ROS, increase with age and it is possible 
that accumulation of ROS-derived damage with age leads to senescent cell 
accumulation over time (Hamilton, Van Remmen et al. 2001; Chung, Cesari et al. 2009). 
Moreover, the increasing number of senescent cells can lead to further induction of 
senescence in surrounding cells via SASP factor release (Acosta, Banito et al. 2013). 
Recent findings suggest that senescent cells can be cleared by host mechanisms, such as 
activation of the immune system. For example, in a murine model of liver carcinoma, 
p53-dependent induction of cellular senescence leads to the induction of the innate 
immune response culminating in tumour cell clearance (Xue, Zender et al. 2007). Other 
studies also support the notion that senescent cells signal the innate and adaptive 
immune systems, probably through secretion of SASP factors, leading to their clearance 
and thus can be responsible for their own elimination (Krizhanovsky, Yon et al. 2008; 
Kang, Yevsa et al. 2011; Lujambio, Akkari et al. 2013). Therefore, another possibility is 
that immune surveillance and clearance of senescent cells becomes more inefficient 
with age (Sagiv and Krizhanovsky 2013). Indeed, immune cells can also become 
senescent, which may contribute to age-associated immune deficiency (Effros and 
Pawelec 1997; Lanna, Henson et al. 2014). Additionally, it has been suggested that the 
development of deeply senescent cells, which are likely to have evolved increasingly 
heterogeneous SASPs, may allow evasion of immune cell clearance as the efficiency by 
which immune cells recognise and clear senescent cells may be dependent on SASP 
composition (van Deursen 2014).  
1.6.3 Senescence and age-related disease  
Further support for the existence of senescence in vivo comes from the extensive 
evidence linking the age-dependent increase in senescent cell frequency to age-related 
decline in tissue structure and function and development of age-related disease (Naylor, 
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Baker et al. 2013; Ovadya and Krizhanovsky 2014). Cells with senescent cell properties 
are found at sites of chronic age-related pathology, such as osteoarthritis, atherosclerosis, 
type II diabetes and Alzheimer’s disease (McShea, Harris et al. 1997; Vasile, Tomita et 
al. 2001; Price, Waters et al. 2002; Sone and Kagawa 2005). Direct evidence that 
senescent cells drive age-related pathologies was provided by one study, which 
demonstrated that genetic inactivation of p16 in BubR1 insufficient mice prevented 
cellular senescence in skeletal muscle and fat and attenuated the premature onset of age-
related pathologies that are associated with BubR1 insufficiency in these tissues (Baker, 
Perez-Terzic et al. 2008). In a subsequent study, it was shown in the BubR1 progeroid 
mouse background that drug-induced elimination of p16-positive senescent cells 
delayed the onset of age-related pathologies in skeletal muscle, adipose tissue and eye. 
Furthermore, clearance of p16-positive senescent cells later in life attenuated the 
progression of already established age-related disorders, suggesting that senescent cells 
are causally implicated in age-related dysfunction (Baker, Wijshake et al. 2011). 
Interestingly, it has also been demonstrated that the number of p16 positive cells in 
human skin is associated with the occurrence of age-related pathologies, such as 
cardiovascular diseases (Waaijer, Parish et al. 2012).  Thus, senescent cells are 
associated with ageing and age-related diseases in vivo.  
There are a number of potential mechanisms by which senescent cells may 
promote age-related tissue dysfunction. One scenario is that the build-up of senescent 
cells in tissues with age progressively depletes the organism of functional cells critical 
for maintaining tissue repair and regeneration, such as stem and progenitor cells 
(Conboy, Conboy et al. 2005; Choudhury, Ju et al. 2007; Wang, Sun et al. 2012; Jurk, 
Wilson et al. 2014). 
Human ageing is characterised by chronic, low-grade inflammation, termed 
‘inflammaging’ (Franceschi, Capri et al. 2007; Chung, Cesari et al. 2009). In 
accordance, many age-related diseases are characterised by chronic inflammation and 
therefore one way that senescent cells may drive ageing and age-associated pathology is 
via the SASP (Tchkonia, Zhu et al. 2013; Franceschi and Campisi 2014). Senescent 
cells secrete a number of SASP factors, including pro-inflammatory growth factors, 
cytokines and chemokines, such as GROα, IL-1, IL-6, IL-8, and monocyte chemo-
attractant proteins (MCPs) (Coppe, Patil et al. 2008; Freund, Orjalo et al. 2010). 
Therefore, senescent cells, which accumulate with ageing, may promote chronic tissue 
inflammation, characterised by infiltration of immune cells and thus causally contribute 
to the development of age-related disease (Freund, Orjalo et al. 2010). Additionally, 
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SASP components, such as IL-6 and IL-8 may stimulate tissue fibrosis in epithelial 
tissues by inducing epithelial-mesenchymal transition (EMT) (Laberge, Awad et al. 
2012). Furthermore, SASP factors include proteases, such as matrix metalloproteinases 
(MMPs) and collagenases, which may compromise the structural and functional 
integrity of surrounding tissue by cleaving components of the extracellular matrix 
(ECM), promoting disease (West, Pereira-Smith et al. 1989; Millis, Hoyle et al. 1992; 
Parrinello, Coppe et al. 2005; Coppe, Patil et al. 2008). Although, as previously alluded 
to, the SASP can have positive consequences, such as promoting clearance of tumour 
cells and limiting fibrosis (Xue, Zender et al. 2007; Krizhanovsky, Yon et al. 2008), it is 
also strongly implicated in tumourigenesis. The release of MMPs and pro-inflammatory 
mediators is thought to promote a microenvironment that favours survival and 
progression of neoplastic cells and may also induce malignant phenotypes in 
neighbouring cells through paracrine mechanisms (Krtolica, Parrinello et al. 2001; 
Martens, Sieuwerts et al. 2003; Bavik, Coleman et al. 2006; Coppe, Patil et al. 2008). 
Recently, it has been demonstrated that RAS activation in conjunction with 
mitochondrial dysfunction induces cellular senescence in Drosophila imaginal 
epithelium, leading to activation of the SASP and overgrowth of neighbouring tissue 
(Nakamura, Ohsawa et al. 2014). Therefore senescent cells, which cannot form tumours 
themselves, may facilitate the development of cancer in ageing organisms via the SASP, 
which may partially explain why cancer rates increase exponentially beyond middle age 
(DePinho 2000). Finally, as the SASP can spread from cell to cell through paracrine 
mechanisms (Nelson, Wordsworth et al. 2012), this may amplify sterile inflammation, 
age-related tissue deterioration and disease progression (Tchkonia, Zhu et al. 2013).  
Therefore, there is abundant evidence to suggest that the accumulation and 
persistence of senescent cells with age contributes to the ageing process and to the 
development of age-related diseases. While many correlations have been made, data 
also suggests that the senescence programme, late in life, is causally implicated in the 
generation of many age-related pathologies.  
  
1.7 The role of mTOR in senescence and ageing 
The mechanistic target of rapamycin (mTOR) is a serine/threonine protein kinase of the 
PI3K-related family that functions as a regulator of cell growth and metabolism in 
response to nutrient and hormonal cues (Johnson, Rabinovitch et al. 2013). mTOR can 
be found in two structurally and functionally distinct complexes: mTOR complex 1 
(mTORC1) and mTOR complex 2 (mTORC2), which are defined by their adaptors 
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Raptor and Rictor, respectively (Laplante and Sabatini 2012). Much more is known 
about the mTORC1 pathway and its reported functions involve integrating inputs from 
growth factors, environmental nutrients, stress and cellular energy status to modulate 
anabolic processes via control of translation, protein synthesis, lipid biosynthesis, 
glucose metabolism and autophagy (Johnson, Rabinovitch et al. 2013). mTORC1 
functions through at least two well-described downstream substrates: ribosomal protein 
S6 kinases (S6Ks) and eukaryotic translation initiation factor 4E (eIF4E)-binding 
protein 1 (4E-BP1) (Ekim, Magnuson et al. 2011). In contrast, little is known about the 
role of mTORC2 but it is known that this complex receives signals from growth factors 
to regulate glucose metabolism, lipogenesis, the actin cytoskeleton and apoptosis 
(Laplante and Sabatini 2012). 
Multiple lines of evidence support a role for mTOR in modulating the ageing 
process. It has been demonstrated that inhibition of mTOR and components of the 
mTORC1 pathway through genetic means extends lifespan of yeast, worms and flies 
(Fabrizio, Pozza et al. 2001; Vellai, Takacs-Vellai et al. 2003; Jia, Chen et al. 2004; 
Kapahi, Zid et al. 2004; Kaeberlein, Powers et al. 2005).  Similarly, dietary restriction 
(DR) is the most robust intervention able to extend lifespan and slow the progression of 
age-related diseases in many diverse species from yeast to primates (Fontana, Partridge 
et al. 2010). It is thought that decreased mTORC1 activity mediates longevity and 
health benefits resulting from DR interventions, which seems likely given its function in 
responding to nutrient availability and growth cues (Kenyon 2010). In agreement with 
this assumption, it has been demonstrated that DR fails to further extend replicative 
lifespan when combined with mutations in the mTORC1 pathway in yeast and worms 
(Kaeberlein, Powers et al. 2005; Hansen, Taubert et al. 2007). 
Rapamycin, a compound isolated from Streptomyces hygroscopicus present in 
the soil from Rapa Nui island (Vezina, Kudelski et al. 1975), is a chemical inhibitor of 
mTORC1 (Sabatini, Erdjument-Bromage et al. 1994). Rapamycin (also known as 
sirolimus) is a widely used immunosuppressant but is now predominantly recognised 
for its lifespan extending effects, consistent with a beneficial role for inhibiting mTOR 
signalling to reduce ageing. Indeed, a number of studies have shown that rapamycin 
extends lifespan in yeast, worms, flies and mice (Powers, Kaeberlein et al. 2006; 
Harrison, Strong et al. 2009; Bjedov, Toivonen et al. 2010; Anisimov, Zabezhinski et al. 
2011; Miller, Harrison et al. 2011; Robida-Stubbs, Glover-Cutter et al. 2012). 
Interestingly, Harrison and colleagues demonstrated that mTOR inhibition as a result of 
a rapamycin-supplemented diet lead to increased median and maximum lifespan even 
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when this intervention was started later in life (600 days of age) (Harrison, Strong et al. 
2009). Recent studies have described that chronic treatment with rapamycin may also 
inhibit mTORC2 in some cell types (Sarbassov, Ali et al. 2006). Emerging evidence 
suggests that, like DR, mTORC1 inhibition by rapamycin may also have positive effects 
on age-related pathologies. For example, rapamycin treatment delays disease 
progression in mouse models of Alzheimer’s disease (Spilman, Podlutskaya et al. 2010; 
Majumder, Richardson et al. 2011). Similarly, rapamycin attenuates cardiomyopathy in 
mice and improves cardiac and skeletal muscle function in mice lacking A-type lamins 
(Shioi, McMullen et al. 2003; McMullen, Sherwood et al. 2004; Ramos, Chen et al. 
2012). Additionally, rapamycin slows the occurrence of age-related alterations in heart, 
liver, adrenal glands, endometrium and tendon (Wilkinson, Burmeister et al. 2012) and 
also reduces the number of cancer-related deaths in mice (Anisimov, Zabezhinski et al. 
2011). 
Recent data suggest an important role for mTOR in cellular senescence. In vitro, 
progression from transient cell-cycle arrest induced by experimental p21 overexpression 
to permanent arrest is dependent upon continuous mTOR activation in response to 
growth factors (Blagosklonny 2012). Additionally, long-term cell-cycle arrest via p21 
overexpression may be reversible if mTOR is inhibited (Blagosklonny 2012). 
Furthermore, evidence suggests that rapamycin treatment can decelerate cellular 
senescence. For example, it was demonstrated in primary human fibroblasts undergoing 
either OIS or replicative senescence that mTOR inhibition by rapamycin or depletion of 
mTORC1 can delay several aspects of the senescence phenotype, including decreased 
proliferation rate, IL-8, p21 and Sen-β-Gal expression (Kolesnichenko, Hong et al. 
2012). Similar effects have been reported in rat embryonic cells (Pospelova, Leontieva 
et al. 2012). Consistently, rapamycin treatment attenuates drug- and H2O2-induced 
senescence in fibroblast and epithelial cell lines, respectively (Demidenko and 
Blagosklonny 2008; Demidenko, Zubova et al. 2009). On the other hand, it has been 
shown that rapamycin promotes OIS in a mouse model of pancreatic cancer (Kennedy, 
Morton et al. 2011). Nevertheless, mTOR hyper-activation induces senescence, while 
its inhibition induces quiescence in a p53-dependent manner (Korotchkina, Leontieva et 
al. 2010). Additionally, it has been shown that mTOR regulates NF-κB activity, 
suggesting that mTOR may be involved in the control of some senescence-associated 
inflammatory pathways (Dan, Cooper et al. 2008). 
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1.8 Cellular senescence and age-related lung disease 
The incidence of chronic respiratory diseases increases with age and so the 
accumulation of senescent cells in lung tissue might play a critical role in the 
development of a number of lung diseases (Bartling 2013). The biggest link between 
senescence and age-related lung disease comes from research into chronic obstructive 
pulmonary disease (COPD) (see below). However, the ageing process and cellular 
senescence have also been implicated in other pulmonary diseases, such as idiopathic 
pulmonary fibrosis (IPF), a progressive lung disease characterised by fibrosis of the 
interstitium, affecting the alveolar walls, with limited airway-centred pathology (Raghu, 
Weycker et al. 2006; Alder, Chen et al. 2008; Alder, Cogan et al. 2011; Minagawa, 
Araya et al. 2011). Bronchiectasis is another chronic lung disease, characterised by 
irreversible dilation of the bronchi and bronchioles, but in contrast to IPF has very 
limited interstitial aspects (King 2011). Similar to COPD, chronic inflammation is a 
major component of bronchiectasis that perpetuates disease progression (King 2011). 
However, cigarette smoking is not a major risk factor, with the majority of cases being 
labelled as idiopathic or post-infectious (Pasteur, Helliwell et al. 2000). Up to 50% of 
patients with COPD also have bronchiectasis (Patel, Vlahos et al. 2004). Thus, it is 
possible that there is overlap in the causative mechanisms underlying COPD and 
bronchiectasis. Currently there are, to our knowledge, very little data linking senescence 
to bronchiectasis.  
1.8.1 Accelerated lung ageing and senescence in COPD 
Chronic obstructive pulmonary disease (COPD) is one of the most common chronic 
respiratory diseases in the UK and a leading cause of morbidity and mortality globally 
(Hogg and Timens 2009). COPD is the fifth highest cause of death worldwide and is 
predicted to be the third highest by 2020 (Mannino and Buist 2007). COPD is 
characterised by chronic inflammation of both the large and peripheral airways. COPD 
also affects the lung parenchyma and thus may involve a degree of peri-airway fibrosis, 
mucous hypersecretion (chronic bronchitis) and destruction of alveolar airspaces 
(emphysema) (Bourdin, Burgel et al. 2009; Barnes 2013). These processes can and 
often occur in one individual although some patients may have either an emphysema or 
chronic bronchitis predominant phenotype.  
There are numerous lines of evidence that suggest accelerated ageing processes 
underlie the pathogenesis of COPD (Ito and Barnes 2009; MacNee 2009; Lee, Sandford 
et al. 2011). Inflammation is a key feature of COPD and is linked to tissue-remodelling 
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events and inadequate repair processes that are responsible for the structural changes 
that occur in the COPD lung (Chung and Adcock 2008). Inhalation of toxic particles 
drives inflammation and is linked to the pathogenesis of COPD. Thus, the key risk 
factor for COPD is cigarette smoking (Forey, Thornton et al. 2011). Around 15-20% of 
smokers develop COPD and almost all patients with COPD have significant smoking 
histories (Lokke, Lange et al. 2006). The inflammatory response to cigarette smoke that 
occurs in the COPD lung is enhanced compared to the inflammatory response that 
occurs in non-COPD smokers. Even after smoking cessation, chronic inflammation still 
persists (Willemse, ten Hacken et al. 2005). This suggests that inflammation is 
maintained by feedback loops in the COPD lung. The inflammation in COPD is 
complex, involving several types of immune cells and multiple inflammatory mediators 
(Barnes 2004; Fischer, Pavlisko et al. 2011). Levels of neutrophils, macrophages and 
CD8
+
 T lymphocytes are elevated in the COPD lung and show positive correlations 
with disease severity (Finkelstein, Fraser et al. 1995; Keatings, Collins et al. 1996; 
O'Shaughnessy, Ansari et al. 1997; Saetta, Baraldo et al. 1999). Pro-inflammatory 
cytokines, including tumour necrosis factor-α (TNF-α) and IL-6 are elevated in blood 
and sputum from patients with COPD (Di Francia, Barbier et al. 1994; Keatings, Collins 
et al. 1996; Bhowmik, Seemungal et al. 2000; Song, Zhao et al. 2001) and IL-8 levels 
are increased in the sputum and broncho-alveolar lavage fluid (BALF) of COPD 
patients (Keatings, Collins et al. 1996; Pesci, Balbi et al. 1998; Soler, Ewig et al. 1999). 
Additionally, baseline IL-8 release is increased from alveolar macrophages and 
epithelial cells from COPD patients (Culpitt, Rogers et al. 2003; Schulz, Wolf et al. 
2003). Growth factors, such as TGF-β, are also produced in COPD-associated 
inflammation and it has been demonstrated that TGF-β expression is increased from 
small airway epithelial cells and alveolar macrophages in patients with COPD 
(Takizawa, Tanaka et al. 2001). Finally, release and activity of proteases, such as 
MMP2 and MMP9, is increased from peripheral blood monocytes and alveolar 
macrophages from patients with COPD and likely contribute to connective tissue 
breakdown and reinforcement of inflammatory processes (Russell, Culpitt et al. 2002; 
Aldonyte, Jansson et al. 2003). Therefore, one way in which accelerated lung ageing is 
linked to COPD is in the nature of the inflammatory processes that occur in the COPD 
lung, with many inflammatory cytokines akin to the SASP (Kumar, Seeger et al. 2014). 
Moreover, the ability of senescent cells to potentially recruit immune cells (Xue, Zender 
et al. 2007), may also place them as key culprits in the COPD-associated inflammatory 
process.     
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The Free Radical Theory of Ageing suggests that ROS react with cellular 
constituents such as DNA and proteins, the accumulation of which leads to the 
progressive changes of senescence and ageing (Harman 1956). There is accumulative 
evidence that oxidative stress is a major driving mechanism in the pathophysiology of 
COPD. Indeed, there are an estimated 10
14-17 
oxidative particles per puff of cigarette 
smoke and patients with COPD show increased markers of oxidative stress both 
systemically and in the lung (MacNee 2001). Levels of 4-hydroxy-2-nonenal (4-HNE) 
(a lipid peroxidation end-product that reacts with extracellular proteins forming adducts) 
modified proteins were increased in airway and alveolar epithelial cells, endothelial 
cells and neutrophils present in lung tissue from patients with COPD (Rahman, van 
Schadewijk et al. 2002). Both RNA and DNA oxidation has been described in the 
alveolar wall cells of patients with COPD (Deslee, Woods et al. 2009). A common by-
product of guanine oxidation by reactive oxygen and nitrogen species is 8-hydroxy-2'-
deoxyguanosine (8-OHdG), which serves as an established marker of oxidative stress 
(Kasai 1997). It has been shown that 8-OHdG is increased in the peripheral lungs of 
patients with COPD and smokers without COPD compared to non-smokers and in 
induced sputum from patients with COPD compared to smokers and non-smokers 
(Caramori, Adcock et al. 2011; Tzortzaki, Dimakou et al. 2012). Moreover, antioxidant 
levels are decreased in patients with COPD (Houben, Mercken et al. 2009). 
In addition to cigarette smoking, ageing is a major risk factor for COPD. Indeed, 
the prevalence of COPD increases exponentially with increasing age (Lee, Sandford et 
al. 2011; Rycroft, Heyes et al. 2012). COPD is characterised by declining lung function, 
measured by forced expiratory volume in 1 second (FEV1). The decline in FEV1 that 
occurs as COPD progresses resembles that which occurs naturally with age, however, a 
larger volume is lost per year in COPD patients (Fletcher and Peto 1977). The ageing 
lung is associated with structural changes, such as alveolar dilatation, distal airspace 
enlargement and loss of supporting tissue for peripheral airways (Janssens, Pache et al. 
1999). These structural changes resemble those that occur in COPD, causing similar 
physiological consequences, including loss of elastic recoil. Additionally, mouse 
models of accelerated ageing, such as the homozygous mutant klotho (-/-) mouse, show 
premature onset of emphysema (Suga, Kurabayashi et al. 2000).   
The concept of accelerated lung ageing underlying the pathogenesis of COPD is 
further strengthened by studies demonstrating the presence of senescence-associated 
markers in the COPD lung and cells isolated from patients with COPD. For example, 
there are higher percentages of alveolar type II cells and pulmonary vascular endothelial 
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cells positive for p16 and p21 expression in lung tissue from patients with COPD 
compared to smokers without COPD and non-smokers (Tsuji, Aoshiba et al. 2006; 
Aoshiba and Nagai 2009; Tsuji, Aoshiba et al. 2010; Amsellem, Gary-Bobo et al. 2011). 
Similarly, there are significantly more γH2A.X and 53BP1 foci in type I and type II 
alveolar epithelial cells and endothelial cells in the lungs of patients with COPD 
(Aoshiba, Zhou et al. 2012). The HDAC SIRT1 is present at decreased levels in the 
peripheral lung tissue of smokers and COPD patients, likely due to increased oxidative 
stress (Rajendrasozhan, Yang et al. 2008; Nakamaru, Vuppusetty et al. 2009; Caito, 
Rajendrasozhan et al. 2010; Yao, Chung et al. 2012). Cells isolated from and cultured 
outside of the COPD lung, such as pulmonary vascular endothelial cells, retain markers 
of senescence including, Sen-β-Gal positivity and high p21 and p16 mRNA expression 
(Amsellem, Gary-Bobo et al. 2011). Similarly, lung fibroblasts from patients with 
advanced COPD appear senescent in culture, exhibiting reduced proliferation capacity 
and Sen-β-Gal expression (Holz, Zuhlke et al. 2004; Muller, Welker et al. 2006).  
Moreover, a number of studies report telomere shortening, a known inducer of 
senescence, in circulating leukocytes from COPD patients (Houben, Mercken et al. 
2009; Mui, Man et al. 2009; Savale, Chaouat et al. 2009). Savale et al., have shown that 
telomere length in circulating leukocytes of patients with COPD negatively correlates 
with plasma IL-6 levels (Savale, Chaouat et al. 2009). Interestingly, a dose-dependent 
relationship between smoking history and telomere length of circulating lymphocytes 
has also been described (Morla, Busquets et al. 2006). In one study of over 40 000 
individuals, shorter telomere length was associated with decreased lung function and 
increased risk of COPD (Rode, Bojesen et al. 2013). However, other studies have failed 
to find associations between telomere length and FEV1 or smoking history (Houben, 
Mercken et al. 2009; Savale, Chaouat et al. 2009).  
Cigarette smoking is the major risk factor for COPD and it has been 
demonstrated that in vitro exposure to cigarette smoke extract (CSE) results in 
senescence-associated phenotypic changes to the cell. In cultured alveolar epithelial 
cells, exposure to CSE lead to growth arrest, an enlarged morphology, Sen-β-Gal 
activity and increased p21 expression (Tsuji, Aoshiba et al. 2004). Similar findings have 
been reported in lung fibroblasts, with CSE exposure leading to an enlarged and 
flattened morphology, increased Sen-β-Gal activity and increased p16 expression 
(Nyunoya, Monick et al. 2006; Aoshiba and Nagai 2009). Cigarette smoke exposure 
also triggers H2A.X phosphorylation in normal bronchial epithelial cells (Albino, 
Huang et al. 2004) and leads to reduced SIRT1 expression in macrophages and primary 
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human epithelial cells in vitro (Rajendrasozhan, Yang et al. 2008; Caito, 
Rajendrasozhan et al. 2010). 
Therefore, it could be that accumulation of senescent cells, occurring naturally 
with ageing and as a result of chronic insult from cigarette smoke exposure, contributes 
to the structural changes and inflammatory processes that occur in the COPD lung.  
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1.9 Aims of this research 
Although there are a number of studies implicating cellular senescence in the 
pathogenesis of COPD, it is still largely unknown whether telomere dysfunction is a 
significant contributor to cigarette smoke induced senescence and COPD-associated 
pathology. Additionally, the role of cellular senescence in bronchiectasis has not been 
investigated. The overall aim of this work was to investigate cellular senescence and 
telomere dysfunction in the ageing lung, in age-related lung disease and in the context 
of cigarette smoke exposure. 
 
Specifically, the aims of this research were:  
1) To investigate large and small airway epithelial cell senescence in patients with 
COPD and patients with bronchiectasis  
2) To investigate airway epithelial cell senescence in the ageing murine lung and 
following cigarette smoke exposure, in particular the role of telomere 
dysfunction in this process 
3) To determine whether long-term cigarette smoke exposure induces telomere 
dysfunction and senescence in vitro, and if so, to uncover the potential 
mechanisms involved 
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Chapter 2: Materials and Methods 
2.1 Chemicals and Reagents  
Unless otherwise stated, all reagents used in this research were obtained from Sigma-
Aldrich Company Ltd (Poole, Dorset, UK).  
2.2 Buffers and Solutions 
A list of buffers and solutions used during this research is provided in Table 2.1. 
  
Chapter 2    Materials and Methods 
 
 38 
Solution  Components 
Sen-β-Gal staining solution 150mM NaCl, 2mM MgCl2, 40mM citric 
acid, 12mM sodium phosphate pH6, 
400g/ml X-Gal, 2.1mg/ml Potassium 
hexacyanoferrat(II)trihydrate, 1.65mg/ml 
Potassium hexacyanoferrat (III) trihydrate 
 
PBG-Triton 0.2% fish skin gelatin (Sigma, G7765), 
0.5% BSA, 0.5% Triton X-100, 1% PBS 
 
Hybridisation buffer for Immuno-FISH 70% deionised formamide (Sigma), 25 
mM MgCl2, 1 M Tris pH 7.2, 5% blocking 
reagent (Roche,Welwyn, UK), 4ng/μL Cy-
3 labelled telomere specific (CCCTAA) 
peptide nuclei acid probe (Panagene, 
F1002-5), distilled H2O 
2 x SSC 17.53g of NaCl, 8.82g of sodium citrate, 
1L of H2O (pH7.0) 
 
Citrate buffer (0.01M) 29.41g of trisodium citrate, 1L of distilled 
H2O (pH 6.0) 
 
1 x EDTA buffer  10 mM Tris-CL, 1 mM EDTA, distilled 
H2O (pH 7.5) 
Haematoxylin 5g Haematoxylin (Sigma, H3136), 300 ml 
Glycerin (Sigma, G2289), 50g Aluminium 
potassium sulphate (Sigma, 7210), 0.5g 
Sodium iodate (Sigma, S4007), 40 ml 
glacial acetic acid (Sigma, 537020) in 
700 ml H2O 
 
 
1 x TBS 50 mM Tris-Cl, 150 mM NaCl, distilled 
H2O (pH 7.5) 
Table 2.1. Buffers and solutions used during this research. 
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2.3 Cell culture 
2.3.1 Cell lines 
MRC5 cells (normal human foetal lung fibroblasts) were obtained from European 
Collection of Cell Cultures (ECACC, #05090501) (Salisbury, UK). 
2.3.2 Primary cells  
Primary human airway epithelial cells were isolated from bronchial brushings carried 
out during research bronchoscopy (normal controls) or from explant lung tissue 
specimens (COPD). COPD patients were characterised by a physician as having COPD 
according to smoking pack years, FEV1 measurements and ranked in Global Initiative 
for Chronic Obstructive Lung Disease (GOLD) criteria. Patients underwent 
bronchoscopy after a stable phase of at least 4 weeks. Normal controls identified from a 
volunteer register or local adverts were confirmed not to have COPD by FEV1 testing- 
never and ex-smokers were eligible. Further PBECs from explant lung tissue specimens 
of patients with advanced COPD were collected. Patients and volunteers gave written 
informed consent prior to inclusion in the study. The work was performed under 
approval of the Newcastle and North Tyneside 1 Research Ethics Committee (RES-
10/H0906/44) and (RES-11/NE/0291).   
2.3.3 Routine cell culture  
MRC5 cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Sigma, 
D7596) supplemented with foetal bovine serum (FBS) (10% v/v) (Sigma, 12133C), L-
glutamine (2mM) (Sigma, G3126), penicillin (100 units/ml)/streptomycin (100 g/ml) 
(Sigma, P4333) and maintained at 37C, 5% CO2. Cell culture was carried out using 
aseptic technique in a class II safety cabinet. Cell passaging included a phosphate 
buffered saline (PBS) wash, subsequent trypsinisation with pre-warmed Trypsin-EDTA 
(TE) (0.5% Trypsin, 0.2% EDTA) (Sigma, T3924) at 37C followed by neutralisation 
with cell culture medium. Cells were then collected by centrifugation or resuspended in 
fresh medium at a suitable density and reseeded into tissue culture flasks or dishes.  
Primary airway epithelial cells were cultured on 0.5% PureCol® (Invitrogen, 
Carlsbad, CA)-coated dishes in large or small airway epithelial cell growth medium 
(L/SABM, CC-3171/19) supplemented with 2% FBS, 100 U ml
-1
 penicillin and 100 mg 
ml
-1
 streptomycin (Lonza, Basel, Switzerland) and maintained at 37C, 5% CO2. 
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2.3.4. Cryogenic storage  
Exponentially growing adherent cells were trypsinised and centrifuged at 800 g for 5 
minutes at room temperature. The supernatant was removed and cells were washed in 
sterile PBS, re-centrifuged and re-suspended in FBS containing 5% (v/v) dimethyl 
sulfoxide (DMSO) (Sigma, D2650) at a density of 1 x 10
6 
cells/ml. Aliquots of 1ml cell 
suspension were immediately transferred to cryo-vials and placed in a Nalgene
TM 
Cryo 
freezing container filled with isopropanol. Cells were kept for 24 hours at -80C to 
allow them to slowly freeze before being stored long-term in liquid nitrogen.  
2.3.5 Resuscitation of frozen cells 
Cryo-vials were removed from liquid nitrogen and quickly thawed at 37C for 1 to 2 
minutes. Cells were immediately seeded into a 75 cm
2 
with 20 ml pre-warmed medium. 
Medium was replaced after 24 hours to remove DMSO and cell debris. 
  
2.3.6 Calculation of cell density and population doublings  
To determine the concentration of cells within the cell suspension, 20 l of suspension 
was added to a Fuchs-Rosenthal 0.2 mm haemocytometer (VWR International UK) and 
cells manually counted under a standard microscope (DMIL, Leica Microsystems, UK). 
The average of four counts of 8 squares was taken, which is equivalent to the number of 
cells x 10
4
/ml. Cells within and touching the top and left sides of the square were 
counted. Total cell number was calculated by multiplying the total volume of cell 
suspension by the number of cells per ml. With every cell passage, population doubling 
(PD) was calculated by comparing total cell number with number previously plated, 
using the following equation: 
PD = X + (ln(N1/N2))/ln2 
Where: 
PD= population doubling 
X= previous PD 
N1 = number of cells harvested  
N2 = number of cells seeded 
2.4 Cell treatments 
All cell treatments were performed on MRC5 cells at a PD of 20-30 (stress-induced 
senescence) or after replicative exhaustion (replicative senescence).  
Primary airway epithelial cells were treated at P1 and kept for a maximum of 3 days in 
culture.  
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2.4.1 Cigarette smoke extract 
Cigarette smoke extract (CSE) was generated in a fume hood by burning one research 
grade cigarette (Tobacco Health Research Institute, University of Kentucky, Lexington, 
KY, 4A1) and bubbling the smoke produced into 25 ml of DMEM using a vacuum 
pump (KNF lab, N811KVP) (flow rate: 13l/min). The generated CSE solution was 
filtered (0.22 μm) for sterility and to remove large particles. The resulting solution was 
designated 100% CSE. The CSE solution was diluted in DMEM to the appropriate 
working concentration and used immediately. 
 
 
Figure 2.1 Set up of equipment used to generate cigarette smoke extract.  
2.4.2 CSE treatment 
MRC5 cells at PD 20-25 (when 70-80% confluent), grown under normoxia (20% 
oxygen) were treated with 5% CSE until replicative senescence. Media + 5% CSE was 
replaced every 48 hours. Controls were grown in the absence of CSE and media was 
changed every 48 hours. Cells were harvested for analysis at 3, 7, 13, 24, 38 and 60 
days after first treatment. At these time points, 5 x 10
4 
cells were seeded per well into 
12-well plates containing sterile 16 mm coverslips to be fixed for further analysis. 25 x 
10
4 
cells were also seeded into T-25 flasks to harvest media for cytokine analysis. The 
remaining cells were used for mitochondrial function and reactive oxygen species (ROS) 
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production assessment using flow cytometry and pelleted for protein and RNA analysis 
and stored at -80C. 
Primary airway epithelial cells (P1) were grown under normoxia in 12-well 
plates on sterile coverslips. Cells were treated with 5% CSE on two separate occasions, 
48 hours apart. Cells were fixed 8 hours following the final treatment and stored at -
80C until further analysis.  
2.4.3 Hypoxia treatment 
MRC5 cells at PD 20-25 were cultured under 3% oxygen in combination with 5% CSE 
or DMEM alone. MRC5 cells cultured under normal conditions were run in parallel. 
Media + 5% CSE was replaced every 48 hours. Controls were grown in the absence of 
CSE and media was changed every 48 hours. Cells were harvested for analysis at 14 
and 25 days following the initial treatment. At these time points, cells were seeded into 
12-well plates, replated for cytokine analysis and analysed using flow cytometry, as 
described above.  
 2.5 Treatment with pathway inhibitors 
2.5.1 Inhibition of mTORC1 
MRC5 fibroblasts (PD 20-25), confluent to 70-80%, were treated with 5% CSE or 
DMEM alone (control) in combination with rapamycin (100nM, diluted in DMSO) 
(Sigma, R8781). Rapamycin was replaced every 48 hours along with 5% CSE or fresh 
DMEM. Controls treated with the same concentration of DMSO were included. Cells 
were harvested for analysis at 14 and 25 days following the initial treatment. At these 
time points, cells were seeded into 12-well plates, re-plated for cytokine analysis and 
analysed using flow cytometry, as described above.  
2.5.2 Inhibition of ATM 
MRC5 fibroblasts (PD 20-25), confluent to 70-80%, were treated with 5% CSE and 
treated with the ATM chemical inhibitor KU55933 (10M, diluted in DMSO) (R&D, 
3544). MRC5 cells cultured in DMEM alone were also treated with 10M of KU55933. 
The chemical inhibitor KU55933 was replaced every 48 hours along with 5% CSE or 
fresh DMEM. Controls treated with the same concentration of DMSO were included. 
Cells were harvested for analysis at 14 and 25 days following the initial treatment. At 
these time points, cells were seeded into 12-well plates, re-plated for cytokine analysis 
and analysed using flow cytometry, as described above. 
Chapter 2    Materials and Methods 
 
 43 
2.6 Flow cytometry 
Calibration of the flow cytometer (Partec, http://www.partec.com) was carried out using 
fluorescent beads to ensure optimum performance and reproducibility. For each 
independent experiment, measurements were performed in triplicate and 10 x 10
4 
cells 
were analysed per measurement.  
2.6.1 MitoSOX staining  
MitoSOX is a red fluorogenic dye used to detect mitochondrial-derived superoxide 
anions, which are produced in the mitochondrial matrix. MitoSOX permeates live cells 
and selectively targets mitochondria. It is rapidly oxidised by superoxide, but not by 
other ROS, resulting in red fluorescence. MRC5 cells were harvested and centrifuged at 
1600 RPM for 3 minutes. Supernatant was discarded and cells were resuspended in 
MitoSOX Red (5 M, diluted in serum-free DMEM) (Invitrogen, M36008) and 
incubated for 10 minutes at 37C in the dark. Cells were centrifuged at 1600 RPM for 3 
minutes and supernatant removed. The cell pellet was resuspended in 2ml of serum free 
DMEM and MitoSOX median fluorescence intensity was measured by flow cytometry 
(Red – FL3 channel). The population of live cells was defined in a FSC/SSC dotplot 
and apoptotic cells and debris excluded by gating.  
2.6.2 DHR staining 
Dihydrorhodamine (DHR) is a cell-permeable dye used to detect ROS, including 
peroxynitrite and peroxide. Upon oxidation by ROS, the colourless dihydrorhodamine 
123 is oxidised to form rhodamine 123, which is highly fluorescent. The fluorescent 
product accumulates in the mitochondria. MRC5 cells were harvested and centrifuged at 
1600 RPM for 3 minutes. Supernatant was discarded and cells were resuspended in 
DHR (30 M, diluted in serum-free DMEM) (Invitrogen, D1168) and incubated for 30 
minutes at 37C in the dark. Cells were centrifuged at 1600 RPM for 3 minutes and 
supernatant removed. The cell pellet was resuspended in 2ml of serum free DMEM and 
DHR mean fluorescence intensity was measured by flow cytometry (Green – FL1 
channel). 
2.7 Senescence associated-β-galactosidase (Sen-β-Gal) staining  
Cells grown on coverslips were washed with PBS and fixed with 2% PFA in PBS for 10 
minutes. Cells were then stained in Sen-β-Gal staining solution (Table 2.1) (pH 6.0) for 
24 hours at 37C. Coverslips were washed two times in PBS and mounted with hardset 
VectaShield mounting media with 4',6-diamidino-2-phenylindole (DAPI) (Vector lab, 
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H1200). Cells showing Sen-β-Gal staining (blue staining) and total number of cells 
(DAPI staining) were counted in 10 randomly chosen fields (20X objective) per 
experiment using a Leica DM5500B microscope. Images were captured using a Leica 
DFC420 camera using LASAF software (Leica). Percentage of positive cells was 
quantified manually using ImageJ.  
2.8 Mice 
2.8.1 Mice groups and treatments  
All work was compiled with the guiding principles for the care and use of laboratory 
animals. 
Male C57BL/6 mice were split into groups (n=3-5/group) according to age and 
diet: 6.5 month old mice fed control or rapamycin-supplemented diet for 3.5 months, 15 
month old mice fed control or rapamycin-supplemented diet for 12 months and 24 
month old mice fed only control diet. Control and rapamycin diets commenced when 
mice were 3 months of age and continued until time of sacrifice. Mice were randomly 
assigned to either control or rapamycin diets. Control and rapamycin diets were 
purchased from TestDiet - Control diet: 5LG6/122 PPM EUDRAGIT 3/8 #1814831 
(5AS0) and Encapsulated Rapamycin diet: 5LG6/122 PPM ENCAP RAP 3/8 #1814830 
(5ARZ). Mice were fed ad libitum and monitored weekly. 
TERC
-/+
 mice (obtained from The Jackson Laboratory) were crossed to generate 
G1 TERC
-/-
 mice. These mice were crossed through successive generations to produce 
fourth-generation (G4) TERC
-/- 
mice. Mice were maintained on C57BL/6J background. 
Mice were monitored weekly. Lungs from G4 TERC
-/- 
mice sacrificed at 6 months of 
age were analysed.  
The project was approved by the Faculty of Medical Sciences Ethical Review 
Committee, Newcastle University. Project license number: 60/3864. 
 
In collaboration, lung tissues from mice exposed to either room air or cigarette 
smoke were a kind gift from Dr Mark Birrell, Imperial College London, UK. Male 
C57BL/6 mice (n=5/group) at 10 weeks of age were subjected to a whole body cigarette 
smoke exposure system or room air, as previously described (Eltom, Stevenson et al. 
2011). Briefly, cigarette smoke was generated using 3R4F cigarettes (Cigarette filter 
removed, University of Kentucky) and pumped into a Teague chamber (136L) for 1 
hour, twice daily (500ml/min) for 14 days. Mice were sacrificed 24 hours after the final 
exposure.  
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2.8.2 Mice housing  
Animal procedures were performed in accordance with the UK Home Office guidelines 
for animal welfare based on the Animals (Scientific Procedures) Act 1986. Animals 
were housed in a temperature-controlled room with a 12 hour light/dark cycle. No 
statistical method was used to predetermine sample size.  
2.8.3 Mice tissue collection and preparation  
Tissues were collected during necropsy and fixed with 4% formaldehyde aqueous 
solution (VWR, 9713.9010) and embedded in paraffin for histochemical analysis.  
2.9 Subjects 
 The cross-sectional investigation of senescence-associated markers in lung tissue 
specimens from patients with COPD, patients with bronchiectasis and smokers without 
COPD or bronchiectasis (controls) undergoing resection surgery was conducted at the 
Sir William Leech Centre for Lung Research, Freeman Hospital (Newcastle upon Tyne, 
UK) with the help of a clinical team. The clinical team (Prof Andrew Fisher, Dr 
Anthony De Soyza, Dr Syba Sunny, Mr Sasha Stamenkovic, Dr Fiona Black and Gail 
Johnson) were involved in subject recruitment and the obtaining of lung tissue 
specimens. Sampling was opportunistic by necessity.   
2.9.1 Subject recruitment  
Control subjects were recruited prospectively between October 2011 and February 2012 
when attending the Freeman Hospital for pulmonary resection for localised lung cancer. 
Lung tissue from patients with COPD and patients with bronchiectasis was acquired 
from archived tissue taken from patients at the time of lung transplantation as part of the 
lung transplant programme at the Freeman Hospital. Where possible, subjects were 
matched for age and smoking status. Table 3.1 gives an overview of the clinical 
characteristics of the subjects.  
2.9.2 Obtaining and processing of lung tissue specimens 
Potentially suitable material was identified from histology reports and requested from 
either the Royal Victoria Infirmary (RVI) pathology archive (Newcastle upon Tyne) or 
the Human Tissue Act (HTA) approved Sir William Leech research archive (Freeman 
Hospital, Newcastle upon Tyne). Tissue blocks containing central airways and blocks 
containing parenchymal tissue were obtained from each subject. Formalin-fixed, 
paraffin-embedded lung tissue blocks were cut into sections at a thickness of 5μm using 
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a Reichert-Jung 2035 rotary microtome (Leica) and mounted onto glass slides. Slides 
were dried by incubating at 60˚C overnight.  
2.9.3 Ethical approval  
The collection of lung tissue from control subjects and patients with COPD was 
approved by the County Durham and Tees Valley 2 Research Ethics Committee (RES-
11/NE/0291) and patients gave written informed consent prior to inclusion in the study.  
2.10 Immunofluorescence  
2.10.1 Immunofluorescence staining on fixed cells  
Cells grown on sterile coverslips were fixed with 2% paraformaldehyde (PFA) (VWR, 
9713.9010) in PBS for 10 minutes at room temperature. PFA was removed and cells 
were washed two times with PBS. To permeabilise, cells were incubated with 1 ml 
PBG-Triton for 45 minutes at room temperature. Cells were incubated with diluted 
primary antibody in PBG-Triton overnight at 4C or for one hour at room temperature 
with gentle agitation. Cells were washed three times with PBG-Triton for 5 minutes and 
incubated for 45 minutes to 1 hour with fluorescein-conjugated secondary antibody 
diluted 1:4000 in PBG-Triton away from light. Cells were washed two times with PBS 
for 10 minutes and stained with 400l of DAPI (Partec, 05-5001) for 10 minutes. Cells 
were washed three times with PBS before mounting cells on slides with anti-fade 
VectaSheild mounting medium (Vector lab, H1000). Slides were analysed using a Leica 
DM5500B microscope and fluorescence images were captured with a DFC360FX 
camera using LASAF software (Leica).   
2.10.2 Immuno-FISH (γH2A.X-TeloFISH) staining on fixed cells  
Fluorescence in situ hybridization (FISH) utilises fluorescent probes to detect specific 
DNA sequences. The bound fluorescent probe can then be visualised using a fluorescent 
microscope.  
Cells grown on coverslips were fixed and γH2A.X immuno-staining was 
performed as described above. Following application of the secondary antibody, cells 
were washed with PBS and FISH was performed.  
Cells were fixed in 1 ml of fixative (methanol: acetic acid, 3:1) for 30 minutes 
and then dehydrated in graded ethanol solutions (70, 90, 100%) for 2 minutes each. 
Cells were immersed in PBS at 37C for 5 minutes and fixed in 4% PFA in PBS at 
37C for 2 minutes. Cells were dehydrated again with cold ethanol solutions (70, 90, 
100%) for 2 minutes each and air-dried before being denatured for 10 minutes at 80C 
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in hybridisation buffer containing PNA probe (see Table 2.1). Cells were then incubated 
for 2 hours at room temperature in the dark to allow hybridisation to occur. Cells were 
washed 3 times for 10 minutes with 70% formamide in 2 x SSC, followed by three 5 
minute washes in TBS-Tween 0.05%. Cells were dehydrated in graded ethanol series 
(70, 90, 100%) for 2 minutes each, air-dried and mounted using VectaSheild mounting 
medium Antifade + DAPI (Vector labs, H1500). Cells were imaged using a Leica 
DM5500B fluorescence microscope. In depth Z stacking was used (a minimum of 40 
optical slices with 100 x objective) followed by Huygens (SVI) deconvolution. DNA 
damage foci and telomere-associated foci were analysed blinded by several experienced 
observers using ImageJ software. The majority of images were quantified by J Birch 
with confirmatory quantifications carried out in a blinded fashion by R Anderson and C 
Melo from our lab.  





Antibody  Species/Isotype Specificity  Dilution  
Anti-Ki67 (Abcam, 
ab15580) 







Mouse monoclonal Human 1:200 
Table 2.2 Primary antibodies used for immunofluorescence on cells  
 












Goat Mouse 1:4000 
Table 2.3 Secondary antibodies used for immunofluorescence on cells  
 
2.10.3 Immunofluorescence staining on paraffin embedded tissues  
Sections cut at 5m (human) or 3m (mouse) thick were deparaffinised in Histoclear 
(National Diagnostics, HS-200) twice (5 minutes each) and hydrated in graded ethanol 
solutions: 100% (2 x 5 minutes), 90% (5 minutes) and 70% (5 minutes), before being 
washed in distilled H2O (2 x 5 minutes). 
To retrieve antigens, sections were incubated in 0.01M citrate buffer (pH 6.0) 
for 5 minutes at high power (800W) in a microwave oven, followed by 10 minutes at 
medium power (400W). Sections were allowed to cool to room temperature in an ice 
bath before being washed in distilled H2O (2 x 5 minutes). 
Sections were incubated for 30 minutes at room temperature in blocking reagent 
(Normal goat serum (NGS) (Vector lab, PK-6101) diluted 1:60 in 0.1% bovine serum 
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albumin (BSA) (Sigma, A9418) in PBS). Sections were incubated with the primary 
antibody (diluted in blocking reagent) overnight at 4C.  
Sections were washed in PBS (3 x 5 minutes) and incubated for 30 minutes with 
secondary antibody (diluted in blocking reagent) at room temperature. Sections were 
washed in PBS (3 x 5 minutes). For γH2A.X staining, sections were incubated with 
Fluorescein Avidin DCS (1:500) (Vector Lab, A-2011) diluted in PBS for 30 minutes at 
room temperature. Sections were washed in PBS (3 x 5 minutes) followed by 
counterstaining with DAPI for 10 minutes. Sections were washed in PBS (3 x 10 
minutes), before being mounted with an anti-fade VectaShield mounting medium 
(Vector lab, H-1000). Staining was analysed using a Leica DM5500B microscope and 
fluorescence images were captured with a DFC360FX camera using LASAF software 
(Leica). 
2.10.4. Immuno-FISH (γH2A.X-TeloFISH) staining on paraffin embedded tissues  
Immunofluorescence staining was carried out as described above. Following incubation 
with Avidin DCS, sections were washed in PBS (3 x 5 minutes) and then samples were 
crosslinked by incubating in 4% PFA in PBS for 20 minutes. Sections were washed in 
PBS (3 x 5 minutes) and then dehydrated in graded ethanol solutions (70%, 90% and 
100%, 3 minutes each). Tissue sections were air dried and denatured in hybridisation 
buffer containing PNA probe (see Table 2.1) for 10 minutes at 80C, followed by 
hybridisation for 2 hours at room temperature in the dark. Sections were washed for 10 
minutes with 70% formamide in 2 x SSC, followed by a 10 minute wash in 2 x SSC and 
a further 10 minute wash in PBS. Nuclei were counterstained with DAPI for 10 minutes 
and washed in PBS (3 x 5 minutes) before being mounted in VectaShield mounting 
medium. Staining was analysed using a Leica DM5500B fluorescence microscope and 
Z-stack images (a minimum of 40 optical slices with 100 x objective) taken with a 
DFC360FX camera using LASAF software (Leica). This was followed by Huygens 
(SVI) deconvolution. The specificity of staining was confirmed by including controls 
where the primary antibody was omitted. Telomere associated foci were analysed by 
several observers as above using ImageJ software.  










Rabbit monoclonal Human 
Mouse 
1:400 
Anti-p16 (Santa Cruz, 
SC-81156) 
Mouse monoclonal Human 1:500 
Table 2.4 Primary antibodies used for immunofluorescence on tissues 
 




ABC Kit) (Vector lab, 
PK-6101) 






Goat Mouse 1:4000 
Table 2.5 Secondary antibodies used for immunofluorescence on tissues 





2.11.1 Immunohistochemistry staining of human tissue  
On aminopropyltriethoxysilane (APES) (Sigma, A3648) treated slides, sections cut at 
5m were deparaffinised in xylene (5 minutes) and rehydrated through graded ethanol 
solutions (99%, 99%, 95%; 1 minute each). Endogenous peroxidase activity was 
blocked by immersing sections in 0.3% H2O2 (Sigma, H1009), diluted in methanol for 
30 minutes. Sections were washed under running tap water for 10 minutes. Antigen 
retrieval was performed as described (Table 2.6). Sections were rinsed in 1 x Tris-
buffered saline (TBS) and blocked in 5% non-fat milk protein (NFMP) diluted in TBS 
where required (Table 2.6). Primary antibodies were diluted in 3% bovine serum 
albumin (BSA) in TBS as per the antibody datasheet and 100μl of diluted antibody or 
isotype control was applied to tissue sections (See Table 2.6 for dilutions). Antigen 
retrieval and primary antibody concentrations were optimised in collaboration with Gail 
Johnson from the Sir William Leech Laboratories, Freeman hospital. Sections were 
incubated in a moist incubating tray for the required time period (Table 2.6). Slides 
were then gently washed in TBS (2 x 5 minutes). Excess TBS buffer was removed and 
100μl of anti-mouse (Dako, K4006) or anti-rabbit (Dako, K4010) secondary antibody 
conjugated with a horseradish-peroxidase (HRP)- labelled polymer added (Envision+ 
System-HRP, Dako). Sections were incubated for 30 minutes at room temperature. 
Slides were gently washed in TBS for 5 minutes and treated with 3,3’-diaminobenzidine 
(DAB) (1 drop DAB chromogen to 1ml DAB substrate buffer) for 5-10 minutes. The 
reaction was checked microscopically. Slides were washed under running tap water and 
nuclei counterstained with Carrazzi Haematoxylin for 1 minute. Sections were washed 
under running tap water until nuclei appeared blue, dehydrated through graded ethanol 
solutions: 95%, 99% and 99% (30 seconds each), cleared in xylene and mounted in Di-
N-Butyle Phthalate in Xylene (DPX) (Thermo Scientific, LAMB-DPX).  
 Central and peripheral airway epithelial cell staining was evaluated using a 
digital camera (MicroPublisher 3.3, QImaging) in a light microscope (Olympus BH-2) 
at 400 X magnification. Sub-epithelial reticular basement membrane length was 
measured in order to calculate the number of positive cells/mm basement membrane as 
previously described (Ward et al., 2004). In brief, an image analyser (Image-Pro Plus, 
6.3, Silver Spring, MD, USA) was used to score the number of positive epithelial cell 
nuclei above all of the reticular basement membrane available in the lung tissue sections. 
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The length of reticular basement membrane in each visual field was confirmed using a 
measuring tool calibrated at 400 X magnification. Total number of positive nuclei/mm 
basement membrane was calculated and an average score for each tissue section 
generated. In order to avoid artefacts introduced by tissue processing, airways were 
positively identified by the presence of intact, well-orientated airway epithelium and the 
attachment of the basement membrane to the rest of the tissue.  
 Level of staining in human tissue was also quantified using a semi-quantitative 
scoring method, whereby anonymised tissue sections were ordered from lowest to 
highest level of staining and given a score of 0-3 based on level of positivity in the 
airway epithelium. Quantifications were carried out in a blinded fashion by two 
independent scientists (J Birch and K Jiwa (NHS biomedical scientist)). Figure 2.2 



























Figure 2.2 Representative images of scores for SIRT1 staining in small airway 
epithelial cells. Sections were scored from 0-3 based on level of positive staining in the 
airway epithelium. Scores were determined based on overall staining observed for that 
marker across all tissue sections. Examples are shown for a score of 0, 1, 2 and 3. 
Images were captured using X20 objective. 
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Table 2.6 Primary antibodies used for immunohistochemistry on human tissues.  
*Isotype controls were diluted to the same protein concentration as the primary 
antibody. NFMP, non-fat milk protein; Ig, Immunoglobulin; EDTA, 
Ethylenediaminetetraacetic acid; NA, not applicable.  




2.11.2 Immunohistochemistry staining of mouse tissue  
On APES treated slides, sections cut at 3m were deparaffinised in Histoclear (2 x 5 
minutes) and hydrated in graded ethanol solutions: 100% (2 x 5 minutes), 90% (5 
minutes) and 70% (5 minutes), before being washed in distilled H2O (2 x 5 minutes).  
To retrieve antigens, sections were incubated in 0.01M citrate buffer (pH 6.0) for 5 
minutes at high power (800W) in a microwave oven, followed by 10 minutes at medium 
power (400W). Sections were allowed to cool to room temperature in an ice bath before 
being washed in distilled H2O (2 x 5 minutes). Endogenous peroxidase activity was 
blocked by incubating sections in 0.9% H2O2 diluted in distilled H2O for 30 minutes. 
Sections were rinsed under running tap water, washed in PBS (5 minutes) and incubated 
for 30 minutes at room temperature in blocking reagent (NGS diluted 1:60 in 0.1% BSA 
in PBS). Sections were incubated with the primary antibody (diluted in blocking reagent) 
overnight at 4C. Sections were washed in PBS (3 x 5 minutes) and incubated with 
biotinylated secondary antibody (diluted in blocking reagent) for 30 minutes at room 
temperature. Sections were washed in PBS (3 x 5 minutes) and secondary antibodies 
detected using the rabbit peroxidase ABC kit (Vector lab, PK-4001) according to the 
manufacturer’s instructions. Substrate was developed using the NovaRed kit (Vector lab, 
SK-4800) according to the manufacturer’s instructions.  Sections were washed in tap 
water (3 x 1 minute) and nuclei were counterstained with haematoxylin for 15-30 
seconds. Sections were washed under running tap water until nuclei appeared blue, 
dehydrated in graded ethanol solutions: 70%, 90% and 100% (30 seconds each), cleared 
in Histoclear and mounted in DPX. Slides were analysed with a NIKON ECLIPSE-
E800 microscope and images were captured with a Leica DFC420 camera using the 
LAS software (Leica). Levels of positive staining were determined by quantifying the 
number of negative and number of positive nuclei and generating an average percentage 
from 10 randomly captured images for each animal.  
 






Antibody  Species/Isotype Specificity  Dilution  
Anti-p21 (Abcam, 
ab7960) 





(Abcam, ab2557)  
Rat Monoclonal Mouse 1: 200 
Table 2.7 Primary antibodies used for immunohistochemistry on mouse tissues 
 




ABC Kit) (Vector lab, 
PK-6101) 
Goat Rabbit 1:200 
Anti-rat IgG (Vector 
lab, BA-9400) 
Goat Rat 1: 200 
Table 2.8 Secondary antibodies used for immunohistochemistry on mouse tissues 
 
2.12 Haematoxylin and eosin (H&E) staining 
Sections mounted onto glass slides were de-waxed in xylene (5 mins), rehydrated 
through graded ethanol solutions (99%, 99%, 95%; 1 min each) and rinsed in water 
until clear. Sections were immersed in Harris Haematoxylin (6765003; Thermo 
Scientific) for 1 min. Sections were then rinsed well in running tap water for 2-3 mins. 
Sections were checked microscopically (Olympus CH-2) and differentiated in 0.1% 
Acid Alcohol when required. Sections were washed again in running tap water until 
nuclei appeared blue microscopically. Sections were counterstained in Eosin-Y 
(6766007; Thermo Scientific) for 2 minutes and washed under running tap water until 
clear. Sections were dehydrated through graded ethanol solutions (95%, 99%, 99%; 1 
min each), cleared in xylene and mounted in DPX.  
2.13 Quantification of alveolar airspace size  
Following H&E staining, for murine lung tissue sections, alveolar airspace size was 
quantified by two methods.  
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2.13.1 Quantification of alveolar airspace size by mean linear intercept 
Images were randomly captured (n=10 per animal) using X20 objective of areas of 
tissue where there were no airways or pulmonary blood vessels contained within the 
visual field. The mean linear intercept (MLI) was determined for each image and an 
average calculated per mouse. MLI was determined using ImageJ software, whereby a 
diagonal line of known length was drawn from the bottom left of each image to the top 
right and number of intersections (from alveolar wall segments) along that line 
quantified. The length of the line in microns was divided by the number of intercepts, as 
previously described (Weibel 1963). Therefore, the fewer the number of intersections, 
indicative of a reduction in alveolar airspaces or increased airspace size, the higher the 
MLI value.   
2.13.2 Quantification of alveolar airspace size by counting number of airspaces  
Changes in alveolar airspace size were also quantified by manually counting the number 
of airspaces present in each visual field and an average number calculated per animal.  
2.14 Analysis of pro-inflammatory cytokine release  
2.14.1 Antibody array  
A Quantibody Human Cytokine Array for 20 cytokines (RayBiotech, QAH-CYT-1) 
was performed. Conditional media was collected at a range of time points (mentioned 
above) for both 5% CSE-exposed and untreated cells following 24h serum deprivation. 
Conditional media was then sent to RayBiotech for analysis using the Quantibody 
Human Cytokine Array. Limit of detection for this assay was 10 ρg/ml. 
2.14.2 Enzyme-linked immunosorbent assays (ELISA) 
IL-6 and IL-8 concentrations in cell culture supernatants were determined using 
commercially available ELISA kits (Duoset, R&D systems, DY206/DY208), according 
to the manufacturer’s instructions. Conditional media was collected at a range of time 
points (noted above) for both 5% CSE-exposed and untreated cells following 24h serum 
deprivation. All assays were carried out at room temperature. Limit of detection for this 
assay was 10 ρg/ml. 
2.15 Protein expression analysis  
2.15.1 Protein Extraction 
MRC5 cells were washed with ice cold PBS before lysis in ice cold RIPA buffer (150 
mM NaCl, 1% NP40, 0.5% NaDoC, 0.1% SDS, 50 mM Tris pH 7.4 and 1x phosphatase 
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and protease inhibitors cocktail (Thermo Scientific, 78442). Samples were collected 
into 1.5 ml microcentrifuge tubes and immediately stored at -80C until further analysis.  
2.15.2 Protein quantification 
Cell lysates were thawed on ice and centrifuged for 10 minutes at 16100g at 4C. 
Protein quantification was performed using a colorimetric Bio-Rad DC Protein Assay 
(Bio-Rad; Reagent A, 500-0113, Reagent B, 500-0114, Reagent S, 500-0115), 
according to the manufacturer’s instructions. Protein absorbance was measured on the 
Fluostar Omega plate reader (BMG Labtech). Protein concentration of each sample was 
then calculated and normalised by mixing adjusted volumes of protein lysate and 
loading buffer (950 μl of 2xLaemmli buffer (Bio-Rad, 161-0737) plus 50 μl of 
mercaptoethanol (Sigma, M6250)). Proteins were denatured by incubating samples at 
100°C for 5 minutes. Samples were placed on ice after denaturation and used 
immediately for western blotting. 
2.15.3 Western blotting 
A running gel was prepared according to the size of the target proteins being analysed 
and poured into a cassette (Invitrogen, NC2015 or NC2010) (see Table 2.9 for gel 
preparation). After the running gel had polymerised, a 5% acrylamide staking gel was 
prepared, poured into the cassette and allowed to polymerise. Gels were placed in a 
XCell SureLock
TM
 Mini-Cell Electrophoresis System (Invitrogen) covered by Tris-
Glycine running buffer (250μM Tris, 1.92mM Glycine and 0.1% SDS). Samples were 
loaded side by side into wells alongside a protein standard (Bio-Rad, 161-0374) and 
electrophoresis was performed at 120V, 35mA for 90 minutes. 
 Proteins were transferred from the gel to a 0.45μm polyvinylidene difluoride 
(PVDF) membrane (Millipore, IPVH00010). Both the membrane and the gel were 
placed between transfer pads (VWR, 732-0594), which were soaked in transfer buffer 
(250μM Tris, 1.92mM Glycine). Transfer was performed using the Trans-Blot® SD 
Semi-Dry Transfer Cell (BioRad) at 20 volts for 1 hour. The membrane was then 
stained with Ponceaux red solution (0.5% Ponceaux and 5 % Acetic Acid in H2O) for 
detection of protein bands. 
The membrane was incubated for 1 hour in blocking buffer (5% Milk in 0.05% 
PBS-Tween) at room temperature on a shaker. The membrane was then incubated 
overnight at 4C while shaking gently with primary antibody diluted in blocking buffer 
(antibodies against phosphorylated proteins were diluted in 5% BSA in 0.05% PBS-
Tween). The membrane was washed 3 times in sterile H2O before incubation with the 
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secondary antibody diluted in blocking buffer for 1 hour at room temperature while 
shaking gently. Membranes were washed 3 times with sterile H2O followed by a 5 
minutes wash in 0.05% PBS-Tween at room temperature while shaking gently, before 
the final wash in sterile H2O (5 times). 
 The blot was incubated with the chemiluminescence agent ClarityTM Western 
ECL substrate (Bio-Rad, 170-5060) for 5 minutes. The blot was visualised using Fuji 
film Intelligent Dark box II and Image Reader Las-1000 Software. The protein of 
interest was confirmed by size comparison of the protein bands to the protein standard 
loaded during electrophoresis. ImageJ analysis software was used to quantify the 
intensity of signal. Intensity quantification of the protein of interest was calculated after 
background subtraction and normalisation to a loading control (GAPDH). 





1 X Gel (10ml) 5% 15% 
Sterile H2O 6.8 ml 3.3 ml 
30% Acrylamide 
(Severn Biotech, 20- 2100-10) 
 
1.7 ml 4 ml 
1.5M Tris pH 8.8 
(Sigma, T6066) 
 




100 μl 100 μl 
10% Ammonium Persulphate 
(Sigma, 215589) 
 




8 μl 100 μl 
Table 2.9 Acrylamide gels for western blotting  
 
 
Antibody  Species/Isotype Specificity  Dilution  
Anti- γ H2A.X 
(Ser139) (Cell 
Signalling, #9718) 
Rabbit polyclonal  Human 
Mouse 
1:1000 




Goat Rabbit 1:5000 
Table 2.10 Primary and secondary antibodies used for western blotting  
 
 
2.16 Telomere length analysis by Real-Time PCR 
Total DNA was isolated from small airway epithelial cell pellets using the spin column 
protocol for the purification of total DNA from the DNeasy® Blood and Tissue Kit 
according to the manufacturer’s instructions (Qiagen, 69506). Telomere length was 
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measured using RT-PCR in collaboration with the Biomarker lab, Newcastle University. 
Telomere length was measured as abundance of telomeric template versus a single gene 
by quantitative real-time PCR (Cawthon, Smith et al. 2003) with modifications as 
described by Martin-Ruiz et al. 2004 (Martin-Ruiz, Saretzki et al. 2004). Measurements 
were performed in quadruplicate. Three DNA samples with known telomere lengths 
(3.0, 5.5 and 9.5 kbp) were run as internal standards, allowing us to estimate telomere 
length in base pairs. 
2.17 Statistical analysis 
Data are expressed as the mean ± SD, mean ± S.E.M or median ± range, where 
appropriate. Where data were normally distributed, statistically significant differences 
between groups were assessed using ANOVA and significant differences between two 
groups were evaluated using an Independent samples t-test. Where data were not 
normally distributed, statistically significant differences between groups were assessed 
using the Kruskal Wallis test and significant differences between two groups were 
evaluated using the Mann-Whitney U test. P values less than 0.05 were considered 
significant. Data were analysed using GraphPad Prism version 6.0, GraphPad Software, 
San Diego California USA, www.graphpad.com and IBM SPSS statistics version 19.  
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Chapter 3. Airway epithelial cell senescence and telomere dysfunction 
in COPD  
Evidence suggests that senescence is involved in the pathogenesis of age-related lung 
disease, including IPF and COPD (Faner, Rojas et al. 2012). Previous reports have 
shown that senescence-associated markers are increased in a number of cells in the 
COPD lung, mainly in alveolar type II cells, endothelial cells and pulmonary artery 
smooth muscle cells (Tsuji, Aoshiba et al. 2006; Aoshiba and Nagai 2009; Tsuji, 
Aoshiba et al. 2010; Amsellem, Gary-Bobo et al. 2011; Noureddine, Gary-Bobo et al. 
2011). The airway epithelium likely endures the brunt of environmental insults, such as 
inhaled toxins present in cigarette smoke, and is one site of the lung most associated 
with development of cigarette smoke-induced abnormalities (Auerbach, Forman et al. 
1957). However, there are very few studies describing senescence-marker expression in 
the airway epithelium of the COPD lung. Zhou and colleagues found that lung tissue 
from patients with COPD had increased numbers of p16-positive Clara cells, the 
progenitors of the distal airway epithelium, as compared to smokers and non-smokers 
without COPD (Zhou, Onizawa et al. 2011). Similarly, it has been shown that SIRT1 
expression is decreased in the small airway epithelium of patients with COPD 
(Rajendrasozhan, Yang et al. 2008). Nonetheless, studies utilising multiple markers to 
investigate airway epithelial cell senescence in COPD are lacking, and furthermore, no 
study has investigated both large and small airway epithelial cell senescence in situ in 
lung specimens from patients with COPD. Bronchiectasis, a chronic respiratory 
condition characterised by inflammation, occurs more commonly in patients with 
COPD (Patel, Vlahos et al. 2004). However, there are currently no data, to our 
knowledge, implicating airway epithelial cell senescence in the bronchiectatic lung.  
The aims of this work were to investigate the expression of multiple markers 
associated with senescence in both the large and small airway epithelium in lung tissue 
from patients with COPD. Additionally, we aimed to investigate whether expression of 
senescence-associated markers was altered in the large and small airway epithelium of 
patients with bronchiectasis.  
3.1 Investigating senescence-associated marker expression in the airway 
epithelium of patients with bronchiectasis and patients with COPD 
To determine whether markers associated with the senescence phenotype are increased 
in the large and small airway epithelium of patients with bronchiectasis and patients 
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with COPD, we obtained explant lung tissue from patients undergoing transplantation 
for end-stage bronchiectasis (n=14) or advanced COPD (n=19) and from controls (n=11) 
undergoing pulmonary resection for localised lung cancer. For each subject, lung tissue 
containing cartilaginous bronchi (large airways) and lung tissue taken from the sub-
pleural parenchyma (containing small airways) was obtained. Expression of the 
proliferation marker Ki67, the DNA damage response marker γH2A.X, CDK inhibitors 
p21 and p16 and the HDAC SIRT1 was assessed by immunohistochemistry. Airway 
epithelial cell expression of markers was quantified in all large (defined in this project 
as cartilaginous and not completely visible under X4 objective) and small (without 
cartilage and with an internal diameter of less than 2mm) airways present in lung tissue 
sections for each subject. Only airways containing intact, well-orientated airway 
epithelium with basement membrane attachment to underlying tissue were included in 
analysis. Figure 3.1 shows representative H&E staining of large and small airway 






























Figure 3.1 Representative H&E staining of human lung tissue containing large and 
small airway material.  Representative H&E staining of lung tissue sections from 
controls, patients with bronchiectasis and patients with COPD. Upper panel: 
photomicrographs showing distal airways present in parenchymal tissue sections, 
captured using X10 objective. Scale bar represents 200 μm. Lower panel: 
photomicrographs showing representative areas of central airway sections, captured 
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3.1.1 Clinical characteristics of the subjects 
The clinical characteristics of patients with COPD, patients with bronchiectasis and 
controls are shown in Table 3.1. Patients with COPD were categorised based upon their 
GOLD staging, used to classify COPD severity (Rabe, Hurd et al. 2007). All patients in 
the COPD group were GOLD stage III (FEV1/FVC <0.70, with 30% ≤ FEV1 < 50% 
predicted) or IV (FEV1/FVC <0.70, with FEV1 < 30% predicted). Although no patients 
in the control group had written documentation of COPD presence, 4 patients had 
spirometric patterns in line with mild COPD (GOLD stage I) (FEV1/FVC <0.70, with 
FEV1 ≥ 80% predicted) and 3 with moderate COPD (GOLD stage II) (FEV1/FVC <0.70, 
with 50% ≤ FEV1 ≤ 80% predicted). Patients with bronchiectasis were not categorised 
using a clinical scoring system. Patients with COPD had lower FEV1 and FEV1 % 
predicted values than patients with bronchiectasis (p < 0.05) and controls (p < 0.001). 
The difference in smoking history (measured in cigarette pack-years) between patients 
with COPD and patients with bronchiectasis was statistically significant (p = 0.001). 
There was no difference in cigarette pack-years between patients with COPD and 
controls (p = 0.66). There was no significant difference in age between patients with 
COPD and patients with bronchiectasis, however controls were significantly older than 
patients with COPD and patients with bronchiectasis (p < 0.001).  







(n = 11) 
Patients with 
bronchiectasis 
(n = 14) 
Patients with 
COPD 
(n = 19) 
Sex, M/F 3/8 10/4 11/8 
Age, yr  70.45± 7.56 52.51± 6.1  52.84 ± 6.9 
FEV1, L 1.79 ± 0.32 0.75 ± 0.21 0.53 ± 0.22 
FEV1, % 84.36 ± 9.45 23.5 ± 6.71 17.63 ± 6.99 
FVC, L 2.69 ± 0.59 1.89 ± 0.59  1.89 ± 0.51 
FVC, % 95.9 ± 16.8 46.57± 14.56   52.05 ± 14.15 
Smoking history, pack-years 31.3 ± 17.93 11± 15.24 39.95 ± 27.1 
GOLD score, I/II/III/IV 4/3/0/0  0/0/1/18 
 
Table 3.1 Clinical characteristics of subjects used in this research Clinical details of 
patients with COPD, patients with bronchiectasis and controls. Values are expressed as 
mean ± SD. FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; 
FEV1 %, percentage of predicted FEV1; FVC %, percentage of predicted FVC; GOLD, 
Global Initiative for Chronic Obstructive Lung Disease; NA, not applicable. 
Chapter 3    Airway epithelial cell senescence and telomere dysfunction in COPD 
 
 67 
3.1.2 Ki67 expression is decreased in the large airway epithelium of patients with 
COPD 
The absence of Ki67, a proliferation marker expressed in all phases of the cell-cycle, 
has been used to identify senescent cells (Lawless, Wang et al. 2010). Ki67 expression 
was assessed in large and small airway epithelial cells present in lung tissue sections 
from controls, patients with bronchiectasis and patients with COPD by 
immunohistochemistry. Expression was analysed using both a quantitative (Figure 3.2 
A and B) and a semi-quantitative (Figure 3.2 C and D) scoring method. To 
quantitatively assess the level of Ki67 positivity in the airway epithelium, the number of 
positive nuclei per mm basement membrane was recorded and an average calculated for 
the whole tissue section. Using this method, we observed a decreased number of Ki67-
positive cells per mm basement membrane in the large airway epithelium of patients 
with COPD compared to patients with bronchiectasis (2.2-fold) (p = 0.015) and 
compared to controls (3.6-fold) (p = 0.025) (Figure 3.2A). Using a semi-quantitative 
scoring approach, whereby each tissue section was given a score from 0-3 based on 
level of positive staining, we observed a similar pattern of expression (Figure 3.2C). 
Ki67 expression was decreased in patients with COPD compared to patients with 
bronchiectasis (2-fold) (p = 0.03) and compared to controls (2-fold) (p = 0.018). In the 
small airways, we observed no significant difference in expression between the three 
groups using either method of quantification, with the exception of patients with 
bronchiectasis, where an increase in Ki67 expression per mm basement membrane was 
observed compared to controls (2.1-fold) (p = 0.02) (Figure 3.2B). We observed a 
similar pattern of expression using the semi-quantitative scoring method (Figure 3.1D), 
with increased Ki67 expression in the epithelium of patients with bronchiectasis 
compared to controls (1.5-fold) (p = 0.036).   




Figure 3.2 Ki67 expression in the large and small airway epithelium of 
patients with bronchiectasis and patients with COPD. Lung tissue sections 
were stained for Ki67 expression using immunohistochemistry and levels of 
expression were quantified in large and small airway epithelial cells using both 
quantitative and semi-quantitative methods. Dot plots represent the number of 
Ki67 positive nuclei per mm basement membrane in large (A) and small (B) 
airway epithelial cells for each individual subject, generated by quantifying the 
whole airway epithelium present in one tissue section and calculating an average 
value. Levels of staining were quantified in a blinded fashion. The horizontal line 
represents group median. Bar graphs represent the level of positive staining in the 
large (C) and small (D) airway epithelium quantified using a semi-quantitative 
scoring method and in a blinded fashion; each column and error bar represents 
median + range. (E) Representative images of immuno-staining (brown) for Ki67 
in the large (upper panel) and small (lower panel) airway epithelium in tissue 
sections from each subject group captured using X40 objective. Lowest panel in 
control column shows representative image of IgG isotype control. Statistics: 
Kruskal-Wallis and Mann-Whitney U test. * p < 0.05. 
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3.1.3 γH2A.X expression is increased in the small airway epithelium of patients with 
COPD 
The DDR protein γH2A.X represents sites of DNA damage and DDR activity, with 
increased γH2A.X foci described in senescent cells (d'Adda di Fagagna, Reaper et al. 
2003). γH2A.X expression was assessed in large and small airway epithelial cells 
present in lung tissue sections from controls, patients with bronchiectasis and patients 
with COPD by immunohistochemistry. Expression was analysed using a semi-
quantitative scoring method (as above). In the large airway epithelium, we observed no 
significant difference in expression between groups, with the exception of increased 
expression in patients with bronchiectasis as compared to patients with COPD (p = 0.03) 
(Figure 3.3A). In the small airway epithelium, we observed increased γH2A.X 
expression in patients with COPD compared to controls (2-fold) (p = 0.015) but there 
was no significant difference compared to patients with bronchiectasis (Figure 3.3B). 
There was no significant difference in γH2A.X expression in the small airway 
epithelium of patients with bronchiectasis compared to controls.  
3.1.4 There is no change in p21 expression in the COPD epithelium  
p21 is a CDK inhibitor and a downstream target of p53, which has been used as a 
marker for senescence (Di Leonardo, Linke et al. 1994; Alcorta, Xiong et al. 1996; 
Herbig, Jobling et al. 2004). p21 expression was assessed in large and small airway 
epithelial cells present in lung tissue sections from controls, patients with bronchiectasis 
and patients with COPD by immunohistochemistry. Expression was analysed using the 
semi-quantitative method previously described. In the large airway epithelium, we 
found the highest levels of p21 expression in the control group and this difference was 
significant compared to patients with COPD (2-fold) (p = 0.04) (Figure 3.4A). In the 
small airway epithelium, there was no significant difference in p21 expression across all 
groups (Figure 3.4B).  





Figure 3.3 γH2A.X expression in the large and small airway epithelium of patients 
with bronchiectasis and patients with COPD. Lung tissue sections were stained for 
γH2A.X expression using immunohistochemistry and levels of expression were 
quantified in large and small airway epithelial cells using a semi-quantitative scoring 
method and in a blinded fashion. Bar graphs represent the level of positive staining in 
the large (A) and small (B) airway epithelium; each column and error bar represents 
median + range. (C) Representative images of immuno-staining (brown) for γH2A.X in 
the large (upper panel) and small (lower panel) airway epithelium in tissue sections 
from each subject group captured using X40 objective. Statistics: Kruskal-Wallis and 
Mann-Whitney U test. * p < 0.05.  
 





Figure 3.4 p21 expression in the large and small airway epithelium of patients with 
bronchiectasis and patients with COPD. Lung tissue sections were stained for p21 
expression by immunohistochemistry and levels of expression were quantified in large 
and small airway epithelial cells using a semi-quantitative scoring method and in a 
blinded fashion. Bar graphs represent the level of positive staining in the large (A) and 
small (B) airway epithelium; each column and error bar represents median + range. (C) 
Representative images of immuno-staining (brown) for p21 in the large (upper panel) 
and small (lower panel) airway epithelium in tissue sections from each subject group 
captured using X40 objective. Statistics: Kruskal-Wallis and Mann-Whitney U test. * p 
< 0.05.  
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3.1.5 p16 expression is increased in the small airway epithelium of patients with 
COPD 
The CDK inhibitor p16, an important regulator of senescence, is expressed by many 
senescent cells and is used to identify senescent cells both in vitro and in vivo (Serrano, 
Lin et al. 1997; Beausejour, Krtolica et al. 2003; Herbig, Ferreira et al. 2006; Jeyapalan, 
Ferreira et al. 2007). Large and small airway epithelial cells present in lung tissue 
sections from controls, patients with bronchiectasis and patients with COPD were 
assessed for p16 expression by immunohistochemistry and expression analysed using 
the semi-quantitative scoring method. In the large airway epithelium, we found no 
significant difference in p16 expression between the three groups (Figure 3.5A). 
However, in the small airway epithelium, we observed increased p16 expression in 
patients with COPD compared to controls (2-fold) (p = 0.04) (Figure 3.5B).  
3.1.6 SIRT1 expression is decreased in the large and small airway epithelium of 
patients with COPD and in the large airway epithelium of patients with 
bronchiectasis 
SIRT1 is a NAD-dependent protein and HDAC that plays critical roles in a variety of 
processes, including stress resistance, senescence and ageing (Michan and Sinclair 2007) 
and decreased levels have been described in the senescence context (Sasaki, Maier et al. 
2006; Vassallo, Simoncini et al. 2014). SIRT1 expression was assessed in large and 
small airway epithelial cells present in lung tissue sections from controls, patients with 
bronchiectasis and patients with COPD by immunohistochemistry and analysed using a 
semi-quantitative scoring method. In the large airway epithelium, SIRT1 expression 
was decreased in patients with COPD compared to patients with bronchiectasis (2-fold) 
(p = 0.02) and compared to controls (2-fold) (p < 0.0001). We also observed a 
statistically significant decrease in SIRT1 expression in patients with bronchiectasis 
compared to controls (p = 0.009), although median values are the same (Figure 3.6A). 
In the small airway epithelium, SIRT1 expression was decreased in patients with COPD 
compared to patients with bronchiectasis (1.5-fold) (p = 0.04) and compared to controls 
(2-fold) (p = 0.016) (Figure 3.6B). 





Figure 3.5 p16 expression in the large and small airway epithelium of patients with 
bronchiectasis and patients with COPD. Lung tissue sections were stained for p16 
expression using immunohistochemistry and levels of expression were quantified in 
large and small airway epithelial cells using a semi-quantitative scoring method and in a 
blinded fashion. Bar graphs represent the level of positive staining in the large (A) and 
small (B) airway epithelium; each column and error bar represents median + range. (C) 
Representative images of immuno-staining (brown) for p16 in the large (upper panel) 
and small (lower panel) airway epithelium in tissue sections from each subject group 
captured using X40 objective. Statistics: Kruskal-Wallis and Mann-Whitney U test. * p 
< 0.05.  





Figure 3.6 SIRT1 expression in the large and small airway epithelium of patients 
with bronchiectasis and patients with COPD. Lung tissue sections were stained for 
SIRT1 expression using immunohistochemistry and levels of expression were 
quantified in large and small airway epithelial cells using a semi-quantitative scoring 
method and in a blinded fashion. Bar graphs represent the level of positive staining in 
the large (A) and small (B) airway epithelium; each column and error bar represents 
median + range. (C) Representative images of immuno-staining (brown) for SIRT1 in 
the large (upper panel) and small (lower panel) airway epithelium in tissue sections 
from each subject group captured using X40 objective. Statistics: Kruskal-Wallis and 
Mann-Whitney U test. * p < 0.05, ** p < 0.01, ***p < 0.001.  
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3.1.7 Senescence-associated markers altered in the COPD lung do not significantly 
correlate with airflow limitation or smoking history 
To determine whether there was a relationship between airway epithelial cell 
senescence and degree of airflow limitation, we tested the markers altered in the COPD 
lung for correlations with FEV1 (% predicted). When subject groups were analysed 
individually, no significant correlations were found between senescence-marker 
expression and lung function across all groups. Figure 3.7 shows correlations between 
markers altered in the COPD lung and FEV1 (% predicted) for COPD subjects only. 
However, when correlations were investigated in the overall population, Ki67 
expression in the large airway epithelium, assessed using both the quantitative (Figure 
3.8A) and semi-quantitative (Figure 3.8B) methods was positively correlated with lung 
function. Similarly, SIRT1 expression in both the large (Figure 3.8E) and small (Figure 
3.8F) airway epithelium was positively correlated with lung function. There were no 
significant correlations found between γH2A.X (Figure 3.8C) and p16 (Figure 3.8D) 
expression in the small airway epithelium when assessing the overall population.  
To determine whether there was a relationship between airway epithelial cell 
senescence and cigarette-smoking habits of subjects, we tested the markers altered in 
the COPD lung for correlations with pack-year number (a clinical tool to indicate 
smoking history) collected for each subject. When subject groups were analysed 
individually, there were no significant correlations observed between senescence 
marker expression and smoking history. Figure 3.9 shows correlations between markers 
altered in the COPD lung and smoking history (pack-year data) for COPD subjects only. 
Additionally, when correlations were investigated in the overall population, there were 
still no significant correlations observed and this finding was true across all markers and 




















Figure 3.7 Relationship between senescence-associated markers altered in the 
COPD lung and degree of airflow limitation. Relationship between number of Ki67 
positive cells/mm basement membrane (A) or Ki67 expression, determined using 
scoring system, (B) in large airway epithelial cells and FEV1 (% predicted). 
Relationship between γH2A.X (C) and p16 (D) expression in small airway epithelial 
cells and FEV1 (% predicted). Relationship between SIRT1 expression in the large (E) 
and small (F) airway epithelium and FEV1 (% predicted). Correlations were assessed 
using Spearman’s rank correlation coefficient. Subject groups were analysed 
individually, only data from COPD group shown. SIRT1, sirtuin 1; FEV1, forced 
expiratory volume in 1 second. 





Figure 3.8 Relationship between senescence-associated markers and degree of 
airflow limitation across overall population. Relationship between number of Ki67 
positive cells/mm basement membrane (A) or Ki67 expression, determined using 
scoring system, (B) in large airway epithelial cells and FEV1 (% predicted). 
Relationship between γH2A.X (C) and p16 (D) expression in small airway epithelial 
cells and FEV1 (% predicted). Relationship between SIRT1 expression in the large (E) 
and small (F) airway epithelium and FEV1 (% predicted). Correlations were assessed 
using Spearman’s rank correlation coefficient. Overall population analysed as one group. 
P values < 0.05 considered significant. SIRT1, sirtuin 1; FEV1, forced expiratory 
volume in 1 second. 
 





Figure 3.9 Relationship between senescence-associated markers altered in the 
COPD lung and smoking history. Relationship between number of Ki67 positive 
cells/mm basement membrane (A) or Ki67 expression, determined using scoring system, 
(B) in large airway epithelial cells and smoking history (pack years). Relationship 
between γH2A.X (C) and p16 (D) expression in small airway epithelial cells and 
smoking history (pack years). Relationship between SIRT1 expression in the large (E) 
and small (F) airway epithelium and smoking history (pack years). Correlations were 
assessed using Spearman’s rank correlation coefficient. Subject groups were analysed 
individually, only data from COPD group shown.  
 
Chapter 3    Airway epithelial cell senescence and telomere dysfunction in COPD 
 
 79 
3.2 Investigating telomere dysfunction in the small airway epithelium of 
patients with bronchiectasis and patients with COPD 
A number of studies have provided evidence for telomere dysfunction in patients with 
COPD. Many studies have shown that circulating leukocytes from patients with COPD 
have shorter telomeres (Morla, Busquets et al. 2006; Houben, Mercken et al. 2009; Mui, 
Man et al. 2009; Savale, Chaouat et al. 2009). Additionally, accelerated telomere 
shortening has been described in resident lung cells in patients with COPD, including 
type II alveolar cells and endothelial cells (Tsuji, Aoshiba et al. 2006). However, there 
are only very few reports of alterations in telomere length in situ in the airway 
epithelium of patients with COPD. Moreover, the presence of a DDR at telomeres, 
identified by telomere-associated foci (TAF), has, to our knowledge, not been 
investigated in human lung tissue or in age-related lung disease. Our lab and others have 
previously underscored the importance of telomeric DDR signalling in senescence and 
TAF are believed to be robust markers for senescence and ageing (Herbig, Ferreira et al. 
2006; Jeyapalan, Ferreira et al. 2007; Fumagalli, Rossiello et al. 2012; Hewitt, Jurk et al. 
2012).  
Following our finding that the DDR protein γH2A.X is increased in the small 
airway epithelium of patients with COPD, along with p16, the importance of which has 
also recently been emphasised in senescence and ageing (Baker, Wijshake et al. 2011), 
we aimed to investigate telomere dysfunction in small airway epithelial cells present in 
lung tissue samples from patients with COPD and patients with bronchiectasis.  
3.2.1 Small airway epithelial cells in the COPD lung have increased DNA damage 
foci and telomere-associated foci without significant telomere shortening 
We investigated the presence of γH2A.X foci and TAF in small airway epithelial cells 
in lung tissue from patients with COPD, patients with bronchiectasis and controls using 
telomere-specific quantitative fluorescence in situ hybridisation (Q-FISH), combined 
with immunofluorescence against γH2A.X (immuno-FISH). Analysis revealed a 
significant increase in the mean number of γH2A.X foci per cell in small airway 
epithelial cells of patients with COPD as compared to controls (2.5-fold) (p = 0.04) 
(Figure 3.10A), confirming earlier findings using immunohistochemistry (Figure 3.3B). 
We observed an even greater increase in γH2A.X foci associated with telomeres (TAF) 
in the small airway epithelium of patients with COPD as compared to controls (3-fold) 
(p = 0.003) (Figure 3.10B). No significant differences were observed in mean number 
of γH2A.X foci or mean number of TAF in the small airway epithelium from patients 
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with bronchiectasis as compared to controls. Analysis of signal intensity from telomeres, 
which is indicative of telomere length, revealed no significant differences between the 
three groups (Figure 3.10C). To determine whether there was a difference in signal 
intensity between non-colocalising telomeres and telomeres that colocalised with 
γH2A.X, over 500 individual telomeres were analysed in the small airway epithelial 
cells of patients with COPD. We found no significant difference in telomere intensity 
between non-colocalising and colocalising telomeres (Figure 3.11A).  
3.2.2 γH2A.X foci and telomere-associated foci do not significantly correlate with 
airflow limitation or smoking history 
To determine whether there was a relationship between mean number of γH2A.X foci 
or mean number of TAF per cell and degree of airflow limitation, we tested these 
markers for correlations with FEV1 (% predicted). Individual group analysis revealed no 
significant correlations between mean number of γH2A.X foci (Figure 3.12A) or mean 
number of TAF (Figure 3.12B) and FEV1 (% predicted). Similarly, there was no 
significant correlation observed between mean number of γH2A.X foci (Figure 3.12C) 
or mean number of TAF (Figure 3.12D) and smoking history of the subjects (pack-
years). When correlations were investigated in the overall population, there was a trend 
towards a negative correlation between mean number of γH2A.X foci (Figure 3.13A) 
and mean number of TAF (Figure 3.13B) with FEV1 (% predicted), however the 
correlation between mean number of γH2A.X foci was not statistically significant (p = 
0.4) and correlations with TAF just failed to reach statistical significance (p = 0.06).  
There were no correlations observed between mean number of γH2A.X foci (Figure 
3.13C) and mean number of TAF (Figure 3.13D) and smoking history of the subjects in 
the overall population.  
 




Figure 3.10 γH2A.X foci, telomere-associated foci and telomere length in large 
and small airway epithelial cells of patients with bronchiectasis and patients 
with COPD. Explant lung tissue sections from patients with COPD and patients 
with bronchiectasis, and lung resection specimens from control subjects, containing 
small airway material were analysed for expression of γH2A.X and TAF by 
immuno-FISH. Dot plots represent the mean number of γH2A.X foci per cell (A), 
the mean number of TAF per cell (B) and mean telomere intensity per cell (C) for 
each individual subject, generated by quantifying Z-stacks of at least 50 cells per 
subject. The horizontal line represents group median. (D) Immuno-FISH images of 
small airway epithelium in patients with COPD and controls colour coded 
according to number of TAF (blue: low number; red: high number). (E) Immuno-
FISH images of small airway epithelium in patients with COPD and controls colour 
coded according to telomere length (blue: short; red: long). (F) Representative 
images of immuno-FISH staining for γH2A.X (green) and telomeres (red) in small 
airway epithelial cells from patients with COPD and controls captured using X100 
oil objective and following Huygens (SVI) deconvolution. Arrows point to γH2A.X 
foci co-localising with telomeres (TAF), depicted by associated histograms and 
shown at higher magnification on the right (images are from one single Z-plane). 
Statistics: Mann-Whitney U test *P < 0.05, **P < 0.01. 






Figure 3.11 Telomere length of non-colocalising and colocalising telomeres in small 
airway epithelial cells of the COPD lung. Explant lung tissue sections from patients 
with COPD, containing small airway material were analysed for expression of γH2A.X 
and TAF by immuno-FISH. (A) Histogram representing telomere intensity of co-
localising and non-co-localising telomeres in small airway epithelial cells of at least 
four randomly selected COPD patients, generated by quantifying at least 500 individual 
telomeres; red line indicates median telomere intensity. (B) Representative Immuno-
FISH (red: telomere PNA probe, green: γH2A.X) of small airway epithelial cell present 
in COPD lung tissue captured using X100 oil objective and following Huygens (SVI) 
deconvolution, image is from one single Z-plane. Arrows indicate telomeres of similar 
length co-localising (a) or not (b) with γH2A.X in one individual cell. (C) 
Quantification of telomere intensity of co-localising (a) or non-co-localising (b) 
telomere. Mann-Whitney U test shows no statistically significant difference.  
 





Figure 3.12. Relationship between γH2A.X foci and TAF in the small airway 
epithelial cells of the COPD lung and degree of airflow limitation and smoking 
history. Relationship between mean number of γH2A.X foci (A) and TAF (B) in small 
airway epithelial cells and FEV1 (% predicted). Relationship between mean number of 
γH2A.X foci (C) and TAF (D) in small airway epithelial cells and smoking history 
(pack years). Correlations were assessed using Spearman’s rank correlation coefficient. 
Subject groups were analysed individually, only data from COPD group shown. TAF, 
telomere-associated foci; FEV1, forced expiratory volume in 1 second. 
 





Figure 3.13. Relationship between γH2A.X foci and TAF in small airway epithelial 
cells and degree of airflow limitation and smoking history across overall 
population. Relationship between mean number of γH2A.X foci (A) and TAF (B) in 
small airway epithelial cells and FEV1 (% predicted). Relationship between mean 
number of γH2A.X foci (C) and TAF (D) in small airway epithelial cells and smoking 
history (pack years). Correlations were assessed using Spearman’s rank correlation 
coefficient. Overall population analysed as one group. TAF, telomere-associated foci; 
FEV1, forced expiratory volume in 1 second. 
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3.2.3 p16 positive cells show increased DNA damage foci and TAF in small airway 
epithelial cells present in COPD lung tissue 
To determine whether γH2A.X foci-positive cells and TAF-positive cells were also 
positive for p16 expression in small airway epithelial cells present in lung tissue from 
patients with COPD, we carried out double immuno-FISH for p16 and γH2A.X. We 
observed on average, a higher number of γH2A.X foci per cell in those cells that stained 
positive for p16 expression compared to those that were negative for p16 (a mean of 2.3 
foci/cell compared to 0.8 foci/cell) (p = 0.01) (Figure 3.14A).  Additionally, we found 
that the mean number of TAF per cell was higher in those cells that were also positive 
for p16 expression compared to p16-negative cells (an average of 0.8 TAF/cell 
compared to 0.2/cell) (p = 0.008) (Figure 3.14B).  





Figure 3.14 Double immuno-FISH staining against p16, γH2A.X and telomeres in 
small airway epithelial cells present in COPD lung tissue. Explant lung tissue 
sections from patients with COPD (n=8) containing small airway material were 
analysed for expression of p16, γH2A.X and TAF by double immuno-FISH to 
determine whether foci and p16 expression co-localise. Dot plots represent the mean 
number of γH2A.X foci (A) and the mean number of TAF (B) per p16-positive and 
p16-negative cells for each individual subject with the horizontal line representing 
group mean. Results were generated by quantifying Z-stacks of at least 50 cells per 
subject. (C) Representative image of double immuno-FISH staining for γH2AX (green) 
and p16 (yellow) combined with telo-FISH (red) captured using X100 oil objective and 
following Huygens (SVI) deconvolution. γH2A.X foci co-localising with telomeres 
(TAF) are shown at higher magnification on the right (images are from one single Z-
plane). Statistics: Independent samples t-test *P < 0.05, **P < 0.01. 
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3.2.4 Small airway epithelial cells isolated from the COPD lung have increased 
telomere-associated foci without significant telomere shortening 
Following our observations that TAF were increased in the small airway epithelial cells 
of lung tissue from patients with COPD compared to controls (who were on average, 20 
years older), we aimed to determine whether TAF were increased in small airway 
epithelial cells isolated and cultured from the COPD lung as compared to healthy aged-
matched controls (Table 3.2). Using Immuno-FISH, we evaluated the presence of TAF 
in small airway epithelial cells isolated from healthy controls during research 
bronchoscopy or cultured from explant COPD lung tissue. This work was carried out in 
collaboration with Dr Nicola Green and Dr Elizabeth Moisey from the Lung 
Immunobiology group, Newcastle University. We found an increase in mean number of 
TAF per cell in patients with COPD (Figure 3.15A), however this was not statistically 
significant, whereas the percentage of cells positive for TAF was (Figure 3.15B). We 
found no significant differences in telomere length between patients with COPD and 
controls as determined by Q-FISH (Figure 3.15C). We also determined whether 
differences in telomere length could be detected using the well-established Real-Time 
PCR method (Cawthon, Smith et al. 2003) in collaboration with the Biomarkers facility 
(Campus for Ageing and Vitality, Newcastle University), using a slightly larger sample 
size (Table 3.3). We found no significant differences in telomere length between 
patients with COPD and controls (Figure 3.15D). We carried out the biochemical assay 
for detection of Sen-β-Gal activity, an established senescence marker (Dimri, Lee et al. 
1995). We observed increased expression of Sen-β-Gal in cells isolated from patients 
with COPD on average, as compared to controls, however these observations failed to 
reach statistical significance (Figure 3.16).  




 Patients with COPD 
(n = 3) 
Normal controls 
(n = 3) 
Sex, M/F 2/1 2/1 
Age, yr 53 ± 8.08 52 ± 7 
FEV1, L 0.42 ± 0.06* 3.53 ± 1.42 
FEV1, % 14.3 ± 3.21** 109.7 ± 20.98 
FVC, L 2.1 ± 0.4 4.8 ± 2.32 
FVC, % 55.6 ± 5.5* 119 ± 32.14 
Smoking history, pack-years 28 ± 10.58* 0 
GOLD score, I/II/III/IV 0/0/0/0/3 0/0/0/0 
 
Table 3.2 Clinical characteristics of patients with COPD and normal controls 
where airway epithelial cells were isolated. COPD, chronic obstructive pulmonary 
disease; FEV1, Forced expiratory volume in one second; FEV1 %, percentage of 
predicted FEV1; FVC, forced vital capacity; FVC %, percentage of predicted FVC; 
GOLD, Global Initiative for Chronic Obstructive Lung Disease. Values are expressed as 
mean ± SD. Statistics: Independent samples t-test *p < 0.05, **p < 0.01 as compared to 
controls.   




 Patients with COPD 
(n = 6) 
Normal controls 
(n = 4) 
Sex, M/F 5/1 3/1 
Age, yr 54.6 ± 7 49.5 ± 7.59 
FEV1, L 0.54 ± 0.17*** 3.75 ± 1.24 
FEV1, % 15.6 ± 4.13**** 111 ± 17.33 
FVC, L 2.59 ± 0.95* 5.02 ± 1.96 
FVC, % 58.8 ± 19.79** 120.25 ± 26.36 
Smoking history, pack-years 38.6 ± 21.67** 0 
GOLD score, I/II/III/IV 0/0/0/0/6 0/0/0/0 
 
Table 3.3. Clinical characteristics of patients with COPD and normal controls 
where airway epithelial cells were isolated for RT-PCR. COPD, chronic obstructive 
pulmonary disease; FEV1, Forced expiratory volume in one second; FEV1 %, 
percentage of predicted FEV1; FVC, forced vital capacity; FVC %, percentage of 
predicted FVC; GOLD, Global Initiative for Chronic Obstructive Lung Disease. Values 
are expressed as mean ± SD. Statistics: Independent samples t-test. *p < 0.05, **p < 
0.01, ***p < 0.001, ****p < 0.0001 as compared to controls.  
 





Figure 3.15 Telomere-associated foci and telomere length in small airway epithelial 
cells cultured from controls and patients with COPD. Small airway epithelial cells 
(P1-P3) from patients with COPD and aged-matched controls were analysed for 
γH2A.X and telomeres by immuno-FISH. Dot plots represent mean number of TAF (A), 
percentage of cells containing TAF (B) and mean telomere length (C) for each 
individual generated by quantifying Z-stacks of at least 40 cells per subject. Telomere 
length was also quantified using Real-Time PCR on small airway epithelial cells 
isolated from a larger number of controls and patients with COPD (D). Data are 
presented as the mean for individual subjects with the horizontal line representing group 
mean. (E) Representative image of immuno-FISH staining for γH2A.X (green) and 
telomeres (red) in small airway epithelial cells from patients with COPD and controls, 
captured using X100 oil objective and following Huygens (SVI) deconvolution. Arrows 
point to γH2A.X foci co-localising with telomeres (TAF), depicted by associated 
histograms and shown at higher magnification on the right (images are from one single 
Z-plane). Statistics: Independent samples t-test *P < 0.05. 





Figure 3.16 Representative images of senescence-associated-β-galactosidase 
staining in small airway epithelial cells cultured from controls and patients with 
COPD. Small airway epithelial cells isolated and cultured from the lungs of patients 
with COPD or healthy aged-matched controls were stained for activity of Sen-β-Gal. 
Dot plot represents percentage of cells positive for Sen-β-Gal staining (A), generated by 
quantifying at least 500 cells per subject. Dots represent mean value per subject with 
horizontal line representing group mean. Representative images of Sen-β-Gal staining 
(blue) in small airway epithelial cells from patients with COPD and controls captured 
using X20 objective. Sen-β-Gal staining was carried out in collaboration with Clara 
Correia Melo from our lab. Sen-β-Gal, senescence-associated-β-galactosidase. 
Independent samples t-test revealed no statistically significant differences.  
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3.3 Discussion  
While numerous studies have described increased expression of senescence-associated 
markers in the COPD lung, very few have investigated senescence marker expression in 
the airway epithelium. Furthermore, very few studies have explored differences in 
airway epithelial cell senescence in the large and small airway compartments of the 
COPD lung, both of which are involved in the disease process. In our cohort of subjects, 
Ki67 and SIRT1 expression was significantly decreased in the large airway epithelium 
of patients with COPD compared to controls, whereas p21 expression was higher in the 
large airway epithelium of controls. We found no significant differences in expression 
of other markers of senescence. We found more evidence for epithelial cell senescence 
in the small airways of the COPD lung; γH2A.X and p16 were significantly increased in 
the small airway epithelium of patients with COPD, while SIRT1 expression was 
decreased. These results confirm previous reports showing that p16-positive Clara cell 
frequency is higher in the small airways of patients with COPD compared to smokers 
without COPD and non-smokers (Zhou, Onizawa et al. 2011), while SIRT1 has been 
shown to be decreased in the small airway epithelium of patients with COPD compared 
to non-smokers (Rajendrasozhan, Yang et al. 2008). Other studies have described 
similar findings when investigating senescence of other cell types in the COPD lung. 
Aoshiba and colleagues note increased γH2A.X foci in type I and type II alveolar 
epithelial cells and endothelial cells of patients with COPD compared to smokers 
without COPD and non-smokers (Aoshiba, Zhou et al. 2012) and others have described 
increased expression of p21 and p16 in these cells in the lungs of patients with COPD 
(Tsuji, Aoshiba et al. 2006; Amsellem, Gary-Bobo et al. 2011). We failed to find any 
significant difference in p21 expression in the small airway epithelium between patients 
with COPD and controls. However, our control tissue was acquired from patients 
undergoing pulmonary resection for localised lung cancer. Due to the common 
aetiology of COPD and lung cancer, there was no significant difference in smoking 
history between subjects with COPD and controls, and although control subjects were 
non-smokers at time of surgery, they may still be regarded as ‘smokers without COPD’. 
It is not surprising then that we did not see differences in p21 expression. Accordingly, 
Tsuji and colleagues failed to find significant differences in endothelial cell expression 
of p21 when comparing patients with COPD to smokers without COPD, with 
significant differences observed only when comparing to non-smokers (Tsuji, Aoshiba 
et al. 2006). Similar findings have also been reported for SIRT1 expression when 
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comparing these subject groups (Rajendrasozhan, Yang et al. 2008). However, the fact 
that our control and COPD group are matched for smoking history may suggest that the 
differences in senescence marker expression that we do detect, are an effect of COPD 
specifically, as opposed to smoking. In fact, in one study where controls and patients 
with COPD had similar smoking histories, increased p21 expression in pulmonary 
endothelial cells in COPD lung tissue was still detectable (Amsellem, Gary-Bobo et al. 
2011). Nonetheless, the inclusion of life-long never smokers as an additional 
comparison group would be desirable. It could be that small changes in markers are not 
detected by our semi-quantitative scoring system, which is likely to be less sensitive 
than more quantitative methods. This is a subjective and cruder method of 
quantification and may result in loss of information, as the extent of staining is being 
forced into a scale of 0-3. However, this method has been well validated and used 
previously by other groups working in similar fields (Kranenburg, De Boer et al. 2002). 
Additionally, we internally validated the use of the semi-quantitative scoring method by 
comparing our results to the levels of Ki67 expression we initially documented using a 
quantitative method, which involved counting total number of positive nuclei per mm 
basement membrane. The patterns of expression we observed using the two methods 
were the same. Re-scoring of a random sample of slides also confirmed that this method 
is reliable and reproducible, as there was generally a strong agreement between the 
scores given by two independent observers (data not shown).  
A major limitation of this work is that the control group were, on average, 20 
years older than patients with COPD. This is of particular importance since senescence 
markers are known to increase with age (Jeyapalan, Ferreira et al. 2007; Wang, Jurk et 
al. 2009). This disparity in age between the control and COPD group may explain why 
increased p21 expression was found in the large airway epithelium of controls 
compared to patients with COPD and possibly the failure to detect differences in other 
markers in the large airway epithelium. The fact that some differences in senescence 
marker expression were still detectable in the small airway epithelium of patients with 
COPD may reflect a predominance of small airway involvement in the disease process. 
Indeed, the emphysematous changes that occur in the COPD lung impact on the 
peripheral airways and are similar to those that occur in the ageing lung (Ito and Barnes 
2009). Additionally, it could be that the more harmful oxidants in cigarette smoke reach 
the lung periphery, causing more damage and cellular senescence. Indeed, early 
abnormalities and pathology linked to smoking and development of COPD manifest in 
the small airway epithelium (Auerbach, Forman et al. 1957). Moreover, it has recently 
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been shown that the small airway epithelium of smokers shows markers of accelerated 
ageing, including enhanced telomere shortening as compared to non-smokers, which 
may suggest that molecular changes occur long before the development of COPD in 
small airway epithelial cells (Walters, De et al. 2014). One caveat of this work is that 
we did not distinguish between the different cell populations in the airway epithelium 
but rather studied it as a whole. Most of the normal human airway is lined by a 
pseudostratified epithelium of ciliated cells, secretory cells and 6–30% basal cells, with 
proportion varying along the proximal-distal axis (Mercer, Russell et al. 1994; 
Nakajima, Kawanami et al. 1998). Basal cells are the stem cells of the pseudostratified 
airway epithelium and a recent review has suggested that disordered basal cell biology 
following chronic cigarette smoke exposure may lead to accelerated loss of lung 
function in susceptible individuals that develop COPD (Crystal 2014). It is plausible 
that basal airway epithelial cell senescence contributes to the development of COPD, 
which would likely exacerbate both defective cell repopulation and inflammatory 
processes in the airway epithelium. Therefore targeting of senescent basal cells may be 
of therapeutic benefit in preventing or slowing COPD progression. Since we did not use 
markers to specifically identify subpopulations of airway epithelial cells, it is unclear 
which cells undergo senescence or harbour telomere dysfunction in our cohort of COPD 
patients. It would be interesting to determine if, and which, cell subsets harbour the 
most telomere dysfunction in the airway epithelium. One possible explanation for the 
lack of increased senescent cell frequencies in the large airway epithelium of the COPD 
lung is that the large and small airway epithelium are made up of differing numbers and 
types of progenitor cell populations, which may lead to different levels of renewal in 
these distinct airway compartments. While Clara cells are generally considered the basal 
cell progenitors of both the large and small airway epithelium, additional epithelial cell 
progenitors with proliferative capacity have been identified in the large airway 
epithelium that are believed to contribute to its maintenance (Hong, Reynolds et al. 
2004). It is possible therefore that large airway epithelial cells have ‘back-up’ 
mechanisms of restoration and are repopulated more frequently or more effectively as 
compared to small airway epithelial cells. It could be that more damaged or senescent 
cells are being shed off form the large airway epithelium, which may explain, in part, 
the inability to detect increased frequencies of senescent cells in the large airways of 
patients with COPD.   
It should also be noted that while none of the subjects in the control group had 
documented evidence of COPD, some subjects had spirometric patterns in line with 
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mild obstructive lung function, possibly due to natural lung ageing or the fact that the 
majority of controls had significant smoking histories. Therefore, caution should be 
taken when forming conclusions based on this study population. Despite the limitations 
of our control group, we still observed a significant increase in the majority of 
senescence-associated markers studied in the small airway epithelium of patients with 
COPD and so it may be that our findings are an underestimation of the true involvement 
of small airway epithelial cell senescence in COPD. 
Short telomeres, known activators of cellular senescence, have been implicated 
in in the pathogenesis of COPD, with a number of studies showing accelerated telomere 
shortening in leukocytes from patients with COPD as compared to smokers and non-
smokers (Houben, Mercken et al. 2009; Savale, Chaouat et al. 2009). However, 
conflicting results have been published with some studies finding no difference in 
leukocyte telomere length when comparing patients with COPD to smokers without 
COPD (Morla, Busquets et al. 2006). Similarly, other studies report accelerated 
telomere shortening in resident cells of the COPD lung when comparisons are made 
with non-smokers, however this difference is not observed when comparing to smokers 
without COPD (Tsuji, Aoshiba et al. 2006). In contrast, Q-PCR revealed shorter 
telomeres in lung tissue extracts from patients with COPD compared to controls with 
similar smoking histories, however this difference was less than 10% (Amsellem, Gary-
Bobo et al. 2011). Using Q-FISH, we found no significant difference in telomere length 
in the small airway epithelial cells of patients with COPD compared to controls. 
However, this could be explained by the similar smoking histories and the younger age, 
on average, of our COPD group. Additionally, our sample size is particularly small (10 
patients with COPD, 8 patients with bronchiectasis and 9 controls) compared to 
previous work demonstrating telomere shortening in COPD as compared to smokers 
without COPD (Savale, Chaouat et al. 2009). Therefore, it could be that changes in 
telomere length are subtle, with larger sample sizes required to demonstrate significant 
differences.  
Evidence suggests that senescence can be induced by activation of a DDR at 
long telomeres in human fibroblasts during stress- (Fumagalli, Rossiello et al. 2012; 
Hewitt, Jurk et al. 2012), replicative (Kaul, Cesare et al. 2012) and OIS in vitro (Suram, 
Kaplunov et al. 2012) and TAF have been found to increase with age in multiple tissues 
in mice and primates in vivo, irrespective of telomere length (Fumagalli, Rossiello et al. 
2012; Hewitt, Jurk et al. 2012). These data suggest that a “critical” telomere length may 
not be the sole determinant in the activation of a persistent DDR. Although we did not 
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find significant differences in telomere length, we have shown, for the first time that 
TAF are significantly increased in the small airway epithelium of patients with COPD 
compared to controls, suggesting that telomere dysfunction might occur independently 
of telomere length in COPD. However, we cannot rule out the possibility that telomere 
shortening has led to TAF accumulation. Our sample size is limited and therefore subtle 
changes in telomere length may not be detected in tissues by Q-FISH. However, we did 
analyse intensity of telomere signals from both co-localising and non-co-localising 
telomeres and found no significant differences in telomere length, suggesting that 
telomere shortening is not contributing to telomere dysfunction. It is possible, however, 
that we are not detecting the shortest of telomeres by our method. Analysis of TAF and 
telomere length, by both Q-FISH and RT-PCR, in small airway epithelial cells isolated 
from patients with COPD and aged-matched healthy controls confirmed our in vivo data. 
While TAF are increased in cells from patients with COPD, no significant differences in 
telomere length are observed. However, our sample size is very limited (n=3 per group 
for Q-FISH analysis and n=4/6 for RT-PCR) and therefore this work should be repeated 
using more subjects in order to confirm our findings. The limited sample size is also a 
possible explanation for the failure to detect significant differences in Sen-β-Gal 
expression between patients with COPD and controls, since there is a lot of variability 
between subjects. At the very least, our results may suggest that TAF are a more robust 
marker of senescence compared to other markers, including telomere length, since we 
find significant differences despite our small sample size. In accordance with our 
findings, another study also failed to find differences in telomere length between 
fibroblasts isolated from patients with emphysema and aged-matched controls but found 
increased expression of other senescence-associated markers (Muller, Welker et al. 
2006). Therefore, we cannot exclude the possibility that telomere shortening is not as 
important to COPD-associated senescence. 
The small airways undergo a number of pathological changes in response to 
chronic cigarette smoke exposure and in respiratory diseases, such as COPD. Airway 
epithelial hyperplasia (thickening of the airway epithelium) is one such change, caused 
by enhanced proliferation of airway epithelial cells (Rock, Randell et al. 2010). 
Proliferation is known to increase content of DNA damage foci and TAF and therefore 
it is possible that the increase in TAF we observe in the COPD epithelium is due to 
increased proliferative activity. However, this an unlikely explanation for our 
observations since we found no significant difference in Ki67 expression in the small 
airway epithelium of patients with COPD as compared to controls. However, a more 
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informative approach to this would have been to test directly whether increased γH2A.X 
foci and TAF occur more commonly in non-proliferating cells by double immuno-FISH 
staining against γH2A.X and a proliferation marker, such as Ki67 or PCNA. However, 
we have shown that small airway epithelial cells positive for the CDK inhibitor p16 had 
more γH2A.X foci and TAF than p16-negative cells in the COPD lung, consistent with 
cellular senescence. Similar findings have been described in type II alveolar cells of the 
COPD lung, with those cells expressing high rates of p16 also containing higher 
numbers of γH2A.X foci (Aoshiba, Zhou et al. 2012).  
Bronchiectasis is a chronic lung disease that affects both the large and small 
airway compartments, the etiopathogenesis of which is still not clear (McShane, 
Naureckas et al. 2013). Bronchiectasis is characterised by cycles of infection and 
inflammation, which lead to structural damage to the airways (Cole 1986). Although 
bronchiectasis is not classed as an age-related disease as such, it is accountable for 
increasing rates of hospitalisations and subsequent mortality, particularly in the elderly 
population (Ringshausen, de Roux et al. 2013). To our knowledge, this is the first report 
describing the investigation of senescence marker expression in the context of 
bronchiectasis. In the large airway epithelium, we found a significant increase in 
γH2A.X foci compared to patients with COPD and a significant decrease in SIRT1 
expression compared to controls. In the small airway epithelium, we observed a 
tendency towards decreased SIRT1 expression and increased number of γH2A.X 
foci/TAF per cell, however these observations were not significant. Unlike COPD, 
bronchiectasis is not linked with cigarette smoking. However, similar to COPD, there is 
a strong inflammatory component to the disease. Inflammation has been reported to 
induce senescence, and senescent cells are thought to perpetuate this inflammatory 
response via the so-called SASP, thus generating a vicious cycle leading to propagation 
and maintenance of senescence and aggravation of chronic inflammation (Acosta, 
O'Loghlen et al. 2008; Coppe, Patil et al. 2008; Kuilman and Peeper 2009). Therefore, 
the inflammatory processes occurring in bronchiectasis may be contributed to by the 
presence of senescent cells. Indeed, it has recently been found that airway epithelial cell 
senescence may play a role in cystic fibrosis (CF), a disease commonly occurring in 
conjunction with bronchiectasis. Increased expression of p16 and γH2A.X in the large 
airway epithelium of patients with CF has been described, which the authors suggest 
could be caused by chronic neutrophilic airway inflammation (Fischer, Wong et al. 
2013). CF is not associated with the ageing process but is characterised by chronic 
cycles of infection and inflammation, similar to bronchiectasis. Interestingly, this study 
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also reports no difference in telomere length between control and CF subjects, measured 
by Q-PCR using DNA extracted from isolated airway epithelial cells (Fischer, Wong et 
al. 2013). Bronchiectasis commonly occurs following early childhood infection, such as 
pneumonia (Pasteur, Helliwell et al. 2000). Therefore it is possible that severe 
inflammation in early life leads to development of senescent cells, which accumulate 
over time and contribute, in part, to the development of bronchiectasis. A recent study 
using a murine model of low-grade chronic inflammation showed that accelerated 
senescence and telomere dysfunction occurred in the liver and gut (Jurk, Wilson et al. 
2014). The effects of chronic inflammation on the lung were not determined, however it 
is possible that accelerated lung senescence occurs in this context. Based on our 
findings, it is not possible to make firm conclusions regarding the presence of airway 
epithelial cell senescence in bronchiectasis. However, given that there was often 
tendency for increased expression of senescence associated markers in the airway 
epithelium in patients with bronchiectasis, or no significant difference at all when 
compared to controls (who on average were 20 years older), it is likely that a certain 
degree of airway epithelial cell senescence occurs in bronchiectasis. This is something 
that should be explored further, with a larger sample size, aged-matched controls and in 
the context of inflammation-induced senescence, as in the murine model described 
above.  
A number of studies have found correlations between cellular senescence and 
airflow limitation. Telomere length in lung cells and circulating leukocytes has been 
found to positively correlate with FEV1 % predicted (Tsuji, Aoshiba et al. 2006; Mui, 
Man et al. 2009) and decreased telomere length is associated with increased risk of 
COPD (Rode, Bojesen et al. 2013). However, some studies have failed to show a 
correlation between telomere length and lung function (Houben, Mercken et al. 2009; 
Savale, Chaouat et al. 2009; Noureddine, Gary-Bobo et al. 2011). Similarly, it has been 
shown that levels of p21 and p16 expression in type II alveolar epithelial cells and 
endothelial cells negatively correlate with FEV1 % predicted (Tsuji, Aoshiba et al. 
2006). We did not find any significant correlations between expression of senescence 
markers altered in the COPD lung and degree of airflow limitation in patients with 
COPD. This could be because our tissue was acquired from patients undergoing lung 
transplantation for end-stage disease and so the range of FEV1 % predicted values were 
very narrow, varying from only 7-36%. When we pooled our subject groups together, 
we found significant positive correlations between Ki67 and SIRT1 expression and a 
strong negative trend between mean number of TAF and FEV1 % predicted (r = -0.35, p 
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= 0.06). In fact, others have only reported correlations between senescence markers and 
FEV1 % predicted when subjects are pooled into one group (Tsuji, Aoshiba et al. 2006). 
One limitation of our study is that we did not asses levels of TAF in alveolar epithelial 
cells. While other studies have reported increased frequencies of alveolar epithelial cells 
expressing p21 and p16 (Tsuji, Aoshiba et al. 2006) and increased content of γH2A.X 
(Aoshiba, Zhou et al. 2012) in the COPD lung, levels of TAF in alveolar epithelial cells 
of the COPD lung have never been reported. While we did observe the presence of TAF 
in both airway epithelial cells and alveolar epithelial cells, we did not image and 
quantify levels of TAF in alveolar epithelial cells. This is a limitation of our study and it 
would be important to determine how levels of TAF are altered in the COPD lung. 
Telomere dysfunction in alveolar epithelial cells may actually be more relevant to lung 
structural changes in the COPD lung, in particular the development of emphysema. It 
has been shown that levels of p21 and p16 in alveolar epithelial cells correlate with 
FEV1 % predicted (Tsuji, Aoshiba et al. 2006). While we found no significant 
correlations between mean number of TAF in small airway epithelial cells with lung 
function, it could be that levels of TAF in alveolar epithelial cells correlate more 
strongly with changes in lung function and that senescence of alveolar epithelial cells is 
more relevant to the structural changes that occur in COPD, or at least the 
emphysematous-like changes.  
When investigating the relationship between senescence marker expression and 
smoking history, measured in pack years, we found no significant correlations 
irrespective of whether groups were analysed individually or pooled. This is not that 
surprising; a number of studies have failed to find any association between telomere 
length of circulating leukocytes and smoking history (Houben, Mercken et al. 2009; 
Mui, Man et al. 2009; Savale, Chaouat et al. 2009). However, a negative correlation 
between pack-year exposure and telomere length was reported in a large cohort of 
women (Valdes, Andrew et al. 2005). One study described an association between p16 
expression in circulating T-lymphocytes and tobacco use (Liu, Sanoff et al. 2009), 
however, other prior studies have not investigated the relationship between senescence 
marker expression in the lung and smoking history. Our findings could simply be 
attributed to a limited sample size or may due to the control group having significant 
smoking histories, similar to COPD patients. However, our pack-year history in the 
overall cohort did range from 0 to 120, though still no significant associations were 
found. This could also be explained by the fact that not all smokers develop COPD, 
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even when smoking histories are extensive, suggesting that a more complex 
susceptibility component is involved.  
Our results suggest that airway epithelial cell senescence and telomere 
dysfunction occur in the small airway epithelium of the COPD lung. It is possible that 
telomere shortening plays little role in this process, however we cannot firmly conclude 
this based on the limitations of our control group and small sample sizes. Future work 
would be to investigate the occurrence of TAF in a large sample size with aged-matched 
controls. There are currently no effective therapies for suppressing chronic 
inflammation in COPD or altering the underlying pathophysiology of the disease and 
therefore important future work would be to determine whether dysfunctional telomere 
signalling contributes to inflammatory processes in COPD. Uncovering whether TAF-
positive cells are associated with areas of increased inflammation and inflammatory cell 
recruitment in the COPD lung would be of significant importance and may shed light on 
whether, and by what mechanisms, telomere dysfunction contributes to COPD 
pathogenesis. TAF may be a more robust marker for senescence and of therapeutic 
benefit in COPD. It remains to be elucidated whether TAF could help stratify patients 
with COPD for example, by predicting subsequent degree of emphysema or by 
predicting susceptibility to development of COPD in current smokers.  
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Chapter 4.  Airway cell senescence and telomere dysfunction in the 
ageing murine lung  
 
In the previous chapter, we demonstrated that TAF increase in the small airway 
epithelial cells of patients with COPD, supporting the range of evidence that suggests 
that COPD is a disease of accelerated lung ageing. In situ investigations into cellular 
senescence in ‘healthy’ human lung ageing are lacking, with only studies using whole 
tissue lysates describing increased senescence-associated makers in the lungs of older 
humans (Shivshankar, Boyd et al. 2011). Similarly, there is little data describing cellular 
senescence in resident cells of the ageing murine lung. One study, by Wang and 
colleagues, previously described an age-dependent increase in DDR foci (γH2A.X) in 
alveolar epithelial cells of the murine lung (Wang, Jurk et al. 2009). Increased 
expression of the histone variant mH2A, enriched in SAHF, has also been reported in 
alveolar epithelial cells and in total lung tissue extracts of old (24 months) as compared 
to young (4 months) mice (Kreiling, Tamamori-Adachi et al. 2011). Similarly, other 
studies have described increased senescence marker expression in the murine lung with 
age, using predominantly lung tissue lysates, however this does not allow us to 
distinguish between individual cell types (Krishnamurthy, Torrice et al. 2004; 
Shivshankar, Boyd et al. 2011). Nonetheless, there are limited studies investigating 
senescence of lung cells during physiological ageing in situ, with little focus on airway 
epithelial cells in particular. Our group have recently demonstrated that TAF 
accumulate in the liver and intestines of mice with age (Hewitt, Jurk et al. 2012) and 
TAF have been shown to quantitatively predict mean and maximum lifespan in both 
short- and long-lived mice cohorts (Jurk, Wilson et al. 2014). While genomic DNA 
damage can be transient, studies have demonstrated that damage at telomeres is 
persistent because telomere-binding proteins, such as TRF2, can inhibit DNA repair 
(Fumagalli, Rossiello et al. 2012; Hewitt, Jurk et al. 2012). Additionally, it has been 
shown that telomeric DNA repair is not as efficient as repair in the rest of the genome 
(Petersen, Saretzki et al. 1998). Therefore, analysis of DNA damage foci alone is 
possibly not a robust enough marker of senescence.  
The occurrence of a DDR at telomeres in the ageing lung has not, to our 
knowledge, previously been investigated. As we have already found an increase in TAF 
in the small airway epithelial cells of patients with COPD, the aim of this work was to 
determine whether TAF increased in the airway epithelium of the murine lung with 
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physiological ageing, and if so, to determine whether telomere dysfunction is 
contributing to the natural age-related decline in lung structure.  
4.1 Telomere dysfunction and senescence in airway epithelial cells of the 
ageing murine lung 
In order to evaluate the role of airway epithelial cell senescence in the lungs of mice 
during physiological ageing, we studied longitudinal sections, containing both large and 
small airways, from the left lungs of male C57BL/6 mice of different ages (6.5, 15 and 
24 months), with 3-5 mice analysed per group. Large airways were defined as being 
0.5-1 mm in diameter with simple, columnar epithelium and small airways were 
identified as being less than 100 μm in diameter (Figure 4.1).  





Figure 4.1 Representative images of H&E staining showing large and small airway 
epithelium of the murine lung. Representative photomicrographs of large and small 
airway sections in lung tissue from 6.5-month-old mice stained with H&E. Arrows 
point to airway epithelium, which was focus of this work. Images were captured using 
X40 objective. H&E, Haematoxylin and Eosin. 
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4.1.1 p21 expression increases in the large and small airway epithelium of the murine 
lung with age  
p21 expression was assessed in large and small airway epithelial cells present in lung 
tissue sections from male C57BL/6 mice of increasing age (6.5, 15 and 24 months) by 
immunohistochemistry. Expression was analysed by manually counting the total 
number of negative and positive airway epithelial cells in 10 randomly captured images 
of both the large and small airway epithelium, for each animal, and percentage 
positivity then calculated. We observed a slight increase in p21 expression in the large 
airways  (Figure 4.2A) from 6.5 to 15 months, however this was not statistically 
significant, and a further increase in expression at 24 months as compared to 15- (p = 
0.04) and 6.5-month-old (p = 0.02) mice. Similar changes were observed for p21 
expression in the small airways (Figure 4.2B). There was no significant difference in 
expression between 6.5- and 15-month-old mice or 24-month-old mice compared to 15 
months (p = 0.058), with significant differences detected only when comparing 6.5- to 
24-month-old mice (p = 0.04).  
 





Figure 4.2 p21 expression in the large and small airway epithelium of the ageing 
murine lung. Lung tissue sections from male C57BL/6 mice of increasing age (6.5-24 
months) were stained by immunohistochemistry for p21 expression and levels of 
expression quantified in the large and small airway epithelium in a blinded fashion.  Dot 
plots represent the percentage of epithelial cells expressing p21 in large (A) and small 
(B) airways generated by quantifying 10 random images for each animal. The total 
number of negative and positive airway epithelial cells per image was quantified 
manually and percentage positivity calculated from these values before an average was 
determined for the whole section. (C) Representative images of p21 immunostaining 
(brown) in large (upper panel) and small (lower panel) airway epithelial cells from 6.5-, 
15- and 24-month-old mice captured using X40 objective and shown at higher 
magnification on the right. Arrows point to p21 positive cells. To ensure staining was 
specific, a control omitting the primary antibody was included (not shown). Data are 
presented as the mean for individual animals with the horizontal line representing group 
mean. Statistics: One-way ANOVA and Independent samples t-test *P < 0.05. 
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4.1.2 DNA damage foci and telomere-associated foci increase in the large and small 
airway epithelial cells of the ageing murine lung, without significant telomere 
shortening 
In order to evaluate DNA damage foci and telomere dysfunction in large and small 
airway epithelial cells of the ageing murine lung, we performed telomere-specific 
quantitative fluorescence in situ hybridisation (Q-FISH), combined with 
immunofluorescence against γH2A.X (immuno-FISH). Analysis revealed a significant 
increase in the mean number of γH2A.X foci per cell in both large (Figure 4.3A) and 
small (Figure 4.3B) airway epithelial cells from 6.5 until 24 months of age. In the large 
airways, we found no significant difference in number of γH2A.X foci from 6.5 to 15 
months, but found a significant increase from 15 to 24 months (p = 0.03) and from 6.5 
to 24 months (p = 0.03). In the small airways, we found no significant difference in 
number of γH2A.X foci from 6.5 to 15 months, or from 15 months to 24 months but 
found a significant increase from 6.5 to 24 months (p = 0.008). Analysis of γH2A.X 
foci associated with telomeres (TAF) revealed a significant increase in mean number of 
TAF from 15 to 24 months (p = 0.014) and from 6.5 to 24 months (p = 0.002) in large 
airway epithelial cells (Figure 4.3C). In the small airways, we observed an increase in 
mean number of TAF from 6.5 to 15 months (p = 0.01) and from 6.5 to 24 months (p = 
0.002) (Figure 4.3D). The increase in mean number of TAF from 15 to 24 months did 
not reach statistical significance (p = 0.06). Analysis of telomere signal intensity 
indicated no statistically significant changes between the three age groups in both the 
large (Figure 4.4A) and small (Figure 4.4B) airway epithelial cells.  
  





Figure 4.3 γH2A.X foci and telomere-associated foci in large and small airway 
epithelial cells of the ageing murine lung. Lung tissue sections from male C57BL/6 
mice of increasing age (6.5-24 months) were analysed for expression of γH2A.X foci 
and telomere-associated foci (TAF) by immuno-FISH. Dot plots represent the mean 
number of γH2A.X foci per cell in large (A) and small (B) airway epithelial cells and 
the mean number of TAF per cell in large (C) and small (D) airway epithelial cells for 
each animal, generated by quantifying Z-stacks of at least 100 cells per mouse. (E) 
Representative image of immuno-FISH for γH2A.X (green) and telomeres (red) in 
small airway epithelial cells from 6.5-month and 24-month-old mice captured using 
X100 oil objective and following Huygens (SVI) deconvolution. Arrows point to 
γH2A.X foci co-localising with telomeres (TAF), depicted by associated histograms and 
shown at higher magnification on the right (images are from one single Z-plane). Data 
are presented as the mean for individual animals with the horizontal line representing 
group mean. Statistics: One-way ANOVA and Independent samples t-test *P < 0.05, 
**P < 0.01.  





Figure 4.4 Telomere length in large and small airway epithelial cells of the ageing 
murine lung. Telomere intensity of large and small airway epithelial cells in lung tissue 
sections from male C57BL/6 mice of increasing age (6.5-24 months) was assessed by 
Q-FISH to give an indication of telomere length. Dot plots represent mean telomere 
length of large (A) and small (B) airway epithelial cells for each animal generated by 
quantifying mean intensity of maximum projections of at least 100 cells per animal 
using a measuring tool on ImageJ analysis software. (C) Representative examples of Q-
FISH images of small airway sections from 6.5-, 15- and 24-month-old mice, colour 
coded according to telomere length (blue: short; red: long). Data are presented as the 
average intensity for individual animals with the horizontal line representing group 
mean. Statistics: One-way ANOVA and Independent samples t-test. Q-FISH, 
quantitative-fluorescence in situ hybridisation. 
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4.1.3 Alveolar airspace size increases in the murine lung with age and this correlates 
with telomere dysfunction and p21 expression   
Alveolar airspace size was determined by analysing H&E sections of the murine lung 
from mice age 6.5, 15 and 24 months of age. Two methods were used to determine 
changes in alveolar airspace size. The mean linear intercept (MLI) method consists of 
drawing a line diagonally from the bottom left of each image to the top right and 
counting the number of intersections (from alveolar wall segments) along that line, 
before dividing the length of the line in microns by the number of intercepts, as 
previously described (Weibel 1963). Therefore, the fewer the number of intersections, 
indicative of a reduction in alveolar airspaces or increased airspace size, the higher the 
MLI value. We also gathered information about airspace size by manually counting the 
number of airspaces, with less airspaces per field indicating increased airspace size, and 
calculating an average number per animal. We gained similar results using both 
methods, with a significant increase in MLI observed from 6.5 to 24 months (p = 0.003) 
and from 15 to 24 months (p = 0.004) (Figure 4.5A) and a significant decrease in mean 
number of airspaces from 6.5 to 24 months (p = 0.0001) and from 15 to 24 months (p = 
0.002) (Figure 4.5B).  





Figure 4.5 Alveolar airspace size in mice of increasing age. Changes in size of 
alveolar airspaces in the lungs from mice of increasing age were assessed by 
carrying out H&E staining on lung tissue sections from C57BL/6 mice in each age 
group (6.5, 15 and 24 months). 10 random images were captured for each tissue 
section using X20 objective and images were analysed using one of two methods. 
Dot plots represent mean linear intercept (MLI) value in microns (A) or the mean 
number of airspaces (B) for individual mice calculated as an average of 10 random 
images. Horizontal line represents group mean. (C) Representative images of H&E 
staining of alveolar airspaces in 6.5-, 15- and 24-month-old mice captured using 
X20 objective. Statistics: One-way ANOVA and Independent samples t-test. **P < 
0.01, ***P < 0.001. H&E, Haematoxylin and Eosin. 
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We tested correlations between mean number of airspaces and DNA damage foci, 
telomere length and p21 expression to determine whether a relationship exists between 
the natural enlargement of alveolar airspaces with age and telomere dysfunction or the 
presence of senescence markers. We observed no significant correlations between mean 
number of γH2A.X foci and mean number of airspaces when looking at both large 
(Figure 4.6A) and small (Figure 4.6B) airway epithelial cell expression. The negative 
correlations we observed between mean number of TAF and number of airspaces were 
statistically significant when investigating TAF content in both the large (Figure 4.6C) 
(p = 0.03) and small (Figure 4.6D) (p = 0.04) airway epithelial cells. Telomere length 
did not correlate with number of airspaces in either the large (Figure 4.6E) or small 
(Figure 4.6F) airway epithelial cells. Interestingly, we observed negative correlations 
between p21 expression in the large (Figure 4.6G) and small (Figure 4.6H) airway 
epithelial cells, although only small airway epithelial cell expression of p21 
significantly correlated with number of airspaces (p = 0.005). As expected, p21 
expression positively correlated with mean number of TAF in both the large (Figure 
4.7A) (p = 0.02) and small (Figure 4.7B) (p = 0.05) airway epithelial cells, however this 
failed to reach significance in the small airways. No correlation was observed between 
p21 expression and telomere length in either the large (Figure 4.7C) or small (Figure 
4.7D) airways.  





Figure 4.6 Relationship between number of alveolar airspaces and senescence-
associated markers in the large and small airway epithelial cells of the ageing 
murine lung. Relationship between mean number of γH2A.X foci in the large (A) and 
small (B) airway epithelial cells, mean number of telomere-associated foci (TAF) in the 
large (C) and small (D) airway epithelial cells, telomere length in the large (E) and 
small (F) airway epithelial cells and p21 expression in the large (G) and small (H) 
airway epithelial cells and number of airspaces in male C57BL/6 mice aged 6.5-24 
months. Not all tissue sections available for analysis of senescence marker expression 
were suitable for morphological analysis hence inconsistencies in numbers included in 
correlations. Correlations were assessed using Pearson’s correlation coefficient. P 
values < 0.05 considered significant.  





Figure 4.7 Relationship between p21 expression and telomere dysfunction in 
large and small airway epithelial cells of the ageing murine lung. Relationship 
between p21 expression and mean number of telomere-associated foci (TAF) in the 
large (A) and small (B) airway epithelial cells and telomere length in the large (C) and 
small (D) airway epithelial cells in male C57BL/6 mice aged 6.5-24 months. Not all 
tissue sections available for analysis of a particular marker were available for analysis 
of other markers, hence inconsistencies in numbers included in correlations.  
Correlations were assessed using Pearson’s correlation coefficient. P values < 0.05 
considered significant.  
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4.1.4 Late-generation TERC-/- mice show increased telomere-associated foci in small 
airway epithelial cells and early-onset emphysema  
To investigate whether telomere dysfunction contributes directly to loss of alveolar 
airspaces, we quantified the number of alveolar airspaces in lung tissue sections from 
mice carrying a homozygous deletion of the RNA component of telomerase (TERC
-/-
), 
the enzyme responsible for maintaining telomere length, bread until fourth generation 
(G4) (Blasco, Lee et al. 1997). G4 TERC
-/- 
mice have severe telomere dysfunction 
induced by telomere shortening, which results in both cell-cycle arrest and apoptosis 
(Lee, Blasco et al. 1998), and exhibit a number of phenotypes indicative of premature 
ageing that are, in part, thought to be due to early onset of senescence (Wong, Maser et 
al. 2003; Choudhury, Ju et al. 2007). First, we carried out immuno-FISH against 
γH2A.X and telomeres, to determine whether TAF increase as a result of telomere 
shortening. We confirmed that at 6.5 months of age, G4 TERC
-/-
 mice do have critically 
short telomeres in small airway epithelial cells, as compared to aged-matched wild-
types (Figure 4.8A) (p = 0.0005). A significant increase in mean number of TAF in the 
small airway epithelial cells of G4 TERC
-/-
 mice compared to age-matched wild-types 
was also observed (p = 0.008) (Figure 4.8B). Consistent with the hypothesis that 
telomere dysfunction in airway epithelial cells contributes to airspace enlargement, we 
found a significant reduction in number of airspaces in G4 TERC
-/-
 mice (p = 0.0002) 
(Figure 4.9A). Additionally, the correlation between mean number of TAF in small 
airway epithelial cells and number of airspaces still holds when G4 TERC
-/- 
mice are 
added (p = 0.003) (Figure 4.9B), however telomere intensity still does not show 
correlations with number of airspaces (p = 0.1) (Figure 4.9C). 





Figure 4.8 Telomere length and telomere-associated foci in small airway epithelial 
cells of late generation mice lacking telomerase. Immuno-FISH staining for γH2A.X 
and telomeres was carried out on lung tissue sections from fourth generation telomerase 
negative (G4 TERC
-/-
) mice and wild type C57BL/6 mice at 6.5 months of age. Dot plots 
represent mean telomere length (A) and mean number of telomere-associated foci (TAF) 
(B) in small airway epithelial cells for each animal generated by quantifying Z-stacks of 
at least 100 cells per mouse taken using X100 oil objective. Data are presented as the 
mean for individual animals with the horizontal line representing group mean. (C) 
Immuno-FISH images of small airway epithelial cells from wild-type and G4 TERC
-/-
 
mice colour coded according to number of TAF (blue: low number; red: high number) 
and telomere length (blue: short; red: long). Statistics: Independent samples t-test **P < 
0.01, ***P < 0.001.  





Figure 4.9 Alveolar airspace size and relationship with telomere dysfunction in late 
generation mice lacking telomerase. H&E staining was carried out on lung tissue 
sections from fourth generation telomerase negative (G4 TERC
-/-
) mice and wild type 
C57BL/6 mice at 6.5 months of age and number of alveolar airspaces manually counted 
from 10 random images taken using X20 objective for each animal. Dot plot represents 
mean number of airspaces (A). Data are presented as the mean for individual animals 
with the horizontal line representing group mean. Relationship between mean number 
of telomere-associated foci (TAF) (B) and telomere length (C) in small airway 
epithelial cells and number of airspaces in male C57BL/6 mice aged 6.5-24 months and 
G4 TERC
-/-
 mice aged 6.5 months. (D) Representative images of H&E staining of 
alveolar airspaces in wild-type and G4 TERC
-/-
 mice captured using X20 objective. 
Statistics: Independent samples t-test, Pearson’s correlation ***P < 0.001. H&E, 
Haematoxylin and Eosin. 
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4.2 Telomere dysfunction in the airway epithelial cells of mice exposed to 
cigarette smoke 
Cigarette smoking is the most important risk factor for COPD (Forey, Thornton et al. 
2011). In accordance, numerous studies have demonstrated early-onset emphysema and 
lung inflammation in mice exposed to cigarette smoke (Shapiro, Goldstein et al. 2003; 
Churg, Wang et al. 2004; Rinaldi, Maes et al. 2012; Yao, Chung et al. 2012; Ganesan, 
Comstock et al. 2014). Reports also describe increased markers of senescence in the 
lungs of mice exposed to cigarette smoke. It has been shown that exposure to cigarette 
smoke for 2 weeks increases Sen-β-Gal staining, p21 expression and lipofuscin 
accumulation in type II alveolar cells in mice, as compared to air-exposed controls 
(Tsuji, Aoshiba et al. 2004). Similarly, only 3 days exposure to cigarette smoke has 
been shown to augment DNA damage (as shown by increased γH2A.X) and increased 
levels of p21, as detected by immunoblotting in whole lung tissue extracts (Yao, Sundar 
et al. 2013). SIRT1 is decreased in whole lung tissue extracts and small airway 
epithelial cells of mice exposed to cigarette smoke (Caito, Rajendrasozhan et al. 2010; 
Yao, Chung et al. 2012). Additionally, p21 disruption attenuates cigarette smoke-
mediated inflammation and airspace enlargement in the murine lung and decreases 
levels of Sen-β-Gal and γH2A.X in the lungs of mice exposed to cigarette smoke (Yao, 
Yang et al. 2008; Yao, Chung et al. 2012; Yao, Sundar et al. 2013). Despite these 
findings, little focus has been given to the effects of cigarette smoke exposure on both 
large and small airway epithelial cell senescence in the lungs of wild-type mice. 
Furthermore, the presence of telomere-associated DNA damage has not yet been 
investigated, to our knowledge, in the context of in vivo cigarette smoke exposure. 
As we have previously found that TAF are increased in the small airway 
epithelium in patients with COPD and we show an age-dependent increase in TAF in 
the large and small airway epithelial cells of the murine lung, we aimed to determine 
whether cigarette smoke exposure leads to increases in TAF in both large and small 
airway epithelial cells of the murine lung.  
4.2.1 DNA damage foci and telomere-associated foci increase in the large and small 
airway epithelial cells of mice exposed to cigarette smoke, without significant 
telomere shortening 
To determine whether cigarette smoke exposure lead to induction of TAF in large and 
small airway epithelial cells of the murine lung, we performed immuno-FISH against 
telomeres and γH2A.X on lung tissue sections from male C57BL/6 mice exposed to 
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cigarette smoke for 1 hour, twice daily, for 2 weeks as compared to air-exposed, aged-
matched (3 months of age) controls. We found that cigarette smoke exposure 
significantly increased mean number of γH2A.X foci in both large (p = 0.02) (Figure 
4.10B) and small (p = 0.01) (Figure 4.10C) airway epithelial cells. Similarly, cigarette 
smoke exposure increased mean number of TAF in the large (p = 0.04) (Figure 4.10D) 
and small (p = 0.03) (Figure 4.10E) airway epithelial cells, as compared to aged-
matched controls. There was no significant differences observed in telomere length in 
both large (Figure 4.10F) and small (Figure 4.10G) airway epithelial cells of smoke-
exposed mice as compared to controls. 
 
4.2.2 Neutrophil infiltration is increased in the lungs of mice exposed to cigarette 
smoke 
It is known that chronic sterile inflammation increases with the ageing process, termed 
“inflammaging” (Franceschi, Capri et al. 2007). Additionally senescent cells may 
impact on the innate immune system and attract immune cells, such as neutrophils, via 
activation of the so-called SASP (Xue, Zender et al. 2007). A previous study has shown 
increased numbers of T-cells, B-cells and macrophages in the lungs of aged (24 months) 
compared to young (12 month) Balb/c mice (Aoshiba and Nagai 2007). We aimed to 
determine whether cigarette smoke exposure for two weeks increased the number of 
neutrophils present in murine lung tissue. 
In order to evaluate whether cigarette smoke exposure promoted neutrophil 
recruitment, immunohistochemistry was carried out on lung tissue sections from 
C57BL/6 mice exposed to cigarette smoke (as above) and air-exposed, aged-matched 
controls using an antibody raised against murine neutrophils (NIMP). We observed on 
average, around a 3-fold increase in the number of neutrophils present per visual field in 
the lung tissue of mice exposed to cigarette smoke (p = 0.0002) (Figure 4.11A).  




Figure 4.10 γH2A.X foci, telomere-associated foci and telomere length in large and 
small airway epithelial cells of mice exposed to cigarette smoke. Male C57BL/6 mice 
at 10 weeks of age were exposed to cigarette smoke for 1 hour, twice daily, or room air 
for 14 days (A) and sacrificed at 3 months of age, one hour following final exposure. 
Immuno-FISH against γH2A.X and telomeres was carried out on sections from the left 
lung. Dot plots represent mean number of γH2A.X foci in large (B) and small (C) 
airway epithelial cells, mean number of telomere-associated foci (TAF) in large (D) and 
small (E) airway epithelial cells and telomere length in large (F) and small (G) airway 
epithelial cells, generated by quantifying Z-stacks of at least 100 cells per animal. Data 
are presented as the mean for individual animals with the horizontal line representing 
group mean. Statistics: Independent samples t-test *P < 0.05.  





Figure 4.11 Neutrophil infiltration in lung tissue from mice exposed to cigarette 
smoke. Male C57BL/6 mice at 10 weeks of age were exposed to cigarette smoke for 1 
hour, twice daily, or room air for 14 days and sacrificed at 3 months of age, one hour 
following final exposure. Immunohistochemistry against murine neutrophils was carried 
out on sections from the left lung. Dot plots represent mean number of neutrophils per 
visual field for each animal, generated by quantifying at least 25 randomly captured 
images, taken using the X40 objective. Black arrows point to neutrophils. 
Immunohistochemistry was performed in collaboration with Anthony Lagnado from our 
lab. Data are presented as the mean for individual animals with the horizontal line 
representing group mean. Statistics: Independent samples t-test ***P < 0.001.  
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4.3 mTORC1 inhibition and ageing of the murine lung  
Inhibition of mTOR activity has been shown to extend lifespan in various model 
systems (Fabrizio, Pozza et al. 2001; Vellai, Takacs-Vellai et al. 2003; Kaeberlein, 
Powers et al. 2005; Harrison, Strong et al. 2009; Miller, Harrison et al. 2011; Wu, Liu et 
al. 2013). Rapamycin, a pharmacological inhibitor of mTORC1, attenuates many forms 
of age-related change in mice, including alterations in heart, liver, adrenal glands, 
endometrium, and tendon, as well as age-dependent decline in spontaneous activity 
(Wilkinson, Burmeister et al. 2012). Decreased mTOR expression by genetic means 
reduces the age-dependent increase in p16 in the kidney and livers of mice as compared 
to aged-matched wild-types (Wu, Liu et al. 2013). Few studies have investigated the 
effects of rapamycin treatment on senescent cell accumulation in vivo. Furthermore, 
there are much less data reporting the effects of rapamycin treatment on senescence 
marker expression in the ageing lung and effects on age-related lung decline.   
Our lab has previously shown that rapamycin treatment is able to prevent an age-related 
increase in TAF in the liver of mice, along with other markers of cellular senescence, 
including Sen-β-Gal and p21 (unpublished). However, it is unknown as to whether 
rapamycin treatment affects the age-related increase in TAF in the lung.  
We aimed to determine whether a rapamycin-supplemented diet is able to 
attenuate the age-related increase in telomere dysfunction and other markers of 
senescence in the large and small airway epithelial cells of the murine lung, along with 
the loss of alveolar integrity that occurs with age.  
In order to evaluate the effects of mTORC1 inhibition on ageing of the murine 
lung, male C57BL/6 mice were fed either a control or rapamycin-supplemented diet, as 
previously described by Harrison and colleagues (Harrison, Strong et al. 2009), and 
sacrificed at different time points (Figure 4.12).  





Figure 4.12 Experimental design of rapamycin-supplemented diet study. Male 
C57BL/6 mice were fed control or rapamycin-supplemented diets. Diets were begun at 
3.5 months of age and mice were sacrificed at either 6.5 months, giving a diet duration 
of 3.5 months, or 15 months of age, giving a diet duration of 12 months. There were 4-5 
animals per group. 
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4.3.1 Telomere-associated foci are decreased in the small airway epithelial cells of the 
murine lung following mTORC1 inhibition with rapamycin 
In order to elucidate whether a rapamycin-supplemented diet prevented the age-related 
increase in DNA damage foci and TAF in the airway epithelial cells of the murine lung, 
we carried out immuno-FISH against telomeres and γH2A.X on lung tissue sections 
from male C57BL/6 mice fed a control or rapamycin-supplement diet until 6.5 and 15 
months of age. We observed a tendency towards decreased γH2A.X foci in both the 
large (Figure 4.13A) and small (Figure 4.13B) airway epithelial cells at each time point, 
however these observations failed to reach statistical significance. Similarly, we 
observed a tendency towards decreased TAF in both the large (Figure 4.13C) and small 
(Figure 4.13D) airway epithelial cells at each time point, however these observations 
also failed to reach significance, with the exception of TAF content in the small airway 
epithelial cells, which was significantly reduced following 12 months rapamycin 
treatment (p = 0.02). It is unlikely that changes in TAF in the small airway epithelial 
cells at 15 months can be attributed to changes in telomere length, since telomere 
analysis revealed no significant difference in telomere length in either the large (Figure 
4.14A) or small (4.14B) airway epithelial cells at all time points following rapamycin 
supplementation. In order to determine whether rapamycin-supplementation affected 
other senescence-associated markers, we investigated p21 expression by 
immunohistochemistry in mice fed control and rapamycin diets at 6.5 and 15 months of 
age, however no significant changes in p21 expression were found (data not shown).  





Figure 4.13 Effect of a rapamycin-supplemented diet on DNA damage foci and 
TAF content in large and small airway epithelial cells of the murine lung. Male 
C57BL/6 mice at 3 months of age were fed a control or rapamcin-supplemented diet (R) 
and sacrificed at either 6.5 or 15 months of age. Immuno-FISH against γH2A.X and 
telomeres was carried out on sections from the left lung. Dot plots represent mean 
number of γH2A.X foci in large (A) and small (B) airway epithelial cells and mean 
number of telomere-associated foci (TAF) in large (C) and small (D) airway epithelial 
cells, generated by quantifying Z-stacks of at least 100 cells per animal. Data are 
presented as the mean for individual animals with the horizontal line representing group 
mean. Immuno-FISH staining and imaging was performed in collaboration with Samuel 
Sharp, a BSc project student in our lab. Statistics: One-way ANOVA and Independent 
samples t-test *P < 0.05.  





Figure 4.14 Effects of a rapamycin-supplemented diet on telomere length in large 
and small airway epithelial cells of the murine lung. Male C57BL/6 mice at 3 months 
of age were fed a control or rapamcin-supplemented diet (R) and sacrificed at either 6.5 
or 15 months of age. Q-FISH analysis was carried out on sections from the left lung. 
Dot plots represent mean telomere length in large (A) and small (B) airway epithelial 
cells, generated by quantifying maximum projections of Z-stack images of at least 100 
cells per animal. Data are presented as the mean for individual animals with the 
horizontal line representing group mean. For all comparisons no statistically significant 
differences were seen. Statistics: One-way ANOVA and Independent samples t-test. Q-
FISH, quantitative-fluorescence in situ hybridisation. 
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4.3.2 mTORC1 inhibition with rapamycin does not significantly affect age-related 
changes in alveolar airspaces in the murine lung. 
To investigate effects of a rapamycin-supplemented diet on alveolar airspace size with 
age, we carried out H&E staining on lung tissue sections. Ten random images were 
taken at X20 objective for each tissue section and airspace size was quantified using the 
MLI method and by manually counting the number of airspaces per visual field, as 
described previously. Using the MLI method of determining airspace size, we observed 
no changes following rapamycin treatment at each time point (Figure 4.15A). Similarly, 
manually counting the number of airspaces revealed no significant changes (Figure 
15B). 





Figure 4.15 Effects of a rapamycin-supplemented diet on alveolar airspace size in 
the ageing murine lung. Changes in size of alveolar airspaces in the lungs from 
C57BL/6 mice fed a control or rapamycin-supplemented diet (R) were assessed by 
carrying out H&E staining on lung tissue sections from mice in each age group.10 
random images were captured for each tissue section using X20 objective and images 
were analysed using one of two methods. Dot plots represent mean linear intercept 
(MLI) value (A) or the mean number of airspaces (B) for individual mice calculated as 
an average of 10 random images. Horizontal line represents group mean. For all 
comparisons no statistically significant differences were seen. H&E staining and image 
analysis was carried out in collaboration with Samuel Sharp. Statistics: One-way 
ANOVA and Independent samples t-test. H&E, Haematoxylin and Eosin. 
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4.4 Discussion  
Our results show that DNA damage foci (γH2A.X) and TAF age-dependently increase 
in both large and small airway epithelial cells of the murine lung. These findings 
corroborate other reports describing increased γH2A.X foci in alveolar epithelial cells 
of the murine lung with age (Wang, Jurk et al. 2009) and findings from our lab, which 
demonstrate an age-dependent increase in TAF in the liver and gut of mice (Hewitt, 
Jurk et al. 2012). Similarly, another study found elevated levels of mH2A, a histone 
variant present in SAHF, in old (24 month) compared to young (4 month) alveolar 
epithelial cells of the murine lung (Kreiling, Tamamori-Adachi et al. 2011). A prior 
study found an increase in γH2A.X foci in mouse lung tissue with age, but rejected the 
possibility that these foci had a telomeric origin, based on the observation that there was 
no significant colocalisation of γH2A.X with telomeres in senescent cells in vitro 
(Sedelnikova, Horikawa et al. 2004). Whereas our lab previously found age-related 
increases in TAF, the number of non-colocalising foci (non-TAF) per cell did not 
significantly increase with age in these tissues, suggesting that TAF persist and 
accumulate with age, whereas non-TAF do not (Hewitt, Jurk et al. 2012). We report a 
significant increase in both colocalising (TAF) and non-colocalising foci (γH2A.X) with 
age in the large and small airways of the murine lung. However, in all cases we did 
observe more significant increases in TAF (i.e. a lower p value), which suggests that 
TAF are a more robust marker for senescence than γH2A.X alone. This is very 
conceivable, since several groups give evidence which supports that DNA damage at 
telomeres is irreparable and persistent, therefore potentially preserving the “memory” of 
the damage accumulated with time (Fumagalli, Rossiello et al. 2012; Hewitt, Jurk et al. 
2012). It is unlikely that the observed increase in TAF with age can be explained by 
telomere shortening, since we found no significant differences in telomere length 
between mice aged 6.5-24 months, although there was a tendency towards decreasing 
telomere length with age. Mice have long telomeres and ubiquitously express the 
enzyme telomerase, hence it was believed that telomere dysfunction did not play a role 
in cellular senescence in murine tissues (Parrinello, Samper et al. 2003). Our lab 
previously found no difference in telomere length between TAF and non-TAF in mice 
intestinal crypts and found a slight increase in telomere length in liver TAF (Hewitt, 
Jurk et al. 2012). These, coupled with our findings, could suggest that the age-related 
increase in telomere dysfunction we have observed in the murine lung is independent of 
telomere length. In accordance, other studies have also described increased senescence 
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markers with age, without significant telomere shortening. For example, it was shown 
in hippocampal neurons and liver hepatocytes of baboons that TAF accumulate with age, 
however telomeres that colocalise with a DDR are not preferentially short (Fumagalli, 
Rossiello et al. 2012). One study demonstrated an age-related increase in p16 
expression in rat kidneys in vivo, without significant telomere shortening (Melk, 
Kittikowit et al. 2003). Interestingly, another study notably reports an inverse 
correlation between telomere length and lifespan across several mammalian species, 
which may suggest that longer telomeres are a more probable target for the 
accumulation of DNA damage (Gomes, Ryder et al. 2011). However, as we did not 
assess lengths of individual telomeres co-localising or not with DNA damage foci, it is 
unknown as to whether long or short telomeres are contributing to TAF in this case. In 
contrast to our findings, Wang and colleagues describe significant telomere shortening 
with age in mouse intestinal enterocytes (Wang, Jurk et al. 2009). However in this study, 
a larger age-range (12-42 months) was covered. C57BL/6 mice have long heterogeneous 
telomeres, thus it may be difficult to detect subtle changes in telomere length unless 
extremes of age are compared (Blasco, Lee et al. 1997). Therefore it is possible that we 
may have detected significant decreases in telomere length had we had access to older 
mice to include in the analysis. Because mice have long telomeres as compared to 
humans, it could be that TAF are more relevant to ageing in mice, since longer 
telomeres may provide a larger area for DNA damage. Whether TAF accumulate in 
human tissue with age is unknown and in this case, induction of telomere dysfunction 
could be telomere length-dependent. However, the fact that TAF accumulate in the skin 
and brains of baboons with age (which are similar to humans in that they have shorter 
telomeres and lack expression of telomerase), without necessary telomere shortening 
(Herbig, Ferreira et al. 2006; Jeyapalan, Ferreira et al. 2007; Fumagalli, Rossiello et al. 
2012) suggests that TAF are likely to increase in human tissues with age and may be 
independent of telomere length.  
One caveat to this study is that we have not analysed the expression of 
proliferation markers with age in the murine lung epithelium. γH2A.X staining alone 
can overestimate frequencies of senescent cells in tissues with high proliferative activity 
because an active DDR can be initiated by replication stress in dividing cells (Zeman 
and Cimprich 2014). Therefore, double-staining for γH2A.X and a proliferation marker, 
such as PCNA or Ki67 should have been conducted. Additionally, some cells 
containing DNA damage may be repaired or undergo apoptosis, also leading to a 
possible overestimation of senescent cell number. However, we did evaluate expression 
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of the CDKi p21 and found that expression increased with age and correlated positively 
with TAF.   
Telomere dysfunction has been associated with increased expression of the 
CDKi p21 by experiments showing that deletion of p21 prolongs the lifespan of mice 
with dysfunctional telomeres (Choudhury, Ju et al. 2007). Consistently, we found with 
increasing age that a greater % of airway epithelial cells stained positive for p21. We 
document a 16- and 10-fold increase in p21 expression in the large and small airways, 
respectively, between 6.5 and 24 months of age. Other groups also report increases in 
p21 in the murine lung and other tissues with age. Krishnamurthy and colleagues report 
increased expression of p21 mRNA in the lung and other tissues including kidney, 
uterus and spleen of old (26 months) compared to young (2.5 months) mice, however on 
average, only a 1.4-fold increase in p21 expression was observed (Krishnamurthy, 
Torrice et al. 2004). One reason for these discrepancies in our findings could be due to 
the fact that we analysed protein levels, as opposed to RNA expression, and it could be 
that p21 expression is upregulated at the translational and post-translational level. The 
increases we observed in p21 with age, matched those observed for TAF, with no 
significant changes occurring between 6.5 and 15 months of age in most cases, with 
significant differences only detected between 15 and 24 months. Mean number of TAF 
also positively correlated with % p21 expression, suggesting the presence of TAF as a 
good marker for large and small airway epithelial cell senescence. These findings are in 
agreement with studies showing that elevation of p21 levels in senescent cells correlate 
with the accumulation of γH2A.X (Herbig, Wei et al. 2003) and TAF (Herbig, Jobling 
et al. 2004). On the contrary, telomere length values did not show any correlations with 
p21 expression. Unfortunately, it was not possible to assess levels of p16 expression in 
the ageing murine lung. In our hands, it has been technically difficult to get p16 
antibodies to work in murine tissue, with other groups in the senescence field reporting 
similar problems. Ideally the use of RT-PCR to test for mRNA expression of 
senescence-associated markers, including p21 and p16, should have been carried out on 
whole tissue lysates. However, this would not be specific to the airway epithelium.  
  The ageing lung is associated with structural changes similar to those that occur 
in emphysema, including alveolar dilatation and distal airspace enlargement (Janssens, 
Pache et al. 1999). We found increases in airspace size (or decreased number of 
airspaces) in the murine lung with age. Number of airspaces negatively correlated with 
p21 expression but this was only significant for p21 expression in the small airways. It 
has been shown that ablation of SIRT1 expression in small airway epithelial cells of the 
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murine lung aggravates airspace enlargement induced by elastase, due to a lack of 
protection against development of airway epithelial cell senescence (Yao, Chung et al. 
2012). This suggests that small airway epithelial cell senescence may increase 
susceptibility to stress-induced emphysema. Interestingly, we found that telomere length 
did not correlate with airspace number, however there was an inverse correlation 
between mean number of TAF and number of airspaces. To determine whether telomere 
dysfunction contributes to airspace enlargement, we quantified the number of airspaces 
in lung tissue sections from G4 TERC
-/-
 mice, which have critically short telomeres and 
increased TAF, as determined in small airway epithelial cells. We found at 6 months of 
age, that G4 TERC
-/-
 mice show a significant reduction in number of airspaces as 
compared to wild-type controls. In fact, the correlation between TAF and number of 
airspaces strengthened when G4 TERC
-/-
 mice were added, however telomere length 
still did not correlate with number of airspaces. Contrary to our work, a previous study 
also using mice null for the RNA component of telomerase at 4
th
 generation report no 
de novo changes in alveolar airspace size as compared to wild-types (Alder, Guo et al. 
2011). However, the authors reported surprisingly small differences in telomere length 
and did not assess telomere dysfunction. In our study, levels of TAF in late G4 TERC
-/-
 
mice at 6 months were similar to those of wild-types at 24 months of age and telomere 
length was almost 4-fold shorter. These discrepancies in our findings may be due to 
difference in technique or strain-specific differences. However, our findings are in 
concordance with a prior study that identified loss of alveolar integrity in G4 TERC
-/-
 
mice and this study also reported similar decreases in telomere length to those that we 
observed (Lee, Reddy et al. 2009). We observed a greater difference in the change in 
alveolar airspace size than this study reports (2-fold as compared to 1.5-fold). However, 
this study uses fourth generation wild-type mice that were bred concurrently, to control 
for effects of inbreeding, whereas we compared to wild-type mice that were not inbred. 
Thus, the changes in alveolar integrity that we report in G4 TERC
-/-
 mice may be 
overestimated. We have evaluated telomere dysfunction in small airway epithelial cells 
and found correlations between TAF and airspace size. However, we cannot conclude 
that dysfunctional telomeres in small airway epithelial cells per se are causal to the 
emphysematous-like changes in the lung in both conditions of stress and with ageing, 
since telomere dysfunction is global in TERC
-/-
 mice. Indeed, we should have 
investigated whether mean number of TAF in alveolar epithelial cells correlated with 
number of airspaces, given that alveolar type I and II cells are directly involved in 
emphysematous-like changes and are therefore likely to be more relevant to these 
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changes than small airway epithelial cells. Additionally, telomerase has other reported 
activities, such as protection of mitochondrial function (Ahmed, Passos et al. 2008). 
Therefore, it is possible that loss of alveolar structural integrity observed in G4 TERC
-/-
 
mice is caused by mechanisms independent of telomere dysfunction.  
A number of studies have shown that cigarette smoke exposure increases 
senescence-marker expression in the lungs of mice in vivo (Tsuji, Aoshiba et al. 2004; 
Yao, Chung et al. 2012; Yao, Sundar et al. 2013). However, the presence of TAF has 
not been investigated. We have found that just 2 weeks of cigarette smoke exposure is 
sufficient to significantly increase both γH2A.X and TAF in the large and small airway 
epithelial cells of the murine lung. This is in accordance with other studies that have 
also described increased γH2A.X in the lungs of mice exposed to cigarette smoke in 
whole tissue lysates (Yao, Sundar et al. 2013) and increased 53BP1 foci in small airway 
epithelial cells in situ (Alder, Guo et al. 2011). In our previous chapter, we found using 
immunohistochemistry that more markers of senescence were upregulated in the small, 
as opposed to large airway epithelial cells in the COPD lung, including γH2A.X foci. 
We observed no obvious differences between the large and small airways of mice 
exposed to cigarette smoke. The predominance of small airway epithelial cell 
senescence that we observed in the COPD lung could be a factor of the disease, duration 
of cigarette smoke exposure or due to differences in breathing technique between mice 
and humans. Mice are obligatory nasal breathers and so some of the more harmful 
products that would be inhaled and potentially reach the distal airways of the human 
lung, may be deposited in the nasal passages of the mice. Additionally, the percentages 
of different cell subsets that comprise the airway epithelium of the murine lung are 
different to those that make up the human airway epithelium (Rock, Randell et al. 2010). 
Therefore the “sensitivities” of the large and small airway epithelial cells to CSE-
induced senescence are probably not comparable between the two species. It could be 
possible that our observations of increased γH2A.X foci and TAF in the airways of mice 
exposed to cigarette smoke are representative of increased damage, rather than 
senescence per se, since we have not explored other markers of senescence, mainly due 
to time limitations. However, other studies have shown that senescence markers, such as  
Sen-β-Gal and p21, are increased in the lungs of mice following 2 weeks of cigarette 
smoke exposure and following short-term exposures (3 days) (Tsuji, Aoshiba et al. 2004; 
Yao, Sundar et al. 2013). We did analyse the presence of neutrophils infiltrating lung 
tissue from mice exposed to cigarette smoke and controls. Similar to previous 
observations (D'Hulst A, Vermaelen et al. 2005; Doz, Noulin et al. 2008; Nikota, Shen 
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et al. 2014), we found that cigarette smoke exposure significantly increased the number 
of neutrophils detected per visual field. We analysed neutrophil number throughout 
tissue sections and did not focus specifically on the airway compartments. While it is 
known that cigarette smoke exposure induces acute inflammation, it is still not clear 
whether senescent cells can be cleared by immune cells or whether senescent cells 
attract inflammatory cells. Future work would be to determine whether neutrophils are 
clustered close to senescent cells, or specifically those that contain higher numbers of 
TAF, and whether interruption of cytokine signalling from the SASP could reduce 
recruitment of neutrophils. We found no differences in telomere length in mice exposed 
to cigarette smoke as compared to controls, which coincides with our previous findings 
of increased TAF, without a necessary decrease in telomere length. However, it could 
be that after just two weeks of smoke exposure, subtle changes in mean telomere length 
are difficult to detect (Blasco, Lee et al. 1997). In accordance, another study, also using 
Q-FISH, failed to detect further shortening of telomeres in small airway epithelial cells 
of G4 mTR
-/-
 mice, following 6 months of cigarette smoke exposure (Alder, Guo et al. 
2011). However, it is still possible that minor telomere shortening occurs. There were 
no obvious changes in alveolar airspace size following cigarette smoke exposure (not 
shown). However, this was not fully investigated, as many studies have shown that 
cigarette smoke exposure causes early-onset emphysema in the murine lung, with 
longer term exposures required for this effect (2-6 months) (Yoshida, Mett et al. 2010; 
Ganesan, Comstock et al. 2014). Although, there are some studies that show even 6 
months of cigarette smoke exposure does not lead to significant airspace disease (Alder, 
Guo et al. 2011).  
To our knowledge, there have been no published studies examining the effects 
of a rapamycin-supplemented diet on the presence of senescence-associated markers 
with age in tissues in situ. We found a tendency towards decreased γH2A.X and TAF 
after 3.5 and 12 months of rapamycin treatment in both the large and small airway 
epithelial cells of the murine lung. However, we only observed statistically significant 
differences in TAF reduction in small airway epithelial cells following 12 months of 
rapamycin supplementation. One limitation of our work is that we could only access 
tissue from mice fed a rapamycin-supplemented diet up to an age of 15 months, despite 
the majority of senescence-associated markers and age-related changes in the lung only 
becoming significantly different from young mice at 24 months of age. Therefore, it 
would be desirable to have included mice at 24 months of age and older. Although, 
rapamycin-supplementation for 12 months, until 15 months of age, has previously been 
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shown by our lab to be sufficient to significantly reduce TAF in murine liver 
hepatocytes in situ (unpublished). Despite not reaching statistical significance, our 
observation of decreased DNA damage foci in rapamycin-fed mice at each time point, 
and in both large and small airway epithelial cells is still an important one and coincides 
with previous studies demonstrating the importance of mTORC1 in the maintenance of 
a DDR in vivo. For example, short-term dietary restriction (DR), a known inhibitor of 
mTOR signalling, in adult mice, significantly reduces the frequencies of γH2A.X foci-
positive cells in both intestines and liver and reduces the frequencies of Purkinje cells 
positive for γH2A.X (Wang, Maddick et al. 2010; Jurk, Wang et al. 2012). In contrast to 
our findings, one study reports that rapamycin reduces p21 expression in murine lung 
tissue, as detected by immunoblotting of homogenised tissue, but does not affect 
expression of the DNA damage/heterochromatin complex marker mH2A and in fact, an 
increase in mH2A in the lungs of those mice fed a low-dose rapamycin diet was found 
(Hinojosa, Mgbemena et al. 2012). We did not observe any significant changes in p21 
expression in airway epithelial cells of the murine lung following rapamycin treatment 
(data not shown) and in some cases, we observed a tendency towards increased p21 
expression in large and small airway epithelial cells of rapamycin-treated mice. The 
discrepancies in our findings could be due to the use of different mouse strains and/or 
different techniques to identify senescence markers. In the study by Hinojosa and 
colleagues, rapamycin was administered for a similar duration as in ours, however lungs 
were analysed at 22 months of age and diet was commenced at 9 months, which may 
also account for some of the differences between our findings. Unpublished data from 
our lab shows that rapamycin decreases p21 expression in the livers of mice that were 
harvested from the same cohort we used herein. Interestingly, Krishnamurthy and 
colleagues report that while DR reduces p16 and p21 expression in several tissues from 
Fischer 344 rats, there was no attenuation of expression in lung tissue. In fact, although 
not significant, there was a slight increase in p16 and p21 expression in lung tissue from 
DR rats (Krishnamurthy, Torrice et al. 2004). Moreover, the genetic overexpression of 
regulated in development and DNA damage responses (Redd1), an inhibitor of 
mTORC1 signalling, in murine lungs, triggers inflammation, oxidative stress and loss of 
alveolar integrity and downregulation of Redd1 protects against cigarette smoke-
induced lung pathology, such as airspace enlargement (Yoshida, Mett et al. 2010). 
Furthermore, when authors used rapamycin pretreatment in Redd1
-/-
 mice, this 
protective effect was partially abrogated. Paradoxically, the authors also report that 
rapamycin protects against acute inflammation induced by cigarette smoke in wild-type 
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mice (Yoshida, Mett et al. 2010). Therefore, the effects of rapamycin or mTOR 
inhibition in the lung are somewhat contradictory at present and further research into 
this area is required. One caveat of our work is that we did not investigate whether 
rapamycin treatment was decreasing mTORC1 activity, something which should have 
been confirmed.   
A number of studies suggest that because rodents have large telomeres and 
heavily express telomerase, the signals that induce senescence markers with age are 
unlikely to be telomere based or telomere shortening may only contribute to cell 
senescence on a minor scale (Krishnamurthy, Torrice et al. 2004; Wang, Maddick et al. 
2010). We observed a tendency towards reduced TAF in the airway epithelial cells of 
mice fed a rapamycin-supplemented diet and a significant decrease in TAF in the small 
airway epithelial cells following 12 months rapamycin supplementation. However, 
despite observing a tendency towards increased telomere length at 15 months of age in 
those mice fed rapamycin, these observations were not statistically significant. 
Therefore we believe this reduction in TAF is probably not explained by maintenance of 
telomere length. Although, there are a number of studies that show DR attenuates age-
related telomere erosion. Prior work has shown that long-term DR reduces telomere 
shortening in various adult mouse tissues, including lung, however these observations 
were made in alveolar epithelial cells (Vera, Bernardes de Jesus et al. 2013). Similarly, 
short-term DR, started later in life, also reduces telomere shortening in murine intestinal 
enterocytes and liver hepatocytes (Wang, Maddick et al. 2010). To our knowledge, 
there are no studies that have investigated the effects of rapamycin treatment on 
telomere length in vivo.  
In summary, we have found that TAF accumulate in the airway epithelial cells 
of the ageing murine lung and following cigarette smoke exposure. It is possible that 
TAF are a more robust marker for senescence and may predict loss of lung structural 
integrity, based on the observation that mice lacking telomerase show early-onset 
emphysematous-like changes. The preliminary observation that rapamycin appears to 
have beneficial effects on airway epithelial cell senescence and age-related changes in 
the lung may suggest that targeting mTORC1 signalling could be of therapeutic benefit 
in diseases of accelerated lung ageing, such as COPD. Further work is required to 
elucidate the role of mTOR in lung cellular senescence and in age-related lung disease.   
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Chapter 5. Cigarette smoke exposure induces telomere dysfunction 
and cellular senescence 
In the preceding chapters, we have shown that DNA damage foci (γH2A.X) and 
telomere-associated foci (TAF) are increased in small airway epithelial cells from 
patients with COPD, in the large and small airway epithelium of the ageing murine lung 
and following cigarette smoke exposure in vivo. Cigarette smoking is the greatest risk 
factor for development of COPD and a number of studies have shown that cigarette 
smoke exposure induces features of senescence in vitro in a range of cell types, 
including alveolar epithelial cells, lung fibroblasts and bronchial epithelial cells (Tsuji, 
Aoshiba et al. 2004; Nyunoya, Monick et al. 2006; Hara, Araya et al. 2013; Kanaji, 
Basma et al. 2014). However, one limitation of most of these studies is that they 
investigate only the effects of short-term cigarette smoke exposure (48 hours to 14 days). 
These models, whilst useful for early studies, are models of acute rather than chronic 
smoke exposure. Moreover, while it has been demonstrated that cigarette smoke 
exposure leads to increased H2A.X phosphorylation in normal bronchial epithelial cells 
and human immortalised stromal fibroblasts (Albino, Huang et al. 2004; Salem, Al-
Zoubi et al. 2013), the role of telomere dysfunction, specifically the presence of a DDR 
at telomeres, in cigarette smoke-induced senescence has not been investigated.  
The aim of this work was to determine whether long-term cigarette smoke 
exposure induces telomere dysfunction and consequently other hallmarks of senescence 
in vitro.  
5.1 Long-term cigarette smoke exposure induces hallmarks of senescence 
In order to determine whether chronic cigarette smoke exposure induces features of 
senescence in vitro, normal human lung fibroblasts (MRC5) at a population doubling 
(PD) of 25 were exposed to cigarette smoke extract (CSE) at 5% concentration every 48 
hours until replicative senescence was reached (around 60 days in culture). At certain 
stages of the passaging process, cells were analysed for several senescence-associated 
markers. MRC5 cells were chosen for long-term experiments, as opposed to airway 
epithelial cells, which would complement the in vivo data, due to the fact that prolonged 
culturing of airway epithelial cells and exposure to cigarette smoke induces EMT in 
these cells.  
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5.1.1 Cigarette smoke exposure reduces MRC5 cell proliferation in vitro  
MRC5 cells, treated with 5% CSE or normal DMEM (untreated controls), were 
passaged when cells were around 70% confluent. With each cell passage, cell counts 
were carried out and PD number calculated as described in Materials and Methods. 
Initially both CSE-exposed and untreated cells replicated at the same rate, however 
exposure to 5% CSE induced cellular senescence in MRC5 cells at an earlier time point, 
evidenced by reduced population doublings as compared to untreated controls (Figure 
5.1A). Additionally, expression of the proliferation marker Ki67 was reduced at all time 
points in cells treated with 5% CSE, however these differences were only significant at 
day 24 (p = 0.05) (Figure 5.1 B and C). Initial viability experiments revealed no 
significant cell death. Viability was tested 24 hours following initial exposure, using 
propidium iodide (PI) staining coupled with flow cytometry, which showed that while 5% 
CSE exposure caused some cell death, viability always remained above 70%, with a 
mean viability of 80% achieved for untreated cells (n = 3 samples from two independent 
experiments) (data not shown).   
  





Figure 5.1 Effect of long-term cigarette smoke exposure on growth of MRC5 
fibroblasts. MRC5 cells exposed to 5% cigarette smoke extract (CSE) or normal cell 
culture media every 48 hours were subjected to repeated passaging and cell number 
counted with each passage. Population doubling (PD) level was calculated for each 
condition and is plotted against number of days in culture (A). Graph A was generated 
from one experiment and confirmed by an independent experiment (data not shown). 
Expression of the proliferation marker Ki67 was analysed at a range of time points by 
immunofluorescence. (B) Quantification of Ki67 expression, representative of one 
experiment; points are mean % Ki67 positivity ± S.E.M of at least 20 random planes. 
Similar changes in Ki67 expression were confirmed in an independent experiment (not 
shown). (C) Representative images of Ki67 staining (red) with DAPI (blue) as a nuclear 
counterstain in MRC5 cells at 3 and 24 days in culture in the presence or absence of 5% 
CSE. Analysis of Ki67 expression by immunofluorescence was performed in 
collaboration with Francisco Marques in our lab. Statistics: Two-way ANOVA 
followed by multiple Independent samples t-test *P < 0.05.   
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5.1.2 Cigarette smoke exposure induces telomere dysfunction in vitro  
In order to evaluate DNA damage foci and telomere dysfunction in MRC5 cells exposed 
to 5% CSE, we performed telomere-specific quantitative fluorescence in situ 
hybridisation (Q-FISH), combined with immunofluorescence against γH2A.X 
(immuno-FISH) on cells fixed at a range of time points from 3-60 days in culture. 
Analysis revealed a tendency towards an increase in the mean number of γH2A.X foci 
per cell in cells exposed to cigarette smoke, which was statistically significant after 24 
days in culture (p = 0.007) but was no longer significant after 60 days in culture (p = 0.8) 
(Figure 5.2A). Analysis of γH2A.X foci associated with telomeres (TAF) revealed a 
tendency towards increased TAF in cells exposed to CSE at most time points (Figure 
5.2B), however these increases were only significant at day 24 (p = 0.002) and day 60 
in culture (p = 0.02). Analysis of % of cells containing TAF revealed significant 
differences between CSE-exposed and untreated cells at all time points, except 
following 60 days in culture where all cells were positive for TAF (Figure 5.2C).  





Figure 5.2 DNA damage foci and telomere-associated foci in MRC5 cells in the 
presence or absence of cigarette smoke. MRC5 cells exposed to 5% cigarette smoke 
extract (CSE) or normal cell culture media every 48 hours were cultured until 
replicative senescence and analysed at a range of time points for γH2A.X foci and 
telomere-associated foci (TAF) by immuno-FISH. Bar graphs represent the mean 
number of γH2A.X foci per cell (A), the mean number of TAF per cell (B) and 
percentage of cells containing TAF (C) from one experiment. Data are presented as 
mean ± S.E.M of 50 cells per condition, generated by quantifying Z-stack images. An 
independent experiment showed similar results (not shown). Statistics: Two-way 
ANOVA followed by multiple Independent samples t-test *P < 0.05, **P < 0.01.  
 





Figure 5.3 Representative images of immunostainings for DNA damage foci and 
telomere-associated foci in MRC5 cells in the presence or absence of cigarette 
smoke. Representative image of immuno-FISH for γH2A.X (green) and telomeres (red) 
in MRC5 cells at 3 and 24 days in culture in the presence or absence of 5% CSE 
captured using X100 oil objective and following Huygens (SVI) deconvolution. Arrows 
point to γH2A.X foci co-localising with telomeres (TAF), shown at higher 
magnification on the right (images are from one single Z-plane). 
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Increased cellular volume and increased nuclear size have been described in 
senescent cells (Bayreuther, Rodemann et al. 1988). Therefore nuclear area of cells 
exposed to CSE and untreated controls was analysed by DAPI staining. While we 
observed an increase in nuclear area with time spent in culture for both conditions, there 
were no significant differences observed between smoke-exposed and untreated cells 
(Figure 5.4A). Additionally, cells were analysed for expression of the senescence-
associated marker Sen-β-Gal. No expression could be detected in either control or 
smoke-exposed cells until day 24, where cells exposed to 5% CSE had an increased 
percentage of Sen-β-Gal positive cells (p = 0.0003). This difference in expression of 
Sen-β-Gal was no longer observed when cells reached replicative senescence (Figure 
5.4B). 
In order to determine whether cigarette smoke exposure also induced telomere 
dysfunction in small airway epithelial cells in vitro, primary human small airway 
epithelial cells were exposed to 5% CSE. Cells were exposed to CSE (two exposures, 
48 hours apart) or to normal cell culture media and were fixed 24 hours following the 
final exposure. Immuno-FISH analysis revealed an increase in mean number of γH2A.X 
foci per cell in those cells exposed to CSE, however this was not statistically significant 
(p = 0.057) (Figure 5.5A). However, there was a significant increase in mean number of 
TAF in cells exposed to CSE (p = 0.04) (Figure 5.5B). Interestingly, not all cells 
analysed had significant increases in TAF, suggesting that patient-specific differences in 
response to cigarette smoke exposure may occur (Figure 5.5C). There were no 
significant differences in telomere length between untreated and smoke-exposed cells (p 
= 0.2). Sen-β-Gal staining revealed low levels of positivity in both untreated and CSE-
exposed cells (less than 5%). No significant differences in positive staining were 
observed between untreated and CSE exposed small airway epithelial cells when 
compared as a group (p = 0.6) (Figure 5.7A), suggesting that 48 hours exposure is too 
short to induce Sen-β-Gal activity. However, comparisons between untreated and smoke 
exposed cells isolated from the same subject revealed slight, but significant, increases in 
Sen-β-Gal positivity for two subjects (Figure 5.7B), suggesting that induction of Sen-β-












Figure 5.4 Nuclear area and Sen-β-Gal positivity in MRC5 cells cultured in the 
presence or absence of cigarette smoke. MRC5 cells exposed to 5% cigarette smoke 
extract (CSE) or normal cell culture media every 48 hours were cultured until 
replicative senescence and nuclear size measured at a range of time points following 
DAPI staining. (A) Changes in nuclear size over time generated from one experiment. 
Data are presented as mean ± S.E.M of 50 cells per condition. An independent 
experiment showed the same pattern (not shown). (B) Sen-β-Gal positivity in cells 
exposed to 5% CSE and untreated controls. Data are presented as mean + SD of at least 
10 random planes and are representative of one experiment. An independent experiment 
confirmed these findings (not shown). (C) Representative images of Sen-β-Gal staining 
in CSE exposed and untreated cells following 24 and 60 days in culture, captured using 
X20 objective. Sen-β-Gal staining was carried out in collaboration with Clara Correia 
Melo from our lab. Statistics: Two-way ANOVA followed by multiple Independent 
samples t-test  ***P < 0.001.  
 





Figure 5.5 DNA damage foci and telomere-associated foci in small airway 
epithelial cells exposed to cigarette smoke in vitro. Primary human small airway 
epithelial cells isolated from the lung during research bronchoscopy (passage 1-2) were 
exposed to 5% CSE (two exposures, 48 hours apart) or normal cell culture media 
(untreated control) and fixed 24 hours following the final exposure. Cells were analysed 
for γH2A.X foci and telomere-associated foci (TAF) content by immuno-FISH. Dot 
plots represent the mean number of γH2A.X foci per cell (A) and the mean number of 
TAF per cell (B) in small airway epithelial cells exposed to 5% CSE or normal media, 
generated by quantifying Z-stacks of at least 50 cells per subject. Data are presented as 
the mean for individual subjects with the horizontal line representing group mean. (C) 
Bar graph showing mean number of TAF per cell for each individual subject when cells 
were exposed to 5% CSE or left untreated. Data are presented as mean ± S.E.M of 50 
cells per condition. (D) Dot plot representing telomere length for each subject when 
cells are left untreated or exposed to 5% CSE. Data are presented as the mean for 
individual subjects with the horizontal line representing group mean. Statistics: One-
way ANOVA and Independent samples t-test *P < 0.05.  
 





Figure 5.6 Representative images of immunostainings for DNA damage foci and 
telomere-associated foci in small airway epithelial cells exposed or not to cigarette 
smoke. Representative image of immuno-FISH for γH2A.X (green) and telomeres (red) 
in small airway epithelial cells exposed to CSE or untreated, captured using X100 oil 
objective and following Huygens (SVI) deconvolution. Arrows point to γH2A.X foci 
co-localising with telomeres (TAF), shown at higher magnification on the right (images 
are from one single Z-plane). 
 





Figure 5.7 Sen-β-Gal positivity in small airway epithelial cells exposed to cigarette 
smoke in vitro. Primary human small airway epithelial cells isolated from healthy 
volunteers during research bronchoscopy (passage 1-2) were exposed to 5% CSE (two 
exposures, 48 hours apart) or normal cell culture media (untreated control) and fixed 24 
hours following the final exposure. Cells were stained for senescence-associated-β-
galactosidase (Sen-β-Gal) activity. (A) Dot plot representing percentage positivity for 
Sen-β-Gal staining, generated by quantifying at least 10 random fields per subject. Data 
are presented as the mean for individual subjects with the horizontal line representing 
group mean. (B) Bar graph showing Sen-β-Gal levels (percentage positivity) for each 
individual subject when cells were exposed to 5% CSE or left untreated. Data are 
presented as mean ± S.E.M of at least 10 random planes. (C) Representative image of 
Sen-β-Gal staining in small airway epithelial cells exposed to CSE or untreated, 
captured using X20 objective. Sen-β-Gal staining was carried out in collaboration with 
Clara Correia Melo from our lab Statistics: One-way ANOVA and Independent samples 
t-test *P < 0.05, ** P < 0.01. 
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5.1.3 Cigarette smoke exposure promotes SASP factor release in vitro  
In order to determine whether long-term cigarette smoke exposure promotes SASP 
factor release from MRC5 cells, conditioned media was harvested from cells at all time 
points. For technical reasons, we were unable to harvest media from cells that had been 
cultured until 60 days, therefore our last time point was 38 days. We first conducted an 
array analysis of 20 pro-inflammatory mediators. Of all mediators analysed only IL-6, 
IL-8, vascular endothelial growth factor (VEGF), growth regulated oncogene (GRO) 
and monocyte chemotactic protein 1 (MCP-1) were upregulated following 5% CSE 
exposure for 38 days (Figure 5.8A and B). However, only IL-6 (p = 0.03) and IL-8 (p = 
0.01) secretion were significantly increased. Most other cytokines or growth factors 
analysed were secreted below detection level. Since IL-6 and IL-8 release were 
significantly increased, we conducted ELISAs for IL-6 and IL-8 detection at all time 
points, which independently confirmed the findings of the cytokine array (Figure 5.8C 
and D). The rise in cytokine secretion following CSE exposure was evident at all time 
points, however differences only became statistically significant after 13 days in culture, 
which became enriched after 38 days. We also observed increasing concentrations of 
cytokine release in untreated MRC5 fibroblasts with increasing PD, consistent with the 
onset of replicative senescence (not shown).  





Figure 5.8 Effect of long-term cigarette smoke exposure on cytokine release from 
MRC5 cells. MRC5 cells exposed to 5% cigarette smoke extract (CSE) or normal cell 
culture media every 48 hours were cultured until replicative senescence and conditioned 
media collected at a range of time points and analysed for the presence of pro-
inflammatory cytokines. Cells were serum starved 24 hours prior to media collection. 
(A) Secreted protein array (RayBiotech) of a variety of inflammatory proteins 38 days 
following 5% CSE exposure, colour coded according to levels of protein detected for 
each pro-inflammatory mediator. (B) Bar graph representing concentrations of those 
pro-inflammatory mediators detected by protein array. Data are mean ± S.E.M of 3 
independent experiments. Bar graph representing concentrations of IL-6 (C) and IL-8 
(D) in cell culture media from MRC5 cells exposed to 5% CSE or untreated media 
measured by ELISA. Data are presented as mean ± SEM of 4 independent experiments. 
Statistics: Two-way ANOVA followed by multiple Independent samples t-test *P < 
0.05, **P < 0.01, ***P < 0.001.   
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5.2 ROS-dependent telomere dysfunction may be involved in cigarette 
smoke-induced senescence   
Mechanistically, it is still unclear how CSE induces telomere dysfunction. Evidence 
suggests that oxidative stress is likely to be involved in the induction and maintenance 
of senescence and a number of studies have shown that ROS can directly damage DNA, 
inducing a DDR and cellular senescence (Chen, Fischer et al. 1995; Rai, Onder et al. 
2009). Telomeres are highly sensitive to oxidative stress compared to the bulk of the 
genome (Petersen, Saretzki et al. 1998). This is possibly due to the fact that telomere 
repeats contain guanine triplets, which are remarkably susceptible to oxidative 
modifications (Henle, Han et al. 1999). In accordance, mild-oxidative stress has been 
shown to accelerate telomere shortening, whereas overexpression of anti-oxidant 
enzymes, the use of free-radical scavengers and low oxygen have been shown to extend 
replicative lifespan and reduce telomere shortening rates in human fibroblasts by 
decreasing ROS generation (von Zglinicki 2002; Serra, von Zglinicki et al. 2003; 
Richter and von Zglinicki 2007). Oxidative stress has been implicated in the 
pathogenesis of COPD. Patients with COPD show increased markers of oxidative stress 
both systemically and in the lung, as well as imbalanced antioxidant defence (Rahman, 
van Schadewijk et al. 2002; Igishi, Hitsuda et al. 2003; Houben, Mercken et al. 2009; 
Caramori, Adcock et al. 2011). Additionally, exposure to cigarette smoke has been 
shown to increase markers of oxidative stress in the lungs of mice in vivo and in human 
lung fibroblasts in vitro (Aoshiba, Koinuma et al. 2003; Deslee, Adair-Kirk et al. 2010). 
Therefore it is possible that TAF are induced by oxidative stress generated by exposure 
to cigarette smoke.  
To determine whether telomere dysfunction, in the context of cigarette smoke-
induced senescence, was caused by oxidative stress, MRC5 fibroblasts were cultured 
under conditions of low (3% O2) or normal (20% O2) oxygen pressure and exposed to 5% 
CSE or normal cell culture media every 48 hours for 25 days (Figure 5.9A). We found 
that low oxygen pressure increased MRC5 cell proliferation, evidenced by a higher 
cumulative cell number being reached as compared to cells cultured under 20% O2 
(Figure 5.9B and C). Similarly, the difference in number of cells between those exposed 
to CSE and untreated controls was supressed when cells were cultured under 3% O2.  
Consistent with a causal role for oxidative stress in induction of telomere 
dysfunction, we found by immuno-FISH that low oxygen pressure was able to supress 
CSE-induced increases in TAF (Figure 5.10B). As shown previously, 5% CSE 
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increased mean number of γH2A.X foci per cell (p = 0.018) and this increase was 
reduced slightly when cells were cultured at 3% O2, but this was not statistically 
significant (p = 0.1) (Figure 5.10A). However, the increase in TAF observed following 
CSE exposure (p = 0.015) was significantly reduced when cells were cultured at low 
oxygen pressure (p = 0.02).  
Analysis of Sen-β-Gal expression revealed that 5% CSE exposure increased the 
percentage of cells positive for Sen-β-Gal at 20% O2 (p = 0.001), as shown previously. 
However, cultivation of cells at 3% O2 drastically reduced frequencies of Sen-β-Gal 
positive cells to undetectable levels, in both cells cultured with normal media and 5% 
CSE (Figure 5.11A).  
Telomere-dysfunction and resulting DDR activation result in increased 
expression of IL-6 and IL-8 (Rodier, Coppe et al. 2009). To determine whether ROS 
contribute to development of the SASP, ELISAs were carried out for detection of IL-6 
and IL-8 in cell culture media from MRC5 cells cultured at normal and low oxygen 
pressure exposed, or not, to CSE. As previous, we found that 25 days of exposure to 5% 
CSE lead to increased release of IL-6 (p = 0.03) (Figure 5.12A), with cultivation at 3% 
O2 reducing levels of IL-6 release in both untreated cells (p = 0.0002) and cells exposed 
to 5% CSE (p = 0.016) (Figure 5.12A). Similarly, we found that exposure to 5% CSE 
lead to increased release of IL-8 (p = 0.006) with cultivation at 3% O2 both decreasing 
release of IL-8 from untreated cells (p = 0.0002) and cells exposed to CSE (p = 0.0009) 
(Figure 5.12B). 
In order to determine whether CSE exposure led to increased ROS and 
mitochondrial-derived ROS, we measured intracellular ROS levels (measured by DHR 
fluorescence) and levels of mitochondrial-derived superoxide production (measured by 
MitoSOX fluorescence). CSE increased intracellular ROS levels, which was suppressed 
when culturing cells under 3% O2 (Figure 5.13A). Increases in mitochondrial-derived 
ROS observed when cells are treated with 5% CSE were also reduced when cells were 
cultured at 3% O2 (Figure 5.13B).  
 





Figure 5.9 Effect of oxygen pressure and cigarette smoke exposure on growth of 
MRC5 fibroblasts. MRC5 cells (PD 25) cultured under normoxia (20% O2) or hypoxia 
(3% O2) were exposed to 5% cigarette smoke extract (CSE) or normal cell culture 
media every 48 hours for 25 days (A). With every cell passage, cell number was 
quantified and is plotted against days in culture (B and C). Graphs are generated from 
one experiment.  





Figure 5.10 Effect of oxygen pressure on cigarette smoke-induced DNA damage 
foci and telomere-associated foci in MRC5 cells. MRC5 cells cultured under 3% O2 
or 20% O2 were exposed to 5% cigarette smoke extract (CSE) or normal cell culture 
media every 48 hours for 25 days and γH2A.X foci and telomere-associated foci (TAF) 
expression evaluated by immuno-FISH. Bar graphs represent the mean number of 
γH2A.X foci per cell (A) and the mean number of TAF per cell (B) from one 
experiment. Data are presented as mean ± S.E.M of 50 cells per condition, generated by 
quantifying Z-stack images. Statistics: One-way ANOVA followed by Independent 
samples t-test *P < 0.05.   





Figure 5.11 Effect of oxygen pressure and cigarette smoke exposure on Sen-β-Gal 
expression in MRC5 cells. MRC5 cells cultured under 3% O2 or 20% O2 were exposed 
to 5% cigarette smoke extract (CSE) or normal cell culture media every 48 hours for 25 
days and stained for senescence-associated-β-galactosidase (Sen-β-Gal) expression. (A) 
Bar graph represents Sen-β-Gal expression (percentage positivity) per condition from 
one experiment. Data are presented as mean ± S.E.M of 10 random planes per condition. 
(B) Representative image of Sen-β-Gal staining in MRC5 cells exposed to CSE or 
normal cell culture media and cultured at 3% O2 or 20% O2, captured using X20 
objective. Sen-β-Gal staining was carried out in collaboration with Clara Correia Melo 
from our lab. Statistics: One-way ANOVA and Independent samples t-test *** P < 
0.001. 





Figure 5.12 Effect of oxygen pressure and cigarette smoke exposure on cytokine 
secretion from MRC5 cells. MRC5 cells cultured under 3% O2 or 20% O2 were 
exposed to 5% cigarette smoke extract (CSE) or normal cell culture media every 48 
hours for 25 days and conditioned media collected and analysed for the presence of pro-
inflammatory cytokines. Cells were serum starved 24 hours prior to media collection. 
Bar graph represents concentrations of IL-6 (A) and IL-8 (B) in cell culture media 
measured by ELISA. Data are presented as mean ± SEM of 3 independent experiments. 
Statistics: One-way ANOVA and Independent samples t-test *P < 0.05, ** P < 0.01, 
*** P < 0.001. 





Figure 5.13 Effect of oxygen pressure and cigarette smoke exposure on 
intracellular ROS levels and mitochondrial-derived ROS in MRC5 cells. MRC5 
cells (PD 25) cultured under normoxia (20% O2) or hypoxia (3% O2) were exposed to 5% 
cigarette smoke extract (CSE) or normal cell culture media every 48 hours for 25 days 
and Dihydrorhodamine (DHR) (A) and MitoSOX (B) staining coupled with FACS 
analysis used to measure ROS levels, and mitochondrial ROS generation, respectively. 
Bar graphs represent mean fluorescence intensity; each column and error bar represents 
mean ± SD of 3 technical repeats of one experiment. One-way ANOVA revealed no 
statistically significant differences between conditions.   
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5.3 ATM inhibition suppresses cigarette smoke-induced telomere 
dysfunction and the SASP 
A number of groups report that persistent DDR activation is required for development 
and stability of senescence (Rodier, Coppe et al. 2009; Passos, Nelson et al. 2010; 
Fumagalli, Rossiello et al. 2014). ATM, a key sensor of DNA damage and transducer of 
the DDR, can trigger activation of NF-B, the main transcriptional activator of the 
SASP (McCool and Miyamoto 2012). Moreover, persistent ATM activation is 
necessary for induction of the SASP (Rodier, Coppe et al. 2009). The effect of 
inhibiting the DDR in the context of cigarette smoke-induced senescence has not yet 
been explored.  
To determine whether suppression of ATM activity affects cigarette-smoke 
induced telomere dysfunction and other senescence-associated phenotypes, MRC5 cells 
exposed to 5% CSE were treated with an inhibitor of ATM (KU55933) or DMSO 
(untreated control) (see methods section 2.5.2). 5% CSE or normal cell culture media, 
along with DMSO or the ATM inhibitor, were replaced every 48 hours and cells 
cultured for 25 days (Figure 5.14A). We first demonstrated that KU55933 supresses 
phosphorylation of H2A.X (a target of ATM kinase) by treating MRC5 cells exposed to 
20Gy X-ray irradiation with the same concentration of the ATM inhibitor used in the in 
vitro experiments and carried out Western blotting for γH2A.X, confirming its role in 
DDR inhibition (Figure 5.14B). Culturing cells in the presence of the ATM inhibitor 
severely affected cell proliferation, evidenced by only small increases in PD value over 
time, as compared to cells treated with DMSO (not shown). Although cells were 
cultured until 25 days, analysis was carried out only following 14 days in culture 
because long-term culture with the ATM inhibitor leads to significant cell death.  
To determine whether ATM inhibition decreased cigarette smoke-induced 
telomere dysfunction, immuno-FISH was carried out following 14 days in culture. As 
expected, ATM inhibition was able to reduce mean number of γH2A.X foci per cell in 
CSE exposed cells (p = 0.001) (Figure 5.15A). Similarly, ATM inhibition reduced mean 
number of TAF in CSE exposed cells (p < 0.0001) (Figure 5.15B).  
In order to test the hypothesis that CSE-dependent activation of a DDR results in 
increased IL-6 and IL-8, ELISAs were carried out for detection of IL-6 and IL-8 in cell 
culture media from MRC5 cells cultured in the presence of DMSO or the ATM 
inhibitor and exposed, or not, to 5% CSE. It was found that 14 days of exposure to the 
ATM inhibitor significantly reduced levels of IL-6 release from both untreated (p = 0.01) 
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and CSE exposed MRC5 cells (p = 0.001) (Figure 5.16A). ATM inhibition also reduced 
IL-8 release from smoke-exposed MRC5 cells (p = 0.03) (Figure 5.16B), supporting the 









Figure 5.14 Set up of ATM inhibition experiments and effect on H2A.X 
phosphorylation. MRC5 cells (PD 25) were exposed to 5% cigarette smoke extract 
(CSE) or normal cell culture media every 48 hours along with DMSO or 10μM of the 
ATM inhibitor KU55933 (ATMi), diluted in DMSO for 25 days (A). (B) Representative 
western blot of γH2A.X expression in MRC5 cells one day after 20Gy X-ray irradiation 
when treated with the same concentration of the ATM inhibitor. Blot is representative 
of one experiment. Western blot analysis was carried out in collaboration with Graeme 
Hewitt from our lab.  






Figure 5.15 Effect of ATM inhibition on cigarette smoke-induced increases in 
γH2A.X foci and TAF. MRC5 cells were exposed to 5% cigarette smoke extract (CSE) 
or normal cell culture media (data not shown) every 48 hours along with DMSO or the 
ATM inhibitor KU55933 (ATMi), diluted in DMSO for 14 days. γH2A.X foci and 
telomere-associated foci (TAF) expression were evaluated by immuno-FISH. Bar 
graphs represent the mean number of γH2A.X foci per cell (A) and the mean number of 
TAF per cell (B) from one experiment. Data are presented as mean ± S.E.M of 50 cells 
per condition, generated by quantifying Z-stack images. (C) Representative image of 
immuno-FISH for γH2A.X (green) and telomeres (red) in MRC5 cells at 14 days in 
culture in the presence of 5% CSE and DMSO or 5% CSE and KU55933 captured using 
X100 oil objective and following Huygens (SVI) deconvolution. Arrows point to 
γH2A.X foci co-localising with telomeres (TAF), shown at higher magnification at the 
bottom (images are from one single Z plane). Statistics: One-way ANOVA followed by 
Independent samples t-test ** P < 0.01, **** P < 0.0001.  
 





Figure 5.16 Effect of ATM inhibition on cigarette smoke-induced cytokine release 
in MRC5 cells. MRC5 cells were exposed to 5% cigarette smoke extract (CSE) or 
normal cell culture media every 48 hours along with DMSO or the ATM inhibitor 
KU55933 (ATMi), diluted in DMSO for 14 days and conditioned media collected and 
analysed for the presence of pro-inflammatory cytokines. Cells were serum starved 24 
hours prior to media collection. Bar graph represents concentrations of IL-6 (A) and IL-
8 (B) in cell culture media measured by ELISA. Data are presented as mean ± SEM of 3 
independent experiments. Statistics: One-way ANOVA and Independent samples t-test 
*P < 0.05, ** P < 0.01. 
Chapter 5    Cigarette smoke exposure induces telomere dysfunction and cellular senescence 
 
 160 
5.4 mTORC1 inhibition suppresses cigarette smoke-induced telomere 
dysfunction and the SASP 
In the previous chapter, we found that mTORC1 inhibition by rapamycin decreased the 
age-related increase in TAF in the small airway epithelial cells of the murine lung. A 
number of DNA damaging agents have been shown to activate mTORC1, including X-
ray irradiation (unpublished work from our group), UV light (Brenneisen, Wenk et al. 
2000) and chemotherapeutic agents (Demidenko and Blagosklonny 2008). However, it 
is unknown whether cigarette smoke exposure also activates mTORC1. One group have 
shown that inhibition of mTOR by Torin1 supresses CSE-induced cellular senescence 
and decline in autophagy activity in human bronchial epithelial cells (HBECs) (Fujii, 
Hara et al. 2012). Our group have also shown that inhibition of mTORC1 by rapamycin 
alleviates features of the senescence phenotype in both replicative and stress-induced 
senescence (unpublished). The effect of mTORC1 inhibition by rapamycin on the 
induction of senescence, and telomere dysfunction in particular, by cigarette smoke has 
not yet been investigated.  
In order to test the impact of mTORC1 inhibition on cigarette smoke-induced 
telomere dysfunction and features of the senescence phenotype, MRC5 cells exposed to 
5% CSE smoke were treated with rapamycin or DMSO (untreated control). 5% CSE or 
normal cell culture media, along with DMSO or rapamycin, were replaced every 48 
hours and cells cultured for 25 days (Figure 5.17A). Similarly to ATM inhibition, we 
found that culturing cells in the presence of rapamycin severely affected cell 
proliferation, evidenced by only small increases in PD value over time, as compared to 
cells treated with DMSO (Figure 5.17B). 
To determine whether mTORC1 inhibition by rapamycin decreased cigarette 
smoke-induced telomere dysfunction, immuno-FISH was carried out following 25 days 
in culture (a time point in which we start observing a shift towards senescence). As 
previous, we found that treatment with CSE increased mean number of γH2A.X foci (p 
< 0.0001) and mean number of TAF per cell (p < 0.0001) (Figure 5.18). Rapamycin 
treatment was able to reduce mean number of γH2A.X foci per cell in cells exposed to 
CSE (p < 0.0001) (Figure 5.18A). Similarly, rapamycin treatment reduced mean 
number of TAF in CSE exposed cells (p < 0.0001) (Figure 5.18B). There was no 
significant effect of rapamycin treatment on mean number of foci and TAF in untreated 
cells.  
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In order to determine whether treatment with rapamycin affected development 
of the SASP in CSE-induced senescence, ELISAs for detection of major SASP factors 
IL-6 and IL-8 were carried out using cell culture media from MRC5 cells cultured in the 
presence of DMSO or rapamycin and exposed, or not, to 5% CSE. We found that 25 
days of exposure to rapamycin significantly reduced levels of IL-6 release from both 
untreated (p < 0.0001) and CSE exposed MRC5 cells (p < 0.0001) (Figure 5.19A). 
Rapamycin treatment also reduced IL-8 release from untreated (p < 0.0001) and smoke-
exposed MRC5 cells (p < 0.0001) (Figure 5.19B), suggesting that mTORC1 over-
activation may contribute to features of the cigarette smoke-induced senescence 
phenotype. 
Analysis of intracellular ROS levels (measured by DHR fluorescence) revealed 
that rapamycin treatment reduced these levels in both untreated and CSE exposed cells 
(Figure 5.20A). Levels of mitochondrial-derived superoxide anions (measured by 
MitoSOX fluorescence) were also reduced in CSE exposed cells treated with rapamycin 
(Figure 5.20B). There was also a reduction in mitochondrial-derived ROS in untreated 
cells cultured with rapamycin (Figure 5.20B).  
 






Figure 5.17 Effect of mTORC1 inhibition by rapamycin and cigarette smoke 
exposure on growth of MRC5 fibroblasts. MRC5 cells (PD 25) were exposed to 5% 
cigarette smoke extract (CSE) or normal cell culture media every 48 hours along with 
DMSO or 100nM of rapamycin (Rapa), diluted in DMSO for 25 days (A). With every 
cell passage, cell number was quantified and changes in population doubling (PD) level 
calculated for each condition. (B) Changes in PD plotted against number of days in 
culture. Graph was generated from one experiment.  
 





Figure 5.18 Effect of mTORC1 inhibition by rapamycin on cigarette smoke-
induced increases in DNA damage foci and TAF. MRC5 cells were exposed to 5% 
cigarette smoke extract (CSE) or normal cell culture media every 48 hours along with 
DMSO or rapamycin (Rapa), diluted in DMSO for 25 days. γH2A.X foci and telomere-
associated foci (TAF) were evaluated by immuno-FISH. Bar graphs represent the mean 
number of γH2A.X foci per cell (A) and the mean number of TAF per cell (B) from 1 
independent experiment. Data are presented as mean ± S.E.M of 50 cells per condition, 
generated by quantifying Z-stack images. Statistics: One-way ANOVA followed by 
Independent samples t-test *P < 0.05, ** P < 0.01, **** P < 0.0001.  
 





Figure 5.19 Effect of mTORC1 inhibition by rapamycin on cigarette smoke-
induced cytokine release in MRC5 cells. MRC5 cells were exposed to 5% cigarette 
smoke extract (CSE) or normal cell culture media every 48 hours along with DMSO or 
rapamycin (Rapa), diluted in DMSO for 25 days and conditioned media collected and 
analysed for the presence of pro-inflammatory cytokines. Cells were serum starved 24 
hours prior to media collection. Bar graph represents concentrations of IL-6 (A) and IL-
8 (B) in cell culture media measured by ELISA. Data are presented as mean ± S.E.M of 
3 independent experiments. Statistics: One-way ANOVA and Independent samples t-
test *P < 0.05, ** P < 0.01. 





Figure 5.20 Effect of mTORC1 inhibition by rapamycin on cigarette smoke-
induced increases in intracellular ROS and mitochondrial-derived ROS levels in 
MRC5 cells. MRC5 cells were exposed to 5% cigarette smoke extract (CSE) or normal 
cell culture media every 48 hours along with DMSO or rapamycin (Rapa), diluted in 
DMSO for 25 days and Dihydrorhodamine (DHR) (A) and MitoSOX (B) staining 
coupled with FACS analysis used to measure ROS levels and mitochondrial ROS 
generation, respectively. Bar graphs represent mean fluorescence intensity; each column 
and error bar represents mean ± SD of 3 technical repeats of one experiment.  
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5.5 Discussion   
We have found that long-term exposure to 5% CSE limits the proliferative capacity of 
MRC5 cells following 25 days in culture. These findings are in line with previous 
studies, showing that exposure of lung fibroblasts to cigarette smoke significantly 
inhibits fibroblast proliferation (Nakamura, Romberger et al. 1995; Nobukuni, 
Watanabe et al. 2002; Nyunoya, Monick et al. 2006; Nyunoya, Monick et al. 2009). 
Similar results have also been described in alveolar epithelial cells (Tsuji, Aoshiba et al. 
2004). One study showed that exposure of human lung fibroblasts (HLF-1) to 3.5% 
CSE for 14 days almost completely inhibited cell growth (Nyunoya, Monick et al. 
2006). In contrast, we showed only a modest decrease in cell growth over time and 
small reductions in Ki67 expression with CSE exposure. This could be due to 
differences in sensitivity of these cell types to cigarette smoke. We found an increase in 
Sen-β-Gal activity following 25 days in culture with 5% CSE, which is in line with 
reports from previous groups showing increased Sen-β-Gal activity in human lung 
fibroblasts following CSE exposure, however other studies have detected differences 
after just 7 days (Nyunoya, Monick et al. 2006; Nyunoya, Monick et al. 2009). Similar 
effects of CSE exposure have also been described in alveolar epithelial cells after just 
36 hours (Tsuji, Aoshiba et al. 2004). The differences we observed in Sen-β-Gal activity 
between CSE-exposed and untreated cells were no longer significant after 60 days in 
culture. Following 60 days in culture, the majority of cells will have reached replicative 
senescence, by which point there may be no detectable differences between CSE-
exposed and untreated cells, therefore these results are not that surprising. Nyunoya and 
colleagues report an increase in cell size with a flat an enlarged morphology (Nyunoya, 
Monick et al. 2006), similar to previous reports following cigarette smoke exposure 
(Tsuji, Aoshiba et al. 2004). While we did not assess changes in cellular morphology, 
area of the nucleus was calculated following DAPI staining. We observed increasing 
nuclear size with time spent in culture, consistent with replicative senescence, however, 
in our hands, no significant differences were found between untreated and CSE-exposed 
cells. 
It has been shown that CSE exposure induces DNA damage in a number of cell 
types, including human lung fibroblasts, (Kim, Liu et al. 2004; Nyunoya, Monick et al. 
2009), bronchial epithelial cells (Albino, Huang et al. 2004; Liu, Conner et al. 2005; 
Fujii, Hara et al. 2012), human immortalised stromal fibroblasts (Salem, Al-Zoubi et al. 
2013) and vascular endothelial cells (Csiszar, Labinskyy et al. 2008) in vitro. In 
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accordance, we report increases in mean number of γH2A.X foci in both CSE-exposed 
MRC5 cells and primary small airway epithelial cells. While changes in number of 
γH2A.X foci following CSE exposure were not significant following 60 days in culture 
or in small airway epithelial cells, the increases we observed in mean number of TAF 
were statistically significant. To or knowledge, this is the first time that TAF have been 
observed following cigarette smoke exposure in human cells. We did not evaluate 
telomere length in this instance, however a prior study has described decreased telomere 
length, measured by Q-FISH, in mouse embryonic stem cells following 2 weeks of 
exposure to low dose cigarette smoke condensate (CSC) (Huang, Okuka et al. 2013). 
Currently there is little data describing the effects of cigarette-smoke exposure on 
telomere length in lung cells in vitro. However one study by Nyunoya and colleagues 
failed to find differences in telomere length, as measured by RT-PCR, between HLF-1 
cells exposed to 3.5% CSE or left untreated for 14 days in culture (Nyunoya, Monick et 
al. 2006). Our previous data suggests that telomere dysfunction can occur independently 
of telomere length and therefore measurements by Q-FISH and RT-PCR should be 
conducted on our samples. While our data suggests that cigarette smoke exposure 
induces telomere dysfunction (i.e. TAF) in human lung fibroblasts in vitro, there are 
limitations of this work.  Due to time constraints and the extended nature of these 
experiments, it was only possible to conduct two independent experiments for the 
majority of this work. Therefore, our results should be further confirmed with additional 
repeats. The use of other cell lines and primary human fibroblasts should also be 
considered, to determine whether CSE induces TAF in other systems. Ideally, we would 
want to conduct these experiments using airway epithelial cells to complement our in 
vivo data. However, it is not possible to test the effects of chronic cigarette smoke 
exposure on airway epithelial cells as prolonged culture leads to fibroblastic changes in 
these cells. Nevertheless, a more thorough characterisation of airway epithelial cells 
following short-term CSE exposure should be carried out. Additionally, investigating 
other DDR markers, such as 53BP1 and phosphorylated ATM, should also be included 
in conjunction with γH2A.X to further confirm our findings.  
It is known that cigarette smoke can induce apoptosis in vitro and increased 
apoptosis has been documented in the lungs of patients with COPD (Kasahara, Tuder et 
al. 2001; Hodge, Hodge et al. 2005; Demedts, Demoor et al. 2006). We chose 5% CSE 
for our experiments based on previous work conducted in our lab, whereby 
concentrations up to 10% were found not to be cytotoxic. Prior studies have also shown 
that a concentration range of between 1 and 5% CSE induces DNA damage but not 
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apoptosis in human lung fibroblasts (Kim, Liu et al. 2004), with much higher 
concentrations (above 20%) required to cause apoptosis (Ishii, Matsuse et al. 2001). 
Furthermore, initial viability experiments using PI staining coupled with flow cytometry, 
revealed that while 5% CSE exposure caused some cell death, viability always remained 
above 70%, with averages of 80% viability achieved for untreated cells.   
In order to determine whether CSE exposure induced TAF in primary human 
small airway epithelial cells, we carried out a short-term exposure to CSE for 48 hours, 
which was based on evidence suggesting that CSE exposure can induce features of 
EMT in airway epithelial cells following periods of CSE exposure longer than 48 hours 
(Eurlings, Reynaert et al. 2014). While we observed overall increases in TAF in CSE-
exposed cells, interestingly we observed that not all cells had significantly increased 
TAF, suggesting that patient-specific differences may occur. Different responses to 
cigarette smoke were also observed in the context of Sen-β-Gal activity, with cells 
isolated from two individuals showing an increase in expression following CSE 
exposure, with one individual showing no significant change. Overall, there were no 
significant changes in Sen-β-Gal activity when the two groups were compared and level 
of staining observed was very low overall (0.8% in untreated compared to 1.3% in CSE-
exposed cells). This is in contrast to previous studies, which report roughly a 10% level 
of Sen-β-Gal positivity in HBECs at baseline, increasing to 30% positivity following 
exposure to 1% CSE for 48 hours (Fujii, Hara et al. 2012; Hara, Araya et al. 2012). 
However, because we are using primary human cells there is a lot of variation between 
individuals and therefore experiments would need to be repeated using a greater sample 
size in order to confirm our findings. 
Senescence is characterised by increased secretion of bioactive, frequently pro-
inflammatory peptides, known collectively as the senescence-associated secretory 
phenotype (SASP). Pro-inflammatory cytokines IL-6 and IL-8 are increased during 
senescence and contribute to maintenance of senescence in autocrine and paracrine 
fashions (Acosta, O'Loghlen et al. 2008; Kuilman, Michaloglou et al. 2008; Acosta, 
Banito et al. 2013). The similarities between pro-inflammatory mediators that comprise 
the SASP and those involved in COPD pathogenesis are becoming increasingly 
acknowledged (Kumar, Seeger et al. 2014). Indeed, the chemokine IL-8, which is highly 
secreted by senescent cells (Coppe, Patil et al. 2008) and known for its ability to 
activate neutrophils and other immune cells (Baggiolini and Loetscher 2000), is 
purported to be one of the most important cytokines playing a critical role in COPD and 
in cigarette smoke-induced airway disease (Nocker, Schoonbrood et al. 1996; Mio, 
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Romberger et al. 1997). Similarly, IL-6 is also a major SASP factor (Coppe, Patil et al. 
2008) and is elevated in the plasma from patients with COPD (Savale, Chaouat et al. 
2009). It has previously been shown that exposure to 1% CSE for 48 hours leads to 
increased IL-8 release in HBECs (Fujii, Hara et al. 2012; Hara, Araya et al. 2012) and 
after just 4 hours, 10% CSE was reported to increase IL-8 release from HBECs (Moon, 
Zheng et al. 2013). 10% CSE also increases release of IL-8 from airway smooth muscle 
cells after 72 hours (Chen, Ge et al. 2014). However, the effect of long-term cigarette 
smoke exposure on SASP induction in vitro has not previously been investigated. 
Compared to untreated cells, we observed an increase in both IL-6 and IL-8 release in 
CSE exposed cells at all time points, however this difference only became significant 
following 13 days in culture. After 39 days in culture, IL-6 and IL-8 release from 
MRC5 cells treated with CSE was increased 23-fold and 12–fold, respectively, 
consistent with early onset of senescence. Previous reports have suggested that the 
SASP is activated 7-10 days following the induction of a DDR (Coppe, Patil et al. 
2008), which suggests that chronic cigarette smoke exposure is likely required to lead to 
a sufficient level of senescence for SASP induction. It could be that a threshold level of 
DNA damage, or indeed TAF, is required before the SASP is activated. The 
mechanisms behind activation of the SASP in response to telomere dysfunction are still 
poorly understood. Data suggests that active ATM can directly activate NF-B 
following induction of a DDR by NEMO-dependent degradation of the NF-B inhibitor 
IB (Wu, Shi et al. 2006). It has also been shown that SASP factor release can occur 
independently of a DDR via p38MAPK-dependent increase in NF-B transcriptional 
activity (Freund, Patil et al. 2011). Epigenetic mechanisms may also be involved in the 
regulation of SASP factor release in response to chronic cigarette smoke exposure. It 
has been shown that SIRT1 inhibits transcriptional activity of NF-B by deacetylating 
the RelA/p65 subunit of NF-B on lysine 310, a site critical for NF-B transcriptional 
activity (Yeung, Hoberg et al. 2004). In lungs of patients with COPD and following 
chronic cigarette smoke exposure both in vitro and in vivo, SIRT1 levels are decreased 
(Yang, Wright et al. 2007; Rajendrasozhan, Yang et al. 2008), thought to be due to 
cigarette smoke-associated oxidative alterations and subsequent degradation of SIRT1. 
Therefore, reductions in SIRT1 following chronic cigarette smoke exposure may be 
partly responsible for increased SASP factor release due to increased RelA/p65 
acetylation and NF-B activity.   
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In order to mechanistically understand how CSE exposure causes telomere 
dysfunction in vitro, cells were cultured under atmospheric (20%) or low (3%) O2. 
Culturing under 20% O2 can lead to early-onset senescence due to supraphysiological 
oxygen levels causing oxidative damage, whereas culturing under 3% O2 is more 
physiological (Parrinello, Samper et al. 2003). Consistent with a role for oxidative stress 
in inducing CSE-associated senescence, we found that low O2 was able to increase 
proliferative capacity of MRC5 cells and supress CSE-induced increases in DNA 
damage foci, TAF, Sen-β-Gal positivity and IL-6 and IL-8 release. These results 
suggest that oxidative stress induced by cigarette smoke exposure may be responsible 
for CSE-associated telomere dysfunction, which contributes to induction of other 
senescence-associated phenotypes, such as Sen-β-Gal activity and activation of the 
SASP. Other studies have also implicated ROS in CSE-induced senescence. The use of 
the antioxidant N-acetylcysteine (NAC) has been shown to reduce CSE-induced 
increases in Sen-β-Gal activity in alveolar epithelial cells (Tsuji, Aoshiba et al. 2004) 
and HBECs (Hara, Araya et al. 2013), and CSE-induced DNA damage in HLF-1 cells 
(Kim, Liu et al. 2004). Additionally, NAC reduces CSE-associated reduction in SIRT1 
expression and activity in human lung epithelial cells by reducing ROS-mediated 
oxidative modifications including carbonylation (Caito, Rajendrasozhan et al. 2010). 
Cigarette smoke is a rich source of ROS, containing 10
15
 free radicals and 4700 
different chemical compounds per puff. Therefore, cigarette smoke may cause damage 
to DNA directly or indirectly, through the generation of endogenous ROS from 
inflammatory and structural cells (Rahman and Adcock 2006). The precise source of 
ROS involved in CSE-induced telomere dysfunction remains to be clearly elucidated. 
We found that 5% CSE exposure resulted in increased ROS generation and an increase 
in mitochondrial-derived ROS. Mitochondria are the major source of endogenous ROS 
(Kowald and Kirkwood 2011). Hence, numerous studies have shown that cellular 
senescence is characterised by mitochondrial dysfunction, contributing to elevated ROS 
(Saretzki, Murphy et al. 2003; Hutter, Renner et al. 2004; Passos, Saretzki et al. 2007). 
Mitochondria are susceptible to damage from cigarette smoke and a higher level of 
oxidative mitochondrial DNA damage has been observed in smokers (Ballinger, Bouder 
et al. 1996). Moreover, it has been shown that cigarette smoke exposure enhances 
mitochondrial ROS production from vascular endothelial cells and lung epithelial cells 
and also leads to mitochondrial fragmentation (Csiszar, Labinskyy et al. 2008; Hara, 
Araya et al. 2013). Additionally, CSE-induced increases in mitochondrial ROS can be 
inhibited by NAC (Hara, Araya et al. 2013), which coincide with our findings of 
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decreased mitochondrial ROS generation when culturing cells at low O2. A positive 
feedback loop has been described by our lab, whereby both telomere-dependent and –
independent DDR signalling cause mitochondrial dysfunction and ROS production, 
leading to continued replenishment of short-lived DDR foci and continued DDR 
signalling (Passos, Nelson et al. 2010). Therefore, it is possible that initial cell-cycle 
arrest caused by cigarette smoke-induced DNA damage leads to mitochondrial 
dysfunction, increased ROS and further DNA damage leading to persistent DDR 
signalling. Thus telomere dysfunction could be induced both directly and indirectly. 
However, other experiments would need to be carried out in order to directly implicate 
mitochondria in CSE-induced telomere dysfunction, such as the use of mitochondrial-
targeted antioxidants or mitochondrial elimination in combination with CSE. One 
interesting consideration is the numerous reports showing that oxidative stress shortens 
telomeres (von Zglinicki 2002). In previous chapters, we have failed to find significant 
differences in telomere length in the context of cigarette smoke exposure and COPD. 
Therefore, if oxidative stress was playing a role in telomere dysfunction then one would 
expect to find significant decreases in telomere length. Although, it has been shown that 
other oxidant stresses, such as hydrogen peroxide and UV light did not lead to telomere 
erosion in cultured human fibroblasts (Gorbunova, Seluanov et al. 2002). The SASP is 
dependent on persistent DNA damage signalling (Rodier, Coppe et al. 2009), such as 
that created by a positive feedback loop between DDR signalling and ROS. Accordingly 
we found that low O2 reduced levels of DNA damage markers and SASP factors, 
regardless of cigarette smoke exposure. Mechanistically, it has been shown that ATM 
activation in response to DNA damage can trigger NEMO-dependent activation of NF-
κB, the main transcriptional activator of the SASP (McCool and Miyamoto 2012). In 
addition, CSE has been shown to significantly increase NF-κB activation both in vitro 
and in vivo (Yang, Wright et al. 2007; Csiszar, Labinskyy et al. 2008). We found that 
inhibition of ATM significantly reduced CSE-associated increases in DNA damage, 
TAF and IL-6 and IL-8 release, supporting the hypothesis that cigarette smoke-induced 
DDR signalling results in increased SASP. However, we cannot conclude that 
dysfunctional telomere signalling, specifically, results in SASP activation since ATM 
inhibition was not targeted to telomeres. While these preliminary results are interesting, 
further repeats are required in order to confirm our findings. The majority of this data is 
generated from technical repeats of one biological experiment, which is a limitation of 
this work. Additionally, it would be interesting to determine whether these findings 
could be reproduced using other cell lines or in primary cells from the lung. Moreover, 
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CSE experiments carried out using cells derived from patients with Ataxia 
Telangiectasia (AT), where ATM is mutated, should be conducted to support our data. 
Other means of reducing oxidative stress in CSE-induced senescence should also be 
considered, such as the use of NAC, which has proved promising in suppressing 
senescence markers but the effect on telomere dysfunction and SASP induction is 
unknown.    
A number of studies suggest a role for mTOR in promoting cellular senescence. 
As previously mentioned, mTOR activity is enhanced by a number of known inducers 
of senescence. In the previous chapter, we showed that mTORC1 inhibition by 
rapamycin attenuates the age-related increases in TAF in small airway epithelial cells of 
the murine lung. However, the role of mTOR in CSE-associated senescence and COPD 
is currently unknown. We questioned whether inhibition of mTORC1 by rapamycin 
could supress some of the senescence-associated changes observed following CSE 
treatment. Due to limited time availability, it was not possible to characterise all aspects 
of the senescence phenotype, however we did find that rapamycin was able to supress 
CSE-induced increases in DNA damage foci and TAF and decreased the release of 
SASP factors IL-6 and IL-8. Our findings are in accordance with other studies, showing 
that mTORC1 inhibition by rapamycin alleviates features of the senescence phenotype. 
For example, in normal human lung fibroblasts (WI-38), rapamycin treatment attenuates 
senescence induced by chemotherapeutic drug doxorubicin (Demidenko and 
Blagosklonny 2008) and decreases H2O2-induced senescence in human retinal pigment 
epithelial cells (Demidenko, Zubova et al. 2009). Short-term rapamycin treatment 
supresses the induction of IL-8 and p21 in replicative-senescent human skin fibroblasts 
(BJ cells) and reduces levels of p21 in RAS-induced senescent BJ cells (Kolesnichenko, 
Hong et al. 2012). The authors also showed that long-term rapamycin treatment starting 
in the pre-senescent stages, similar to our experimental design, prevented loss of 
proliferation potential and increases in Sen-β-Gal staining that occur with replicative 
senescence. Cells also retained their pre-senescent levels of p21, p53 and IL-8. Similar 
findings were also gained when treating RAS-induced senescent BJ cells from the pre-
senescent stage (Kolesnichenko, Hong et al. 2012). In our experience, cells treated with 
rapamycin proliferated much slower than cells treated with DMSO, something that was 
also described previously in rat embryonic cells (Pospelova, Leontieva et al. 2012). 
Similar to our findings, Pospelova and colleagues report a reduction in DNA damage 
foci (γH2A.X and 53BP1) with rapamycin treatment in the context of replicative 
senescence (Pospelova, Leontieva et al. 2012). Our lab have also shown that rapamycin 
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treatment supresses increases in DNA damage foci in MRC5 cells and mouse 
embryonic fibroblasts in the context of stress-induced senescence (X-ray irradiation), 
but has negative effects on cell proliferation (unpublished). It is possible then that the 
reductions in γH2A.X foci and TAF we observe are due to the fact that there is less 
proliferation, which is known to increase cellular content of DNA damage foci due to 
replication stress (Zeman and Cimprich 2014). It could be that the concentration of 
rapamycin used in these experiments was too high and a lower dose, that does not affect 
proliferation, should be tested to determine whether DNA damage content would still be 
reduced. Another caveat of this work is that we did not assess mTOR activity following 
cigarette smoke exposure and treatment with rapamycin. This should be explored to 
confirm that rapamycin is reducing mTORC1 activity and to indicate whether CSE does 
in fact increase signalling from mTOR.  
It is unknown how mTOR activity may regulate the SASP. mTOR plays a 
critical role in maintaining nutrient and energy status through a pathway that regulates 
many essential biological processes, including autophagy, a lysosomal degradation 
pathway (Laplante and Sabatini 2012). mTOR positively regulates protein synthesis and 
negatively regulates autophagy. Therefore, enhanced activity of mTOR during 
senescence may increase protein content of senescent cells due to increased protein 
synthesis and decreased autophagy, which could possibly impact on the cell secretome. 
The impact of autophagy in CSE-induced cellular senescence is poorly defined and 
current findings are conflicting. It has been shown in primary HBECs that autophagy is 
impaired following CSE exposure, which is in line with increased mTOR activity (Fujii, 
Hara et al. 2012), however other studies have found that CSE enhances autophagy in a 
range of different lung cell types (Chen, Kim et al. 2008; Hwang, Chung et al. 2010) 
and in stromal fibroblasts (Salem, Al-Zoubi et al. 2013), which may suggest that 
cigarette smoke exposure inhibits mTOR activity. There may be time-dependent effects 
of acute vs. chronic cigarette smoke exposure, with short-term exposure likely inducing 
autophagy, which might become impaired with prolonged exposure. However, one 
group has observed increased autophagy in lung tissue from patients with COPD (Chen, 
Kim et al. 2008). Further work is required to determine whether altered mTOR 
signalling and autophagy contribute to the development of senescence and the SASP in 
the context of cigarette smoke exposure.  
Mitochondrial dysfunction has been implicated in cellular senescence (Passos, 
Saretzki et al. 2007; Moiseeva, Bourdeau et al. 2009). Mitochondrial biogenesis is 
essential for maintaining functional mitochondria in the cell and mTOR has been linked 
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to mitochondrial biogenesis through the regulation of peroxisome proliferator-activated 
receptor-gamma coactivator (PGC1- α), an activator of transcription and regulator of 
mitochondrial metabolism and biogenesis (Cunningham, Rodgers et al. 2007). 
Moreover, mice fed with a rapamycin-supplemented diet have lower mitochondrial 
content (Harrison, Strong et al. 2009) and show enhanced survival and attenuated 
disease progression in a mouse model of mitochondrial disease (Johnson, Yanos et al. 
2013). Similarly, our lab has shown that rapamycin reduces age-related increases in 
mitochondrial content in the murine liver (unpublished). Our findings suggest that 
mTOR signalling impacts on mitochondria, since rapamycin reduced mitochondrial-
derived ROS, which are increased following CSE exposure. Supporting this finding, a 
previous study showed that rapamycin treatment enhances mitochondrial membrane 
potential, reduces ROS levels and increases replicative lifespan of normal human 
fibroblasts (Lerner, Bitto et al. 2013). Our lab has also demonstrated that rapamycin 
inhibits increases in mitochondrial mass in the context of stress-induced senescence 
(unpublished). It is possible therefore that the effects of rapamycin treatment on the 
SASP are mediated through the effects of mTOR inhibition on mitochondrial function, 
which when dysfunctional may contribute to a positive feedback loop between ROS 
generation and the DDR, as aforementioned, leading to increased SASP activity (Passos, 
Nelson et al. 2010). Additionally, mechanisms of inflammatory activation by mTOR, 
independent of mitochondria, have also been described. For example, it was shown in 
PTEN-null/inactive prostate cancer cells that activation of mTOR downstream of Akt 
regulates activity of NF-κB via stimulation of IKK activity (Dan, Cooper et al. 2008), 
which may also explain how mTOR may regulate the SASP. 
The precise role of mTOR in the context of CSE-induced senescence and COPD 
needs to be clearly elucidated. While our preliminary results are interesting, further 
experiments are required to confirm our findings. Additional repeats and a more 
detailed characterisation of the effects of mTORC1 inhibition on cigarette smoke-
induced senescence are needed. Alternative methods of supressing mTOR activity, such 
as knockdown by siRNA should also be considered as well as enhancing mTOR activity 
alongside CSE exposure to determine whether the ability of CSE to induce senescence 
is altered.  
In summary, our data suggests that chronic cigarette smoke exposure induces 
telomere dysfunction and senescence-associated phenotypes, including Sen-β-Gal 
positivity and SASP activity. The mechanisms behind CSE-induced telomere 
dysfunction are still unclear. While our preliminary data may suggest an involvement 
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for mitochondrial dysfunction and altered mTOR signalling, further work is required in 
order to elucidate the mechanisms behind telomere dysfunction in the context of 
cigarette smoke exposure and COPD.  
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Chapter 6. General discussion and conclusions 
 
Senescence has been firmly implicated in the ageing process and has been shown to 
impact on a number of age-related diseases (van Deursen 2014). A wealth of data has 
linked cellular senescence with COPD (Aoshiba and Nagai 2009; MacNee 2009). 
However, the role played by telomeres in this process is still unclear. Moreover, 
whether senescence has significant impact on the lung during natural ageing and in 
other chronic lung diseases has been poorly studied so far. The aim of this work was to 
investigate airway epithelial cell senescence, and telomere dysfunction in particular, 
during physiological lung ageing, in age-related lung disease and in the context of 
cigarette smoke exposure. We also aimed to explore some of the potential mechanisms 
underlying these processes. 
While there have been many associations found between cellular senescence and 
COPD, the underlying mechanisms of how cellular senescence occurs and promotes the 
development of COPD are still not clear. The role of telomere dysfunction in COPD 
appears to be more complex than simple telomere attrition, based on the many 
conflicting findings from telomere length analysis of smokers and patients with COPD. 
We have found in lung tissue and isolated airway epithelial cells from patients with 
COPD, and from in vitro and in vivo conditions of cigarette smoke exposure, that 
telomere dysfunction (i.e. the co-localisation of DDR proteins at telomeres) is increased, 
without significant changes in telomere length. These findings are in line with previous 
studies demonstrating that TAF can occur irrespective of telomere length (Fumagalli, 
Rossiello et al. 2012; Hewitt, Jurk et al. 2012). An inefficiency of DNA repair has been 
purported to occur in patients with COPD and patients show markers of oxidative DNA 
modifications in the lung, including 8-OHdG, a product of guanine oxidation (Caramori, 
Adcock et al. 2011). Telomeres are particularly susceptible to oxidative damage 
compared to the bulk of the genome, which is thought to be due to the fact that telomere 
repeats contain guanine triplets (Petersen, Saretzki et al. 1998; Henle, Han et al. 1999). 
Moreover, evidence suggests that damage at telomeres is irreparable (Fumagalli, 
Rossiello et al. 2012; Hewitt, Jurk et al. 2012). This may suggest that TAF, given their 
persistence, are excellent markers for senescence and are important to COPD 
pathogenesis. It could be that irreparable damage at telomeres, caused by cigarette 
smoke exposure, may lead to persistent DDR signalling and sustained downstream 
effects, such as activation of the SASP. Moreover, the observation that even after 
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smoking cessation, chronic inflammation still persists in the lungs of patients with 
COPD (Willemse, ten Hacken et al. 2005) suggests that there may be a feedback loop 
maintaining inflammatory signalling processes, such as the one between the DDR and 
SASP factor signalling (Rodier, Coppe et al. 2009), which may be maintained via ROS 
(Acosta, O'Loghlen et al. 2008; Jurk, Wilson et al. 2014). All of these observations 
point to telomeres as one of the key players in cigarette smoke-induced senescence and 
COPD pathogenesis.  
In the majority of systems used in this work, increases in TAF were always 
more clear than increases in γH2A.X foci alone, suggesting that TAF are a more robust 
marker for senescence (Table 6.1). Moreover, TAF correlated with other senescence-
associated markers, including p21, and changes in alveolar airspaces in the murine lung 
with age. This coupled with the observation that G4 TERC
-/-
 mice show enhanced 
telomere dysfunction and early onset emphysema could suggest that TAF may be able 
to predict decline in lung structural integrity in the context of ageing and age-related 
lung disease. Further studies using a larger number of patients (at different stages of the 
disease) and excluding confounding factors such as age and history of cigarette smoke 
exposure need to be done in order to determine if TAF may be used as an indicator of 
COPD disease severity or susceptibility of smokers to develop COPD. Since we 
continually observe significant increases in TAF, both with age and in the context of 
cigarette smoke exposure, despite particularly small sample sizes (n=3-5 mice or 5-10 
patients) this further strengthens the use of TAF as both a biomarker for ageing and 
potentially for COPD. From this work, we still do not know whether telomere 
shortening is causing increases in TAF. While our results suggest that telomere attrition 
may not be the sole determinant of TAF induction, some experimental limitations of our 
work cannot allow us to make a definite conclusion about the relative contributions of 
telomere shortening and telomere damage occurring irrespectively of length. Currently, 
this work is limited by resolution of imaging. In some instances, TAF could simply be a 
telomere and a DDR signal in close proximity, rather than a DDR occurring specifically 
at telomeres. One study reports that in around 70% of senescent nuclei, multiple 
telomeres co-localised with one γH2A.X foci, suggesting that dysfunctional telomeres 
aggregate in senescent cells (Kaul, Cesare et al. 2012). This potential aggregation may 
affect values gained for telomere signal intensity analysis when measured by Q-FISH, 
leading to inaccurate conclusions regarding telomere length. Furthermore, it is likely 
that some TAF are not detected at all, since the shortest of telomeres may generate a 
very weak FISH signal. Telomere shortening may also progress to the almost complete 
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disappearance of telomere repeats (Baird, Rowson et al. 2003), which may affect PNA 
probe binding. Therefore, we still do not know for sure whether telomere shortening is 
inducing TAF. Nevertheless, using well-established methods, we found no significant 
decreases in telomere length and found robust increases in TAF in most system studied, 
suggesting that telomere dysfunction does occur, whether induced by shortening or 
damage at longer telomeres. It is currently unknown how many dysfunctional telomeres 
are required to signal senescence. Since TAF also appeared in young or control 
conditions, this suggests that a certain level of telomere dysfunction can be tolerated by 
the cell and that a threshold level of telomere dysfunction may be required to induce 
senescence. Using cohorts of mice that differed in their maximum and median lifespan, 
it was found that the minimum number of TAF associated with cellular senescence is 
between 2 and 3 in liver hepatocytes and intestinal enterocytes (Jurk, Wilson et al. 
2014). In contrast another report claims that 5 dysfunctional telomeres precede the onset 
of replicative senescence in cells in culture (Kaul, Cesare et al. 2012). Dysfunctional 
telomere aggregation in senescent cells may lead to miscalculations in the number of 
TAF a cell contains, leading to inconsistencies between the numbers of TAF reported to 
be associated with onset of the senescent phenotype. Moreover, it may be difficult to 
compare absolute numbers in 5 μm sections of tissue, as compared to whole cells grown 
in culture. In fact, in some instances, just one dysfunctional telomere has been reported 
to be sufficient for the induction of a persistent DDR and permanent cell-cycle arrest 
(Hemann, Strong et al. 2001; Herbig, Jobling et al. 2004).  
 The mechanisms driving CSE-induced telomere dysfunction are still unclear. 
Oxidative stress has been widely implicated in COPD (Rahman and Adcock 2006) and 
our preliminary data suggest that ROS may contribute to CSE-induced telomere 
dysfunction, given that culturing cells under low levels of oxygen pressure reduced 
CSE-associated increases in TAF and other features of senescence, including Sen-β-Gal 
positivity and release of major SASP factors IL-6 and IL-8. Hypoxia also appeared to 
reduce levels of intracellular ROS and mitochondrial-derived superoxide anions, 
suggesting that mitochondrial dysfunction could be partially responsible for the 
increased oxidative stress and telomere dysfunction following cigarette smoke exposure. 
The role of mTOR signalling in COPD and in the context of cigarette smoke exposure 
is largely understudied. Our preliminary data suggest that decreasing mTORC1 activity 
by rapamycin reduces CSE-induced increases in TAF, SASP factor release and both 
ROS and mitochondrial-derived superoxide anions. This may suggest a causal link 
between altered mTOR signalling, ROS, activation of a DDR at telomeres and the pro-
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inflammatory phenotype characteristic of senescence and COPD. A positive feedback 
loop has been described by our lab, whereby DDR signalling causes mitochondrial 
dysfunction and ROS production, leading to further DNA damage and continued DDR 
signalling (Passos, Nelson et al. 2010). It is possible that initial cell-cycle arrest caused 
by cigarette smoke-induced DNA damage leads to mitochondrial dysfunction, increased 
ROS and further DNA damage leading to persistent DDR signalling. It is unknown how 
mTOR activity may regulate the SASP. mTOR signalling has been linked to the control 
of mechanisms that regulate mitochondrial homeostasis, such as mitophagy and 
mitochondrial biogenesis, which may affect mitochondrial function during ageing 
(Laplante and Sabatini 2012). Our findings suggest that mTOR signalling impacts on 
mitochondria, since rapamycin reduced mitochondrial-derived ROS, which are 
increased following CSE exposure. It is possible therefore that the effects of rapamycin 
treatment on the SASP are mediated through the effects of mTOR inhibition on 
mitochondrial function, which when dysfunctional may contribute to a positive 
feedback loop between ROS generation and the DDR, as aforementioned, leading to 
increased SASP activity (Passos, Nelson et al. 2010). The speculation that altered 
mTOR signalling and mitochondrial dysfunction may be involved in cigarette smoke-
induced telomere dysfunction requires further investigation. Our data are preliminary 
and additional work is required to elucidate the role of mitochondria and mTOR in 
COPD-associated senescence. We also observed that rapamycin treatment in vivo 
reduces age-related increases in TAF in small airway epithelial cells and appeared to 
have positive effects on alveolar airspace size. This is in line with recent data from our 
lab showing that rapamycin treatment reduces a number of senescence-associated 
markers in the murine liver, including age-related increases in TAF (unpublished). It is 
not inconceivable then that targeting mTOR activity may be of therapeutic benefit in 
COPD, but this will require further investigation.  
It is still not clear whether there is a causal link between telomere dysfunction 
and the SASP. However, we found that inhibition of ATM, a key initiator of the DDR, 
represses CSE-induced secretion of IL-6 and IL-8 and increases in TAF.  IL-6 and IL-8 
have been described in multiple publications as the major and more abundant SASP 
components and both have been shown to play roles in stabilisation of senescence 
(Acosta, O'Loghlen et al. 2008; Kuilman, Michaloglou et al. 2008) and induction of 
paracrine effects (Acosta, Banito et al. 2013). Effective targeting of inflammatory 
processes is one of the key therapeutic goals in COPD, since there are currently no 
effective anti-inflammatory treatments that impact on disease progression (Barnes 2013). 
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Patients with COPD are at increased risk of lung cancer (Papi, Casoni et al. 2004; 
Young and Hopkins 2010) and evidence suggests that the SASP can promote malignant 
transformation and progression (Krtolica, Parrinello et al. 2001). Therefore, suppression 
of the SASP could be therapeutically beneficial, not only by reducing inflammatory 
processes that promote progressive lung decline in COPD, but by potentially decreasing 
incidences of lung cancer in patients with COPD.  
Collectively, our data suggest that telomere dysfunction increases in large and 
small airway epithelial cells during normal ageing and in conditions of cigarette smoke-
induced accelerated lung ageing, which may be independent of telomere length. Our 
data proposes that telomere dysfunction may contribute to changes in lung architecture 
and the pro-inflammatory environment that occurs during lung ageing and in COPD. 
Hence, TAF may be more robust markers for senescence and indicators of accelerated 
lung ageing following cigarette smoke exposure. It is possible that TAF could be used 
as markers to predict susceptibility to developing COPD in smokers, to stratify and 
predict disease severity in existing COPD patients and to also predict the efficacy of a 
certain therapy for COPD. Our data suggest a causal link between ROS, activation of a 
DDR at telomeres and the pro-inflammatory phenotype characteristic of senescence 
(Figure 6.1). However, the mechanisms underlying cigarette smoke-induced telomere 
dysfunction are still unclear and may involve altered mTOR signalling and 
mitochondrial dysfunction. Further work is required to elucidate the role of mTOR 
signalling and mitochondrial function in COPD. Targeting of senescent cells may be of 
therapeutic benefit for patients with COPD, which is currently an incurable disease. 
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Table 6.1 Comparisons between γH2A.X foci and γH2A.X foci co-localised with 
telomeres in a range of systems. Changes in γH2A.X foci compared to changes in 
telomere-associated foci (TAF) in treated/COPD as compared to untreated/control 
group.  
 





Figure 6.1 Potential links between reactive oxygen species, activation of a 
permanent DNA damage response at telomeres and induction of senescence in 
development of COPD. Activation of a persistent DNA damage response (DDR) at 
telomeres may be driven by time and/or cigarette smoke exposure. Persistent DDR 
signalling at telomeres may contribute to the loss of cellular regenerative capacity and 
pro-inflammatory conditions that occur in the lung with physiological ageing and in the 
context of COPD. Mechanisms independent of a telomeric DDR may also be 
contributing to the development of senescence in the context of cigarette smoke 
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